Funders › NY › The Leona M and Harry B Helmsley Charitable Trust › 2021
Grants paid by The Leona M and Harry B Helmsley Charitable Trust, tax year 2021
EIN 13-7184401 · New York, NY · Form 990-PF, Part XV · NTEE T20
In tax year 2021, The Leona M and Harry B Helmsley Charitable Trust (EIN 13-7184401) reported 559 grants paid totaling $262,300,602. Dataset version 2026.09.0, built 2026-09-03.
Every grant, 2021 · page 1 of 2
| Tax year | Recipient | Match | Amount | Type | Purpose | Source filing |
|---|---|---|---|---|---|---|
| 2021 | Engineering Ministries International USA Colorado Springs, CO | C | $7,020,410 | approved, future | ALASKA WASH PROJECT | 202240409349100404 |
| 2021 | Regents of the University of Minnesota Minneapolis, MN | U | $6,779,053 | approved, future | REDEFINING THE FUTURE OF EMERGENCY MEDICINE | 202240409349100404 |
| 2021 | Engineering Ministries International USA Colorado Springs, CO | C | $6,733,535 | paid | ALASKA WASH PROJECT | 202240409349100404 |
| 2021 | Engineering Ministries International USA Colorado Springs, CO | C | $6,680,429 | approved, future | ALASKA WASH PROJECT | 202240409349100404 |
| 2021 | Nebraska Department of Health & Human Services Lincoln, NE | U | $5,608,814 | approved, future | NEBRASKA FIRST RESPONDER AED PROJECT | 202240409349100404 |
| 2021 | Jerusalem College of Technology Jerusalem | U | $5,465,000 | approved, future | HELMSLEY FACULTY OF LIFE AND HEALTH SCIENCES BUILDING | 202240409349100404 |
| 2021 | Iowa Department of Public Health Des Moines, IA | U | $5,283,804 | approved, future | IOWA FIRST RESPONDER AED INITIATIVE | 202240409349100404 |
| 2021 | Helmholtz Zentrum Munchen (gmbh) Neuherberg | U | $5,085,075 | approved, future | IDENTIFICATION OF INFANTS WITH HIGH RISK OF T1D - PRIMARY PREVENTION | 202240409349100404 |
| 2021 | Clalit Health Services Tel Aviv | U | $5,000,000 | paid | COVID-19 PANDEMIC RESPONSE | 202240409349100404 |
| 2021 | Avera Mckennan Hospital and University Health Center Sioux Falls, SD | U | $5,000,000 | paid | AVERA BEHAVIORAL HEALTH CENTER EXPANSION | 202240409349100404 |
| 2021 | Iowa Department of Public Health Des Moines, IA | U | $4,586,841 | paid | IOWA FIRST RESPONDER AED INITIATIVE | 202240409349100404 |
| 2021 | Regents of the University of Minnesota Minneapolis, MN | U | $4,220,398 | paid | REDEFINING THE FUTURE OF EMERGENCY MEDICINE | 202240409349100404 |
| 2021 | Kmr Advancement of Medical Centers Ltd Haifa | U | $4,019,770 | paid | ESTABLISHMENT OF THE HEALTH DISCOVERY TOWER | 202240409349100404 |
| 2021 | Clalit Health Services Tel Aviv | U | $3,847,500 | approved, future | YOSEFTAL HOSPITAL ADDITION | 202240409349100404 |
| 2021 | University of Iowa Iowa City, IA | U | $3,770,195 | paid | SIMULATION IN MOTION IOWA (SIM-IA) | 202240409349100404 |
| 2021 | Wyoming Department of Health Cheyenne, WY | U | $3,731,196 | paid | WYOMING FIRST RESPONDER AED PROJECT | 202240409349100404 |
| 2021 | T1d Exchange Inc Boston, MA | U | $3,686,424 | approved, future | DATA TO IMPROVE QUALITY AND OUTCOMES FOR INDIVIDUALS WITH T1D | 202240409349100404 |
| 2021 | Helmholtz Zentrum Munchen (gmbh) Neuherberg | U | $3,500,407 | paid | IDENTIFICATION OF INFANTS WITH HIGH RISK OF T1D - PRIMARY PREVENTION | 202240409349100404 |
| 2021 | Indiana University (ampath Project) Indianapolis, ID | U | $3,474,440 | approved, future | AMPATH MODEL REPLICATION IN GHANA | 202240409349100404 |
| 2021 | T1d Exchange Inc Boston, MA | U | $3,386,424 | paid | DATA APPROACH TO IMPROVE QUALITY AND OUTCOMES FOR T1D | 202240409349100404 |
| 2021 | Helmholtz Zentrum Munchen (gmbh) Neuherberg | U | $3,337,054 | approved, future | THE GPPAD-03 STUDY: THE PRIMARY ORAL INSULIN TRIAL | 202240409349100404 |
| 2021 | Helmholtz Zentrum Munchen (gmbh) Neuherberg | U | $3,337,054 | approved, future | THE GPPAD-03 STUDY: THE PRIMARY ORAL INSULIN TRIAL | 202240409349100404 |
| 2021 | Helmholtz Zentrum Munchen (gmbh) Neuherberg | U | $3,166,777 | paid | THE GPPAD-03 STUDY: THE PRIMARY ORAL INSULIN TRIAL | 202240409349100404 |
| 2021 | Helmholtz Zentrum Munchen (gmbh) Neuherberg | U | $3,131,887 | paid | THE GPPAD-03 STUDY: THE PRIMARY ORAL INSULIN TRIAL | 202240409349100404 |
| 2021 | Clalit Health Services Tel Aviv | U | $3,131,101 | paid | PEDIATRIC REHAB DEPT AND HYDROTHERAPY POOLS | 202240409349100404 |
| 2021 | Helmholtz Zentrum Munchen (gmbh) Neuherberg | U | $3,075,103 | paid | IDENTIFICATION OF INFANTS WITH HIGH RISK OF T1D - PRIMARY PREVENTION | 202240409349100404 |
| 2021 | Brigham and Women's Hospital Boston, MA | C | $3,031,033 | approved, future | GLOBAL PARTNERSHIP TO ACHIEVE UNIVERSAL ACCESS FOR T1D AND NCDS | 202240409349100404 |
| 2021 | South Dakota Parks & Wildlife Foundation Pierre, SD | B | $3,000,000 | approved, future | CUSTER STATE PARK BISON CENTER | 202240409349100404 |
| 2021 | The Broad Institute Inc Cambridge, MA | B | $3,000,000 | approved, future | NOVEL THERAPEUTIC APPROACHES FOR CROHN'S DISEASE | 202240409349100404 |
| 2021 | Avera Mckennan Hospital and University Health Center Sioux Falls, SD | U | $3,000,000 | approved, future | AVERA BEHAVIORAL HEALTH CENTER EXPANSION | 202240409349100404 |
| 2021 | Kmr Advancement of Medical Centers Ltd Haifa | U | $2,950,750 | approved, future | ESTABLISHMENT OF THE HEALTH DISCOVERY TOWER | 202240409349100404 |
| 2021 | Partners in Health a Nonprofit Corporation Boston, MA | C | $2,950,411 | paid | UNIVERSAL ACCESS TO TYPE 1 DIABETES CARE | 202240409349100404 |
| 2021 | Sapir Academic College Shaar Hanegev | U | $2,908,773 | paid | MECHINA COLLEGE PREPARATORY COMPLEX - RENOVATION & CONSTRUCTION | 202240409349100404 |
| 2021 | Jerusalem College of Technology Jerusalem | U | $2,859,000 | approved, future | HELMSLEY FACULTY OF LIFE AND HEALTH SCIENCES BUILDING | 202240409349100404 |
| 2021 | Wateraid America Inc New York, NY | B | $2,839,148 | approved, future | CREATING A NEW REALITY FOR WASH IN HEALTHCARE FACILITIES IN ZAMBIA | 202240409349100404 |
| 2021 | A Glimmer of Hope Foundation Austin, TX | C | $2,783,559 | paid | INTEGRATED COMMUNITY DEVELOPMENT IN ODA BULTUM, ETHIOPIA | 202240409349100404 |
| 2021 | Catholic Relief Services-Usccb Baltimore, MD | C | $2,752,636 | approved, future | COMMUNITY RECOVERY AND RESILIENCE IN EASTERN ETHIOPIA | 202240409349100404 |
| 2021 | Helmholtz Zentrum Munchen (gmbh) Neuherberg | U | $2,705,330 | approved, future | THE GPPAD-03 STUDY: THE PRIMARY ORAL INSULIN TRIAL | 202240409349100404 |
| 2021 | Diabetes Nsw Sydney | U | $2,602,266 | paid | ENHANCE CAPACITY TO EXPAND THE EVIDENCE BASE ON DIABETES | 202240409349100404 |
| 2021 | Catholic Relief Services-Usccb Baltimore, MD | C | $2,589,304 | approved, future | INTEGRATED COMMUNITY WATER, SANITATION AND HYGIENE IMPROVEMENT | 202240409349100404 |
| 2021 | A Glimmer of Hope Foundation Austin, TX | C | $2,579,190 | approved, future | INTEGRATED COMMUNITY DEVELOPMENT IN ODA BULTUM, ETHIOPIA | 202240409349100404 |
| 2021 | Schwartzreisman Science Education Center Rehovot | U | $2,540,089 | approved, future | THE HELMSLEY CAMPUS FOR SCIENCE EDUCATION IN NETIVOT | 202240409349100404 |
| 2021 | Catholic Relief Services-Usccb Baltimore, MD | C | $2,500,993 | paid | INTEGRATED COMMUNITY WATER, SANITATION AND HYGIENE IMPROVEMENT | 202240409349100404 |
| 2021 | Agricultural Research Organization Rishon Letsiyon | U | $2,500,000 | paid | THE HELMSLEY CENTER FOR AI IN AGRICULTURE AT THE VOLCANI CENTER | 202240409349100404 |
| 2021 | Geoscience Australia Symonston | U | $2,500,000 | paid | DIGITAL EARTH AFRICA: PHASE 2 (OPERATIONAL BUILD) | 202240409349100404 |
| 2021 | University of Iowa Iowa City, IA | U | $2,470,869 | approved, future | SIMULATION IN MOTION IOWA (SIM-IA) | 202240409349100404 |
| 2021 | Helmholtz Zentrum Munchen (gmbh) Neuherberg | U | $2,451,335 | approved, future | CONTINUATION OF THE GPPAD-02-STUDY | 202240409349100404 |
| 2021 | Helmholtz Zentrum Munchen (gmbh) Neuherberg | U | $2,451,335 | approved, future | CONTINUATION OF THE GPPAD-02-STUDY | 202240409349100404 |
| 2021 | Helmholtz Zentrum Munchen (gmbh) Neuherberg | U | $2,440,023 | approved, future | CONTINUATION OF THE GPPAD-02-STUDY | 202240409349100404 |
| 2021 | Helmholtz Zentrum Munchen (gmbh) Neuherberg | U | $2,428,367 | approved, future | CONTINUATION OF THE GPPAD-02-STUDY | 202240409349100404 |
| 2021 | Helmholtz Zentrum Munchen (gmbh) Neuherberg | U | $2,428,367 | approved, future | CONTINUATION OF THE GPPAD-02-STUDY | 202240409349100404 |
| 2021 | Sos Children's Villages-USA Inc Washington, DC | C | $2,401,776 | approved, future | EDUCARE 4.0: DEBRE TABOR AND GONDAR CITY, ETHIOPIA | 202240409349100404 |
| 2021 | The Baruch Padeh Medical Center Poriya Tiberias | U | $2,321,666 | approved, future | CONSTRUCTION OF THE 12-BED INTENSIVE CARE AND RESPIRATION UNIT | 202240409349100404 |
| 2021 | Jaeb Center for Health Research Foundation Inc Tampa, FL | C | $2,265,996 | paid | VIRTUAL DIABETES SPECIALTY CLINIC STUDY EVALUATING REMOTE CGM | 202240409349100404 |
| 2021 | Helmholtz Zentrum Munchen (gmbh) Neuherberg | U | $2,234,555 | approved, future | THE GPPAD-03 STUDY: THE PRIMARY ORAL INSULIN TRIAL | 202240409349100404 |
| 2021 | Helmholtz Zentrum Munchen (gmbh) Neuherberg | U | $2,234,554 | approved, future | THE GPPAD-03 STUDY: THE PRIMARY ORAL INSULIN TRIAL | 202240409349100404 |
| 2021 | Catholic Relief Services-Usccb Baltimore, MD | C | $2,224,121 | paid | RURAL EMERGENCY HEALTH SERVICE AND TRANSPORT FOR DEVELOPMENT | 202240409349100404 |
| 2021 | Stanford University Stanford, CA | C | $2,203,369 | paid | EXPANSION & EVALUATION OF ECHO FOR PEOPLE WITH DIABETES ON IIT | 202240409349100404 |
| 2021 | Helmholtz Zentrum Munchen (gmbh) Neuherberg | U | $2,200,346 | approved, future | THE GPPAD-03 STUDY: THE PRIMARY ORAL INSULIN TRIAL | 202240409349100404 |
| 2021 | Helmholtz Zentrum Munchen (gmbh) Neuherberg | U | $2,200,346 | approved, future | THE GPPAD-03 STUDY: THE PRIMARY ORAL INSULIN TRIAL | 202240409349100404 |
| 2021 | Galilee Medical Center Naharyia | U | $2,200,000 | approved, future | RENOVATION OF TWO FLOORS OF THE INTERNAL MEDICINE BUILDING | 202240409349100404 |
| 2021 | Galilee Medical Center Naharyia | U | $2,200,000 | approved, future | RENOVATION OF TWO FLOORS OF THE INTERNAL MEDICINE BUILDING | 202240409349100404 |
| 2021 | Wateraid America Inc New York, NY | B | $2,166,773 | approved, future | CREATING A NEW REALITY FOR WASH IN HEALTHCARE FACILITIES IN ZAMBIA | 202240409349100404 |
| 2021 | Sos Children's Villages-USA Inc Washington, DC | C | $2,111,648 | paid | EDUCARE 4.0: DEBRE TABOR AND GONDAR CITY, ETHIOPIA | 202240409349100404 |
| 2021 | Clalit Health Services Tel Aviv | U | $2,058,214 | approved, future | YOSEFTAL HOSPITAL ADDITION | 202240409349100404 |
| 2021 | Catholic Relief Services-Usccb Baltimore, MD | C | $2,045,026 | approved, future | IMPROVED WASH INFRASTRUCTURE & SERVICES | 202240409349100404 |
| 2021 | Amici Di Adwa Onlus Cento Ferrara | U | $2,026,060 | paid | HOSPITAL FOR ADWA, ETHIOPIA IN TIGRAY REGION | 202240409349100404 |
| 2021 | The United Nations Institute for Training and Research Geneva | U | $2,000,000 | approved, future | ACCELERATING ACCESS: TREATMENT FOR NCDS LOW /MIDDLE-INCOME COUNTRIES | 202240409349100404 |
| 2021 | The Academic College at Tel-Hai Upper Galilee | U | $1,984,100 | paid | SCIENCE BUILDING FOR HEALTH, ENVIRONMENT, AND BIOTECH STUDIES | 202240409349100404 |
| 2021 | Schwartzreisman Science Education Center Rehovot | U | $1,982,305 | approved, future | THE HELMSLEY CAMPUS FOR SCIENCE EDUCATION IN NETIVOT | 202240409349100404 |
| 2021 | Wateraid America Inc New York, NY | B | $1,933,789 | paid | CREATING A NEW REALITY FOR WASH IN HEALTHCARE FACILITIES IN ZAMBIA | 202240409349100404 |
| 2021 | Bar Ilan University Ramat Gan | U | $1,836,200 | paid | EXPANDING AI RESEARCH AT BAR ILAN UNIVERSITY'S COMPUTER SCIENCE DEPT | 202240409349100404 |
| 2021 | American Heart Association Inc Dallas, TX | B | $1,835,938 | approved, future | MISSION: LIFELINE STROKE AND POST-ACUTE STROKE CARE STANDARDS | 202240409349100404 |
| 2021 | End Fund Inc New York, NY | B | $1,812,084 | paid | ADDRESSING TRACHOMA SURGERY GAPS IN ETHIOPIA | 202240409349100404 |
| 2021 | Catholic Relief Services-Usccb Baltimore, MD | C | $1,784,500 | paid | HELPING ZAMBIAN MOTHERS & NEWBORNS SURVIVE & THRIVE | 202240409349100404 |
| 2021 | United States African Development Foundation Washington, DC | U | $1,779,762 | approved, future | LIVELIHOOD IMPROVEMENT PROGRAM | 202240409349100404 |
| 2021 | Living Water International Stafford, NY | U | $1,775,354 | paid | INTEGRATED WASH PROGRAM IN CHIPATA DISTRICT, ZAMBIA | 202240409349100404 |
| 2021 | The Weizmann Institute of Science Rehovot | D | $1,750,000 | approved, future | THE QUANTUM MATERIALS DEVICES FABRICATION LAB | 202240409349100404 |
| 2021 | National Park Foundation Washington, DC | B | $1,750,000 | approved, future | LITTLE BIGHORN BATTLEFIELD NATIONAL MONUMENT VISITOR CENTER | 202240409349100404 |
| 2021 | Helmholtz Zentrum Munchen (gmbh) Neuherberg | U | $1,744,911 | paid | IDENTIFICATION OF INFANTS WITH HIGH RISK OF T1D - PRIMARY PREVENTION | 202240409349100404 |
| 2021 | American Heart Association Inc Dallas, TX | B | $1,654,728 | approved, future | MISSION: LIFELINE STROKE AND POST-ACUTE STROKE CARE QUALITY STANDARDS | 202240409349100404 |
| 2021 | Health Finance Institute Arlington, VA | C | $1,633,848 | approved, future | CATALYZE FINANCE & PARTNERS TO ADDRESS GLOBAL BURDEN OF CHRONIC DISEASE | 202240409349100404 |
| 2021 | Association for the Community in Ramat Hanegev Ramat Hanegev | U | $1,620,172 | paid | RAMAT HANEGEV REGIONAL COUNCIL MEDICAL CENTER | 202240409349100404 |
| 2021 | Catholic Relief Services-Usccb Baltimore, MD | C | $1,597,757 | approved, future | RURAL EMERGENCY HEALTH SERVICE AND TRANSPORT FOR DEVELOPMENT | 202240409349100404 |
| 2021 | Agricultural Research Organization Rishon Letsiyon | U | $1,591,900 | approved, future | THE HELMSLEY CENTER FOR AI IN AGRICULTURE AT THE VOLCANI CENTER | 202240409349100404 |
| 2021 | Barzilai Medical Center Ashkelon | U | $1,586,700 | approved, future | BUILD-OUT OF NEW FORTIFIED SURGICAL DEPARTMENT | 202240409349100404 |
| 2021 | The Sderot Development Foundation Sderot | U | $1,558,573 | approved, future | SDEROT MEDICAL CENTER | 202240409349100404 |
| 2021 | Catholic Relief Services-Usccb Baltimore, MD | C | $1,556,214 | approved, future | INTEGRATED COMMUNITY WATER, SANITATION AND HYGIENE IMPROVEMENT | 202240409349100404 |
| 2021 | Partners in Health a Nonprofit Corporation Boston, MA | C | $1,544,914 | approved, future | GLOBAL PARTNERSHIP TO ACHIEVE UNIVERSAL ACCESS FOR T1D AND NCDS | 202240409349100404 |
| 2021 | Brigham and Women's Hospital Boston, MA | C | $1,544,914 | approved, future | GLOBAL PARTNERSHIP TO ACHIEVE UNIVERSAL ACCESS FOR T1D AND NCDS | 202240409349100404 |
| 2021 | Barzilai Medical Center Ashkelon | U | $1,519,500 | approved, future | BUILD-OUT OF NEW FORTIFIED SURGICAL DEPARTMENT | 202240409349100404 |
| 2021 | Ziv Medical Center Zefat | U | $1,503,124 | approved, future | REINFORCE CRUCIAL SITES DURING EMERGENCIES | 202240409349100404 |
| 2021 | Children's Mercy Hospital Kansas City, MO | B | $1,500,000 | paid | TYPE 1 DIABETES RAPID LEARNING LAB | 202240409349100404 |
| 2021 | The Broad Institute Inc Cambridge, MA | B | $1,500,000 | approved, future | NOVEL THERAPEUTIC APPROACHES FOR CROHN'S DISEASE | 202240409349100404 |
| 2021 | Avera Mckennan Hospital and University Health Center Sioux Falls, SD | U | $1,500,000 | approved, future | AVERA BEHAVIORAL HEALTH CENTER EXPANSION | 202240409349100404 |
| 2021 | The Broad Institute Inc Cambridge, MA | B | $1,500,000 | approved, future | NOVEL THERAPEUTIC APPROACHES FOR CROHN'S DISEASE | 202240409349100404 |
| 2021 | The Broad Institute Inc Cambridge, MA | B | $1,500,000 | approved, future | NOVEL THERAPEUTIC APPROACHES FOR CROHN'S DISEASE | 202240409349100404 |
| 2021 | Avera Mckennan Hospital and University Health Center Sioux Falls, SD | U | $1,500,000 | approved, future | AVERA BEHAVIORAL HEALTH CENTER EXPANSION | 202240409349100404 |
| 2021 | The Broad Institute Inc Cambridge, MA | B | $1,500,000 | approved, future | NOVEL THERAPEUTIC APPROACHES FOR CROHN'S DISEASE | 202240409349100404 |
| 2021 | Ariel University Ariel | U | $1,497,915 | paid | THE ARIEL UNIVERSITY REGIONAL MEDICAL CENTER BUILDING | 202240409349100404 |
| 2021 | University of Nebraska Foundation Lincoln, NE | C | $1,496,078 | paid | NEBRASKA COVID-19 CARDIAC PREPAREDNESS AND SIMULATION IN MOTION | 202240409349100404 |
| 2021 | Seattle Children's Hospital Seattle, WA | U | $1,487,551 | paid | DEVELOPMENT OF ANTIGEN-SPECIFIC ETREG THERAPY IN T1D | 202240409349100404 |
| 2021 | Synergos Institute Inc New York, NY | B | $1,485,316 | approved, future | IMPROVING LIVES AND LIVELIHOODS OF SMALLHOLDER FARMERS | 202240409349100404 |
| 2021 | Synergos Institute Inc New York, NY | B | $1,485,316 | paid | IMPROVING LIVES AND LIVELIHOODS OF SMALLHOLDER FARMERS | 202240409349100404 |
| 2021 | Helmholtz Zentrum Munchen (gmbh) Neuherberg | U | $1,482,901 | approved, future | SUPPLEMENTATION WITH B. INFANTIS FOR MITIGATION OF T1D AUTOIMMUNITY | 202240409349100404 |
| 2021 | Helmholtz Zentrum Munchen (gmbh) Neuherberg | U | $1,482,900 | approved, future | SUPPLEMENTATION WITH B. INFANTIS FOR MITIGATION OF T1D AUTOIMMUNITY | 202240409349100404 |
| 2021 | Katholieke Universiteit Leuven Leuven | U | $1,467,112 | paid | INNODIA - CONTINUED SUPPORT | 202240409349100404 |
| 2021 | Helmholtz Zentrum Munchen (gmbh) Neuherberg | U | $1,454,620 | approved, future | SUPPLEMENTATION WITH B. INFANTIS FOR MITIGATION OF T1D AUTOIMMUNITY | 202240409349100404 |
| 2021 | Helmholtz Zentrum Munchen (gmbh) Neuherberg | U | $1,454,619 | approved, future | SUPPLEMENTATION WITH B. INFANTIS FOR MITIGATION OF T1D AUTOIMMUNITY | 202240409349100404 |
| 2021 | United States African Development Foundation Washington, DC | U | $1,436,892 | paid | LIVELIHOOD IMPROVEMENT PROGRAM | 202240409349100404 |
| 2021 | Southcentral Foundation Anchorage, AK | B | $1,425,805 | approved, future | FWWI NU'IJU TRANSFORMATIONAL LIVING COMMUNITY PROGRAM | 202240409349100404 |
| 2021 | Children's Mercy Hospital Kansas City, MO | B | $1,425,523 | paid | TYPE 1 DIABETES RAPID LEARNING LAB | 202240409349100404 |
| 2021 | The Weizmann Institute of Science Rehovot | D | $1,421,110 | approved, future | PERSONALIZED NUTRITIONAL, MICROBIOME AND HOST PATTERNS IN CROHN'S | 202240409349100404 |
| 2021 | The Sderot Development Foundation Sderot | U | $1,415,714 | paid | RESILIENCE COMPLEX, RESILIENCE CENTER AND PARENTHOOD HOUSE | 202240409349100404 |
| 2021 | The Regents of the University of New Mexico Albuquerque, NM | U | $1,413,438 | approved, future | THE ECHO INSTITUTE: REPLICATION OF THE ECHO MODEL | 202240409349100404 |
| 2021 | King's College London London | U | $1,413,293 | paid | MULTIPEPT1DE PROOF-OF-CONCEPT STUDY: STAGE III | 202240409349100404 |
| 2021 | Helmholtz Zentrum Munchen (gmbh) Neuherberg | U | $1,410,856 | approved, future | SUPPLEMENTATION WITH B. INFANTIS FOR MITIGATION OF T1D AUTOIMMUNITY | 202240409349100404 |
| 2021 | Helmholtz Zentrum Munchen (gmbh) Neuherberg | U | $1,410,856 | approved, future | SUPPLEMENTATION WITH B. INFANTIS FOR MITIGATION OF T1D AUTOIMMUNITY | 202240409349100404 |
| 2021 | Clalit Health Services Tel Aviv | U | $1,405,714 | approved, future | KIRYAT SHMONA MEDICAL CLINIC | 202240409349100404 |
| 2021 | National Park Foundation Washington, DC | B | $1,400,000 | approved, future | LITTLE BIGHORN BATTLEFIELD NATIONAL MONUMENT VISITOR CENTER | 202240409349100404 |
| 2021 | Children's Mercy Hospital Kansas City, MO | B | $1,399,624 | approved, future | TYPE 1 DIABETES RAPID LEARNING LAB | 202240409349100404 |
| 2021 | Children's Mercy Hospital Kansas City, MO | B | $1,399,623 | approved, future | TYPE 1 DIABETES RAPID LEARNING LAB | 202240409349100404 |
| 2021 | Helen Keller International New York, NY | C | $1,398,422 | paid | IMPROVE HEALTH, NUTRITION AND LIVELIHOODS IN SISSILI PROVINCE | 202240409349100404 |
| 2021 | The Broad Institute Inc Cambridge, MA | B | $1,387,769 | paid | NOVEL THERAPEUTIC APPROACHES FOR CROHN'S DISEASE | 202240409349100404 |
| 2021 | Children's Mercy Hospital Kansas City, MO | B | $1,387,612 | approved, future | TYPE 1 DIABETES RAPID LEARNING LAB | 202240409349100404 |
| 2021 | Children's Mercy Hospital Kansas City, MO | B | $1,387,611 | approved, future | TYPE 1 DIABETES RAPID LEARNING LAB | 202240409349100404 |
| 2021 | Sos Children's Villages-USA Inc Washington, DC | C | $1,386,577 | approved, future | EDUCARE 4.0: DEBRE TABOR AND GONDAR CITY, ETHIOPIA | 202240409349100404 |
| 2021 | New Venture Fund Washington, DC | B | $1,375,225 | paid | TYPE 1 DIABETES CAMPS PROJECT (2019-2021) | 202240409349100404 |
| 2021 | Living Water International Stafford, CT | U | $1,369,113 | approved, future | INTEGRATED WASH PROGRAM IN CHIPATA DISTRICT, ZAMBIA | 202240409349100404 |
| 2021 | Avera Health Sioux Falls, SD | B | $1,354,776 | paid | TELEHEALTH EDUCATION PROGRAM | 202240409349100404 |
| 2021 | Avera Health Sioux Falls, SD | B | $1,346,286 | approved, future | TELEHEALTH EDUCATION PROGRAM | 202240409349100404 |
| 2021 | Jdrf Australia Sydney | U | $1,345,269 | paid | ENDIA FOLLOW UP 2020-2022 | 202240409349100404 |
| 2021 | Catholic Relief Services-Usccb Baltimore, MD | C | $1,344,542 | approved, future | RURAL EMERGENCY HEALTH SERVICE AND TRANSPORT | 202240409349100404 |
| 2021 | American Heart Association Inc Dallas, TX | B | $1,344,150 | paid | MISSION: LIFELINE STROKE AND POST-ACUTE STROKE CARE QUALITY STANDARDS | 202240409349100404 |
| 2021 | Helmholtz Zentrum Munchen (gmbh) Neuherberg | U | $1,339,873 | approved, future | SUPPLEMENTATION WITH B. INFANTIS FOR MITIGATION OF T1D AUTOIMMUNITY | 202240409349100404 |
| 2021 | Helmholtz Zentrum Munchen (gmbh) Neuherberg | U | $1,339,873 | approved, future | SUPPLEMENTATION WITH B. INFANTIS FOR MITIGATION OF T1D AUTOIMMUNITY | 202240409349100404 |
| 2021 | Monash University Clayton | U | $1,328,837 | paid | DOSE OPTIMIZATION AND CLINICAL TESTING FOR IVERMECTIN | 202240409349100404 |
| 2021 | Brigham and Women's Hospital Boston, MA | C | $1,305,411 | paid | PASSIVE WIRELESS MONITORING TO PREDICT AND TRACK CROHN'S DISEASE | 202240409349100404 |
| 2021 | Helmholtz Zentrum Munchen (gmbh) Neuherberg | U | $1,301,918 | approved, future | SUPPLEMENTATION WITH B. INFANTIS FOR MITIGATION OF T1D AUTOIMMUNITY | 202240409349100404 |
| 2021 | Helmholtz Zentrum Munchen (gmbh) Neuherberg | U | $1,301,917 | approved, future | SUPPLEMENTATION WITH B. INFANTIS FOR MITIGATION OF T1D AUTOIMMUNITY | 202240409349100404 |
| 2021 | Stanford University Stanford, CA | C | $1,296,812 | approved, future | EXPANSION & EVALUATION OF ECHO FOR PEOPLE WITH DIABETES ON IIT | 202240409349100404 |
| 2021 | Stanford University Stanford, CA | C | $1,296,812 | approved, future | EXPANSION & EVALUATION OF ECHO FOR PEOPLE WITH DIABETES ON IIT | 202240409349100404 |
| 2021 | Sos Children's Villages-USA Inc Washington, DC | C | $1,292,968 | paid | EDUCATION & EMPOWERMENT IN DEBRE MARKOS & WOLDIYA, ETHIOPIA | 202240409349100404 |
| 2021 | United States African Development Foundation Washington, DC | U | $1,283,255 | approved, future | LIVELIHOOD IMPROVEMENT PROGRAM | 202240409349100404 |
| 2021 | Helmholtz Zentrum Munchen (gmbh) Neuherberg | U | $1,277,602 | approved, future | SUPPLEMENTATION WITH B. INFANTIS FOR MITIGATION OF T1D AUTOIMMUNITY | 202240409349100404 |
| 2021 | Helmholtz Zentrum Munchen (gmbh) Neuherberg | U | $1,277,602 | approved, future | SUPPLEMENTATION WITH B. INFANTIS FOR MITIGATION OF T1D AUTOIMMUNITY | 202240409349100404 |
| 2021 | Avera Health Sioux Falls, SD | B | $1,252,083 | paid | ECARE TELE-PSYCHIATRY 24/7 CARE TEAM | 202240409349100404 |
| 2021 | Living Water International Stafford, TX | B | $1,251,684 | approved, future | INTEGRATED WASH PROGRAM IN CHIPATA DISTRICT, ZAMBIA | 202240409349100404 |
| 2021 | Seattle Children's Hospital Seattle, WA | U | $1,224,949 | approved, future | DEVELOPMENT OF ANTIGEN-SPECIFIC ETREG THERAPY IN T1D | 202240409349100404 |
| 2021 | University of Florida Gainesville, FL | U | $1,208,349 | paid | NETWORK FOR PANCREATIC ORGAN DONORS WITH T1D | 202240409349100404 |
| 2021 | Centracare Health System for the St Cloud Hospital St Cloud, MN | U | $1,200,000 | paid | EMPATH UNIT AT CENTRACARE HEALTH SYSTEM | 202240409349100404 |
| 2021 | University of Florida Gainesville, FL | U | $1,199,692 | approved, future | T1D RESEARCH: NETWORK FOR PANCREATIC ORGAN DONORS WITH T1D | 202240409349100404 |
| 2021 | University of Florida Gainesville, FL | U | $1,199,692 | approved, future | NETWORK FOR PANCREATIC ORGAN DONORS WITH T1D | 202240409349100404 |
| 2021 | The Regents of the University of New Mexico Albuquerque, NM | U | $1,188,238 | approved, future | THE ECHO INSTITUTE: REPLICATION OF THE ECHO MODEL | 202240409349100404 |
| 2021 | Jdrf Australia Sydney | U | $1,133,601 | approved, future | ENDIA FOLLOW UP 2020-2022 | 202240409349100404 |
| 2021 | Clalit Health Services Tel Aviv | U | $1,118,393 | approved, future | KIRYAT SHMONA MEDICAL CLINIC | 202240409349100404 |
| 2021 | South Dakota Broadcasters Association Pierre, SD | B | $1,110,000 | paid | COVID-19 PUBLIC AWARENESS AND BEHAVIOR | 202240409349100404 |
| 2021 | Parker Institute for Cancer Immunotherapy San Francisco, CA | B | $1,108,140 | approved, future | STUDYING AUTOIMMUNE T1D FOLLOWING CANCER IMMUNOTHERAPIES. | 202240409349100404 |
| 2021 | Parker Institute for Cancer Immunotherapy San Francisco, CA | B | $1,106,748 | paid | STUDYING AUTOIMMUNE T1D FOLLOWING CANCER IMMUNOTHERAPIES | 202240409349100404 |
| 2021 | Catholic Relief Services-Usccb Baltimore, MD | C | $1,105,829 | paid | BOUSSOUMA AND ZIGA, BURKINA FASO IMPROVED WASH INFRASTRUCTURE | 202240409349100404 |
| 2021 | Zefat Academic College Zefat | U | $1,103,914 | paid | EQUIPPING THE MEDICAL SIMULATION & TRAINING CENTER | 202240409349100404 |
| 2021 | Catholic Relief Services-Usccb Baltimore, MD | C | $1,100,098 | approved, future | HELPING ZAMBIAN MOTHERS & NEWBORNS SURVIVE & THRIVE | 202240409349100404 |
| 2021 | National Park Foundation Washington, DC | B | $1,100,000 | approved, future | BADLANDS NATIONAL PARK CEDAR PASS VISITOR CENTER | 202240409349100404 |
| 2021 | Stichting Health Action International Amsterdam | U | $1,099,311 | paid | SOLVING PROBLEMS OF INSULIN SOURCES AND SUPPLY STUDY | 202240409349100404 |
| 2021 | Clalit Health Services Tel Aviv | U | $1,094,286 | paid | YOSEFTAL HOSPITAL ADDITION | 202240409349100404 |
| 2021 | The Baruch Padeh Medical Center Poriya Tiberias | U | $1,077,334 | paid | CONSTRUCTION OF THE 12-BED INTENSIVE CARE AND RESPIRATION UNIT | 202240409349100404 |
| 2021 | Catholic Relief Services-Usccb Baltimore, MD | C | $1,066,649 | approved, future | HELPING ZAMBIAN MOTHERS & NEWBORNS SURVIVE & THRIVE | 202240409349100404 |
| 2021 | Synergos Institute Inc New York, NY | B | $1,063,518 | approved, future | IMPROVING LIVES AND LIVELIHOODS OF SMALLHOLDER FARMERS | 202240409349100404 |
| 2021 | King's College London London | U | $1,061,247 | approved, future | MULTIPEPT1DE PROOF-OF-CONCEPT STUDY: STAGE III | 202240409349100404 |
| 2021 | Ncd Alliance Geneva | U | $1,055,700 | approved, future | NCDS FIRST: DRIVING ADVOCACY, CHANGE, IMPROVING CARE | 202240409349100404 |
| 2021 | University of Florida Gainesville, FL | U | $1,043,638 | approved, future | HUMAN ATLAS NEONATAL DEVELOPMENTAL EARLY LIFE PANCREAS/IMMUNITY | 202240409349100404 |
| 2021 | American Heart Association Inc Dallas, TX | B | $1,034,941 | approved, future | MISSION: LIFELINE STROKE SYSTEM OF CARE IN NEBRASKA | 202240409349100404 |
| 2021 | University of Florida Gainesville, FL | U | $1,034,449 | approved, future | HUMAN ATLAS NEONATAL DEVELOPMENTAL EARLY LIFE PANCREAS/IMMUNITY | 202240409349100404 |
| 2021 | American Heart Association Inc Dallas, TX | B | $1,018,534 | paid | MISSION: LIFELINE STROKE SYSTEM OF CARE IN NEBRASKA | 202240409349100404 |
| 2021 | International Bowel Ultrasound Group Ev Munster | U | $1,016,631 | paid | THE DEVELOPMENT OF A DISEASE ACTIVITY INDEX FOR INTESTINAL ULTRASOUND | 202240409349100404 |
| 2021 | Ncd Alliance Geneva | U | $1,015,450 | approved, future | PUTTING PEOPLE WITH NCDS FIRST: ADVOCACY, CHANGE, IMPROVING CARE | 202240409349100404 |
| 2021 | Public Health Solutions New York, NY | B | $1,015,000 | paid | NEW YORK CITY COLLABORATIVE FOR HOMELESS HEALTHCARE | 202240409349100404 |
| 2021 | Tidepool Project Palo Alto, CA | B | $1,010,231 | paid | EXPANDING THE AVAILABILITY OF THE LOOP AID SYSTEM | 202240409349100404 |
| 2021 | The Sheba Fund for Health Services and Research Ramat Gan | U | $1,000,000 | paid | CRITICAL CORONA CARE INTENSIVE CARE UNIT | 202240409349100404 |
| 2021 | Shaare Zedek Medical Center Jerusalem | D | $1,000,000 | paid | COVID-19 EMERGENCY MEDICAL RESPONSE PROGRAM | 202240409349100404 |
| 2021 | Hadassah Medical Organization Jerusalem | U | $1,000,000 | paid | EQUIP A WARD TO TREAT VENTILATED & NON-VENTILATED COVID PATIENTS | 202240409349100404 |
| 2021 | The United Nations Institute for Training and Research Geneva | U | $1,000,000 | approved, future | ACCELERATING ACCESS: FOR NCDS IN LOW /MIDDLE-INCOME COUNTRIES. | 202240409349100404 |
| 2021 | Friends of Tel Aviv Sourasky Medical Center Inc New York, NY | U | $1,000,000 | paid | COMBATTING THE CORONAVIRUS PANDEMIC IN ISRAEL | 202240409349100404 |
| 2021 | Avera Mckennan Hospital and University Health Center Sioux Falls, SD | U | $1,000,000 | approved, future | AVERA BEHAVIORAL HEALTH CENTER EXPANSION | 202240409349100404 |
| 2021 | Adventist Health Systemsunbelt Inc Orlando, FL | C | $1,000,000 | paid | DETERMINING WHETHER AGONISTS MIGHT PREVENT HYPOGLYCEMIA IN T1D | 202240409349100404 |
| 2021 | Jaeb Center for Health Research Foundation Inc Tampa, FL | C | $1,000,000 | paid | VIRTUAL DIABETES CLINIC STUDY EVALUATING REMOTE INITIATION CGM | 202240409349100404 |
| 2021 | Global Solidarity Fund New York, NY | D | $1,000,000 | paid | CONSORTIUM TO MAXIMIZE SERVICES FOR REFUGEES, MIGRANTS & IDPS - ETHIOPIA | 202240409349100404 |
| 2021 | Rambam Health Corporation Haifa | D | $1,000,000 | paid | COVID 19 PANDEMIC RESPONSE | 202240409349100404 |
| 2021 | Jaeb Center for Health Research Foundation Inc Tampa, FL | C | $1,000,000 | paid | VIRTUAL DIABETES CLINIC STUDY EVALUATING REMOTE INITIATION CGM | 202240409349100404 |
| 2021 | South Dakota Parks & Wildlife Foundation Pierre, SD | B | $1,000,000 | paid | CUSTER STATE PARK BISON CENTER | 202240409349100404 |
| 2021 | University of Iowa Iowa City, IA | U | $999,877 | approved, future | SIMULATION IN MOTION IOWA (SIM-IA) | 202240409349100404 |
| 2021 | Synergos Institute Inc New York, NY | B | $998,553 | approved, future | IMPROVING LIVES AND LIVELIHOODS OF SMALLHOLDER FARMERS | 202240409349100404 |
| 2021 | New York University New York, NY | C | $969,747 | approved, future | IDENTIFYING ENVIRONMENTAL CONTRIBUTORS TO CROHN'S | 202240409349100404 |
| 2021 | Oregon Health & Science University Portland, OR | U | $967,386 | paid | THE IMPLEMENTATION OF NICH IN ANOTHER HEALTHCARE SYSTEM | 202240409349100404 |
| 2021 | Children's Hospital Corporation Boston, MA | C | $960,683 | paid | MOLECULAR + SPATIAL SINGLE-CELL REMODELING IN PEDIATRIC CROHN'S DISEASE | 202240409349100404 |
| 2021 | The Regents of the University of California at Irvine Irvine, CA | C | $945,841 | paid | DEVELOPMENT OF A MULTI-ANALYTE SENSOR FOR PEOPLE WITH T1D | 202240409349100404 |
| 2021 | Amc Medical Research Bv Amsterdam | U | $942,690 | approved, future | IDENTIFICATION OF BIOMARKERS FOR PERIANAL FISTULIZING DISEASE | 202240409349100404 |
| 2021 | International Water Management Institute Battaramulla | D | $942,226 | approved, future | WATER SECURE AFRICA INITIATIVE: OPEN DATA CUBE EXTENSION | 202240409349100404 |
| 2021 | Partners in Health a Nonprofit Corporation Boston, MA | C | $940,787 | approved, future | GLOBAL PARTNERSHIP TO ACHIEVE UNIVERSAL ACCESS FOR T1D AND NCDS | 202240409349100404 |
| 2021 | Brigham and Women's Hospital Boston, MA | C | $940,787 | approved, future | GLOBAL PARTNERSHIP TO ACHIEVE UNIVERSAL ACCESS FOR T1D AND NCDS | 202240409349100404 |
| 2021 | Clalit Health Services Tel Aviv | U | $919,309 | approved, future | CLINICAL TRIAL TO EVALUATE A NOVEL MDI-BGM DECISION SUPPORT SYSTEM | 202240409349100404 |
| 2021 | Clalit Health Services Tel Aviv | U | $919,308 | approved, future | CLINICAL TRIAL TO EVALUATE A NOVEL MDI-BGM DECISION SUPPORT SYSTEM | 202240409349100404 |
| 2021 | Australasian Gastro Intestinal Research Foundation Ltd Fitzroy | U | $907,233 | approved, future | FECAL MICROBIOTA TRANSPLANTATION IN CROHN'S DISEASE | 202240409349100404 |
| 2021 | Southcentral Foundation Anchorage, AK | B | $903,283 | approved, future | FWWI NU'IJU TRANSFORMATIONAL LIVING COMMUNITY PROGRAM | 202240409349100404 |
| 2021 | Billings Clinic Foundation Billings, MT | C | $898,186 | paid | MONTANA PSYCHIATRY RESIDENCY PROGRAM | 202240409349100404 |
| 2021 | Massachusetts General Hospital Boston, MA | C | $893,605 | paid | DEVELOP A DEVICE TO IMPROVE ROUTINE DISEASE MONITORING FOR CD. | 202240409349100404 |
| 2021 | Sage Bionetworks Seattle, WA | B | $888,278 | paid | IMPROVING SCIENTIFIC INSIGHTS THROUGH COMMUNITY-BASED RESEARCH | 202240409349100404 |
| 2021 | Wyoming State Parks and Cultural Resources Cheyenne, WY | U | $885,000 | approved, future | INTERPRETIVE CENTER AT FORT PHIL KEARNY STATE HISTORIC SITE | 202240409349100404 |
| 2021 | Jaeb Center for Health Research Foundation Inc Tampa, FL | C | $878,930 | approved, future | CGM MONITORING OF MATERNAL DYSGLYCEMIA | 202240409349100404 |
| 2021 | Helmholtz Zentrum Munchen (gmbh) Neuherberg | U | $870,315 | approved, future | GPPAD COORDINATION CENTER CONTINUATION | 202240409349100404 |
| 2021 | Helmholtz Zentrum Munchen (gmbh) Neuherberg | U | $870,314 | approved, future | GPPAD COORDINATION CENTER CONTINUATION | 202240409349100404 |
| 2021 | King's College London London | U | $858,213 | approved, future | MULTIPEPT1DE PROOF-OF-CONCEPT STUDY: STAGE III | 202240409349100404 |
| 2021 | Public Health Solutions New York, NY | B | $854,669 | paid | NEW YORK CITY FUND FOR YOUTH AND FAMILY HOMELESSNESS | 202240409349100404 |
| 2021 | The Regents of the University of California at Irvine Irvine, CA | C | $851,633 | approved, future | DEVELOPMENT OF A MULTI-ANALYTE SENSOR FOR PEOPLE WITH T1D | 202240409349100404 |
| 2021 | Ezrath Nashim Sarah Herzog Memorial Hospital Jerusalem | U | $850,000 | paid | SUPPORT FOR NEW COMPREHENSIVE REHABILITATION CENTER | 202240409349100404 |
| 2021 | Helmholtz Zentrum Munchen (gmbh) Neuherberg | U | $847,748 | approved, future | GPPAD COORDINATION CENTER CONTINUATION | 202240409349100404 |
| 2021 | Helmholtz Zentrum Munchen (gmbh) Neuherberg | U | $847,748 | approved, future | GPPAD COORDINATION CENTER CONTINUATION | 202240409349100404 |
| 2021 | Massachusetts General Hospital Boston, MA | C | $843,986 | approved, future | DEVELOP A DEVICE TO IMPROVE ROUTINE DISEASE MONITORING FOR CD | 202240409349100404 |
| 2021 | The Regents of the University of California at Irvine Irvine, CA | C | $837,543 | approved, future | DEVELOPMENT OF A MULTI-ANALYTE SENSOR FOR PEOPLE WITH T1D | 202240409349100404 |
| 2021 | The Regents of the University of California at Irvine Irvine, CA | C | $837,542 | approved, future | DEVELOPMENT OF A MULTI-ANALYTE SENSOR FOR PEOPLE WITH T1D | 202240409349100404 |
| 2021 | Stanford University Stanford, CA | C | $836,979 | approved, future | INVESTIGATING THE ROLE OF THE HUMAN EXPOSOME IN CROHN'S | 202240409349100404 |
| 2021 | Amc Medical Research Bv Amsterdam | U | $835,601 | paid | IDENTIFICATION OF BIOMARKERS FOR PERIANAL FISTULIZING DISEASE | 202240409349100404 |
| 2021 | Catholic Relief Services-Usccb Baltimore, MD | C | $835,103 | paid | FOOD FOR ALL - ETHIOPIA 2.0 | 202240409349100404 |
| 2021 | Helmholtz Zentrum Munchen (gmbh) Neuherberg | U | $830,769 | approved, future | GPPAD COORDINATION CENTER CONTINUATION | 202240409349100404 |
| 2021 | Helmholtz Zentrum Munchen (gmbh) Neuherberg | U | $830,769 | approved, future | GPPAD COORDINATION CENTER CONTINUATION | 202240409349100404 |
| 2021 | Stichting Pharmaccess International Amsterdam | U | $822,634 | paid | IMPROVING MEDICINE QUALITY THROUGH DIGITAL PROCUREMENT | 202240409349100404 |
| 2021 | Southcentral Foundation Anchorage, AK | B | $818,171 | approved, future | FWWI NU'IJU TRANSFORMATIONAL LIVING COMMUNITY PROGRAM | 202240409349100404 |
| 2021 | Stanford University Stanford, CA | C | $817,475 | approved, future | INCREASING DIABETES DEVICE UPTAKE IN PEOPLE DIABETES | 202240409349100404 |
| 2021 | King's College London London | U | $797,447 | approved, future | MULTIPEPT1DE PROOF-OF-CONCEPT STUDY: STAGE III | 202240409349100404 |
| 2021 | The Massachusetts General Hospital Boston, MA | C | $794,394 | paid | TETHERED CAPSULE ENDOMICROSCOPY VISUALIZATION OF THE CROHN'S BOWEL WALL | 202240409349100404 |
| 2021 | Shaare Zedek Medical Center Jerusalem | D | $791,105 | approved, future | EQUIPMENT PURCHASES FOR THE NEW RADIOTHERAPY CENTER | 202240409349100404 |
| 2021 | The Weizmann Institute of Science Rehovot | D | $788,086 | paid | PERSONALIZED NUTRITIONAL, MICROBIOME AND HOST PATTERNS IN CROHN'S | 202240409349100404 |
| 2021 | The Weizmann Institute of Science Rehovot | D | $788,085 | paid | PERSONALIZED NUTRITIONAL, MICROBIOME AND HOST PATTERNS IN CROHN'S | 202240409349100404 |
| 2021 | Insulin for Life USA Inc Gainesville, FL | B | $784,533 | paid | DIABETES DEVICES FOR CLINICS IN THE U.S. DURING COVID-19 | 202240409349100404 |
| 2021 | International Bowel Ultrasound Group Ev Munster | U | $779,377 | approved, future | THE DEVELOPMENT OF A DISEASE INDEX FOR INTESTINAL ULTRASOUND | 202240409349100404 |
| 2021 | New York University New York, NY | C | $772,565 | approved, future | IDENTIFYING ENVIRONMENTAL CONTRIBUTORS TO CROHN'S DISEASE | 202240409349100404 |
| 2021 | Grand Canyon University Phoenix, AZ | U | $766,986 | approved, future | DEVELOPMENT OF A CONTINUOUS INSULIN-GLUCOSE SENSOR | 202240409349100404 |
| 2021 | Health Finance Institute Arlington, VA | C | $761,650 | paid | CATALYZE FINANCE & PARTNERS TO ADDRESS BURDEN OF CHRONIC DISEASE | 202240409349100404 |
| 2021 | Stanford University Stanford, CA | C | $758,929 | approved, future | INVESTIGATING THE ROLE OF THE HUMAN EXPOSOME IN CROHN'S | 202240409349100404 |
| 2021 | T1d Exchange Inc Boston, MA | U | $752,710 | paid | DATA APPROACH TO IMPROVE QUALITY AND OUTCOMES FOR T1D | 202240409349100404 |
| 2021 | Massachusetts General Hospital Boston, MA | C | $752,326 | approved, future | DEVELOP A DEVICE TO IMPROVE ROUTINE DISEASE MONITORING FOR CD. | 202240409349100404 |
| 2021 | National Park Foundation Washington, DC | B | $750,000 | approved, future | BADLANDS NATIONAL PARK CEDAR PASS VISITOR CENTER | 202240409349100404 |
| 2021 | Catholic Relief Services-Usccb Baltimore, MD | C | $749,145 | approved, future | IMPROVED WASH INFRASTRUCTURE & SERVICES | 202240409349100404 |
| 2021 | University of Iowa Iowa City, IA | U | $748,244 | approved, future | SIMULATION IN MOTION IOWA (SIM-IA) | 202240409349100404 |
| 2021 | Aleh Negev for Rehabilitation and Development Ofakim | U | $746,031 | paid | CONSTRUCTION OF A NEW REHABILITATION HOSPITAL | 202240409349100404 |
| 2021 | Jaeb Center for Health Research Foundation Inc Tampa, FL | C | $724,198 | approved, future | VIRTUAL DIABETES CLINIC STUDY EVALUATING REMOTE INITIATION CGM | 202240409349100404 |
| 2021 | The Broad Institute Inc Cambridge, MA | B | $719,309 | approved, future | HUMAN COLON AND SMALL INTESTINE CELL ATLAS IN CROHN'S | 202240409349100404 |
| 2021 | International Bowel Ultrasound Group Ev Munster | U | $718,578 | approved, future | THE DEVELOPMENT OF A DISEASE ACTIVITY INDEX FOR INTESTINAL ULTRASOUND | 202240409349100404 |
| 2021 | The Sderot Development Foundation Sderot | U | $715,938 | paid | SDEROT MEDICAL CENTER | 202240409349100404 |
| 2021 | Stanford University Stanford, CA | C | $709,794 | paid | INVESTIGATING THE ROLE OF THE HUMAN EXPOSOME IN CROHN'S DISEASE | 202240409349100404 |
| 2021 | The University of Edinburgh Edinburgh | U | $708,833 | approved, future | MITOCHONDRIAL AS MECHANISTIC BIOMARKERS OF MUCOSAL INFLAMMATION | 202240409349100404 |
| 2021 | The Regents of the University of Colorado Denver Aurora, CO | D | $705,874 | approved, future | FEASIBILITY EVAL OF AID IN PRIMARY CARE AND THROUGH TELEHEALTH | 202240409349100404 |
| 2021 | Stanford University Stanford, CA | C | $704,175 | paid | DIABETESWISE-PRO: INCREASING DIABETES DEVICE UPTAKE | 202240409349100404 |
| 2021 | University of Melbourne Carlton | D | $703,827 | approved, future | ANIMAL AND CLINICAL EVALUATION OF A NOVEL CONTINUOUS KETONE SENSOR | 202240409349100404 |
| 2021 | King's College London London | U | $700,333 | approved, future | IDENTIFYING THE ROLE OF FOOD ADDITIVE EMULSIFIERS IN CROHN'S DISEASE | 202240409349100404 |
| 2021 | International Bowel Ultrasound Group Ev Munster | U | $693,935 | approved, future | THE DEVELOPMENT OF A DISEASE INDEX FOR INTESTINAL ULTRASOUND | 202240409349100404 |
| 2021 | Children's Hospital Medical Center Cincinnati, OH | B | $692,740 | approved, future | BIOMARKERS OF INTESTINAL FIBROSIS IN SMALL BOWEL CROHN'S DISEASE | 202240409349100404 |
| 2021 | Stanford University Stanford, CA | C | $690,953 | approved, future | INVESTIGATING THE ROLE OF THE HUMAN EXPOSOME IN CROHN'S | 202240409349100404 |
| 2021 | King's College London London | U | $683,167 | paid | MULTIPEPT1DE PROOF-OF-CONCEPT STUDY: STAGE II | 202240409349100404 |
| 2021 | University of North Carolina at Chapel Hill Chapel Hill, NC | B | $681,830 | approved, future | MONITORING COVID-19 VACCINE EFFECTIVENESS IN IBD PATIENTS | 202240409349100404 |
| 2021 | Jerusalem College of Technology Jerusalem | U | $676,000 | paid | HELMSLEY FACULTY OF LIFE AND HEALTH SCIENCES BUILDING | 202240409349100404 |
| 2021 | Grand Canyon University Phoenix, AZ | U | $673,774 | paid | DEVELOPMENT OF A CONTINUOUS INSULIN-GLUCOSE SENSOR | 202240409349100404 |
| 2021 | Catholic Relief Services-Usccb Baltimore, MD | C | $669,615 | paid | ADDRESSING MISSIONARIES OF CHARITY CRITICAL NEEDS | 202240409349100404 |
| 2021 | Helmholtz Zentrum Munchen (gmbh) Neuherberg | U | $668,907 | approved, future | GPPAD COORDINATION CENTER CONTINUATION | 202240409349100404 |
| 2021 | Helmholtz Zentrum Munchen (gmbh) Neuherberg | U | $668,906 | approved, future | GPPAD COORDINATION CENTER CONTINUATION | 202240409349100404 |
| 2021 | 4youandme Seattle, WA | U | $667,500 | paid | WEARABLES TO MEASURE STRESS AND FORECAST CROHN'S SYMPTOMS | 202240409349100404 |
| 2021 | Shaare Zedek Medical Center Jerusalem | D | $666,492 | approved, future | RCT OF TASTY & HEALTHY DIETARY APPROACH FOR REMISSION IN CROHN'S | 202240409349100404 |
| 2021 | The Weizmann Institute of Science Rehovot | D | $660,000 | approved, future | THE QUANTUM MATERIALS DEVICES FABRICATION LAB | 202240409349100404 |
| 2021 | Clalit Health Services Tel Aviv | U | $659,275 | paid | EMEK MEDICAL CENTER - NEW OPERATING SUITES | 202240409349100404 |
| 2021 | T1d Exchange Inc Boston, MA | U | $655,806 | paid | DATA APPROACH TO IMPROVE QUALITY AND OUTCOMES FOR T1D | 202240409349100404 |
| 2021 | Villages of Hope Africa Society Mississauga | D | $655,350 | paid | ZAMBIA DEVELOPMENT: FOOD PRODUCTION, WATER SUPPLY, EDUCATION | 202240409349100404 |
| 2021 | Aleh Negev for Rehabilitation and Development Ofakim | U | $638,318 | paid | CONSTRUCTION OF A NEW REHABILITATION HOSPITAL | 202240409349100404 |
| 2021 | University of Miami Coral Gables, FL | U | $637,761 | approved, future | A HOLISTIC DIET INTERVENTION FOR PEOPLE WITH CROHN'S DISEASE | 202240409349100404 |
| 2021 | Alimentiv Inc (fka Robarts) London | U | $636,012 | paid | STENOSIS THERAPY AND ANTI-FIBROTIC RESEARCH (STAR) CONSORTIUM | 202240409349100404 |
| 2021 | The Academic College at Tel-Hai Upper Galilee | U | $634,900 | approved, future | HELMSLEY SCIENCE BUILDING FOR HEALTH, ENVIRONMENT, AND BIOTECH | 202240409349100404 |
| 2021 | University of Oxford Oxford | U | $627,089 | approved, future | STUDY OF COVID-19 ANTIBODY RESPONSE UNDER IMMUNE SUPPRESSION | 202240409349100404 |
| 2021 | Sanford Research Sioux Fall, SD | C | $625,757 | approved, future | SANFORD PLEDGE: PHASES 1 AND 2 | 202240409349100404 |
| 2021 | Jaeb Center for Health Research Foundation Inc Tampa, FL | C | $625,000 | approved, future | EXERCISE IN DIABETES INITIATIVE: PEDIATRIC STUDY | 202240409349100404 |
| 2021 | Villages of Hope Africa Society Mississauga | D | $622,818 | approved, future | FOOD PRODUCTION, WATER SUPPLY, EDUCATION FACILITIES | 202240409349100404 |
| 2021 | Sanford Health Sioux Falls, SD | B | $620,895 | paid | SANFORD HEALTH COVID-19 CARDIAC PREPAREDNESS PROJECT | 202240409349100404 |
| 2021 | The Regents of the University of Colorado Denver Aurora, CO | D | $620,366 | paid | FEASIBILITY EVAL OF AID IN PRIMARY CARE AND THROUGH TELEHEALTH | 202240409349100404 |
| 2021 | World Vision Inc Federal Way, WA | B | $615,413 | paid | FLOOD MITIGATION AND COMMUNITY RESILIENCE PHASE 2 | 202240409349100404 |
| 2021 | The Sderot Development Foundation Sderot | U | $614,379 | approved, future | SDEROT MEDICAL CENTER | 202240409349100404 |
| 2021 | Simulation in Motion Montana Inc Helena, MT | B | $612,500 | paid | CAPACITY BUILDING TOWARD A SUSTAINABLE SIMULATION IN MOTION MONTANA | 202240409349100404 |
| 2021 | Amc Medical Research Bv Amsterdam | U | $610,817 | approved, future | IDENTIFICATION OF BIOMARKERS FOR PERIANAL FISTULIZING DISEASE | 202240409349100404 |
| 2021 | University of Oxford Oxford | U | $608,272 | paid | COVID-19 ANTIBODY RESPONSE UNDER SUSTAINED IMMUNE SUPPRESSION | 202240409349100404 |
| 2021 | Federal Institute of Technology Zurich Ethz Zurich | U | $608,166 | paid | SPHERE-SEQUENCING TO STUDY ABERRANT CELLULAR INTERACTIONS IN CROHN'S. | 202240409349100404 |
| 2021 | Schwartzreisman Science Education Center Rehovot Rehovot | U | $605,811 | paid | THE HELMSLEY CAMPUS FOR SCIENCE EDUCATION IN NETIVOT | 202240409349100404 |
| 2021 | Association of Diabetes Care & Education Specialists Chicago, IL | B | $600,000 | paid | AADE TECHNOLOGY INSTITUTE: DANA - DIABETES ADVANCED NETWORK ACCESS | 202240409349100404 |
| 2021 | Jaeb Center for Health Research Foundation Inc Tampa, FL | C | $600,000 | approved, future | EXERCISE IN DIABETES INITIATIVE: PEDIATRIC STUDY | 202240409349100404 |
| 2021 | The Regents of the University of California San Diego La Jolla, CA | C | $593,026 | paid | PERSONALIZING CROHN'S DISEASE THERAPEUTICS | 202240409349100404 |
| 2021 | The Regents of the University of California San Diego La Jolla, CA | C | $593,024 | approved, future | PERSONALIZING CROHN'S DISEASE THERAPEUTICS | 202240409349100404 |
| 2021 | University of Nebraska Foundation Lincoln, NE | C | $592,963 | approved, future | MOBILE RURAL HEALTHCARE PROVIDER TRAINING | 202240409349100404 |
| 2021 | University of Nebraska Foundation Lincoln, NE | C | $592,963 | paid | MOBILE RURAL HEALTHCARE PROVIDER TRAINING | 202240409349100404 |
| 2021 | Crohn's & Colitis Foundation Inc New York, NY | B | $588,266 | approved, future | SYSTEMATIZING INTERVENTIONS OF URGENT CARE MANAGEMENT IN CD | 202240409349100404 |
| 2021 | Crohn's & Colitis Foundation Inc New York, NY | B | $588,266 | approved, future | SYSTEMATIZING INTERVENTIONS OF URGENT CARE MANAGEMENT IN CD | 202240409349100404 |
| 2021 | University of North Carolina at Chapel Hill Chapel Hill, NC | B | $585,750 | approved, future | MOLECULAR PROFILES PREDICTIVE OF POST-OPERATIVE CD OUTCOMES | 202240409349100404 |
| 2021 | University of North Carolina at Chapel Hill Chapel Hill, NC | B | $585,750 | approved, future | IDENTIFYING PROFILES PREDICTIVE OF POST-OPERATIVE CD OUTCOMES | 202240409349100404 |
| 2021 | Clalit Health Services Tel Aviv | U | $582,660 | paid | BIO-MDT APPROACH TO PERSONALIZED TREATMENT OF POUCHITIS | 202240409349100404 |
| 2021 | Clalit Health Services Tel Aviv | U | $582,660 | approved, future | BIO-MDT APPROACH TO PERSONALIZED TREATMENT OF POUCHITIS | 202240409349100404 |
| 2021 | University of Nebraska Foundation Lincoln, NE | C | $582,072 | approved, future | MOBILE RURAL HEALTHCARE PROVIDER TRAINING | 202240409349100404 |
| 2021 | University of North Carolina at Chapel Hill Chapel Hill, NC | B | $581,625 | paid | IDENTIFYING MOLECULAR PROFILES OF POST-OPERATIVE CD OUTCOMES | 202240409349100404 |
| 2021 | University of North Carolina at Chapel Hill Chapel Hill, NC | B | $581,625 | approved, future | IDENTIFYING MOLECULAR PROFILES OF POST-OPERATIVE CD OUTCOMES | 202240409349100404 |
| 2021 | Amc Medical Research Bv Amsterdam | U | $580,202 | paid | DEVELOPMENT OF AN EPIGENETIC BIOMARKER THAT PREDICTS SUCCESS | 202240409349100404 |
| 2021 | The Regents of the University of California San Diego La Jolla, CA | C | $575,441 | paid | PERSONALIZING CROHN'S DISEASE THERAPEUTICS | 202240409349100404 |
| 2021 | The Regents of the University of Colorado Denver Aurora, CO | D | $574,167 | paid | CULTURALLY SENSITIVE GROUP CLINIC MODEL FOR LATINO PATIENTS | 202240409349100404 |
| 2021 | Clalit Health Services Tel Aviv | U | $573,675 | paid | BIO-MDT APPROACH TO PERSONALIZED TREATMENT OF POUCHITIS | 202240409349100404 |
| 2021 | The Tel Aviv Jaffa Academic College Tel Aviv Yaffo | U | $573,359 | paid | SCHOLARSHIPS FOR ULTRA-ORTHODOX MEN PURSUING NURSING DEGREES | 202240409349100404 |
| 2021 | The Cleveland Clinic Foundation Cleveland, OH | C | $573,271 | approved, future | CROHN'S FISTULIZING PROGRAM INVESTIGATOR INITIATED CLINICAL TRIALS | 202240409349100404 |
| 2021 | The Cleveland Clinic Foundation Cleveland, OH | C | $573,271 | paid | CROHN'S FISTULIZING PROGRAM INVESTIGATOR INITIATED CLINICAL TRIALS | 202240409349100404 |
| 2021 | The Cleveland Clinic Foundation Cleveland, OH | C | $573,271 | approved, future | CROHN'S FISTULIZING PROGRAM INVESTIGATOR INITIATED CLINICAL TRIALS | 202240409349100404 |
| 2021 | The Cleveland Clinic Foundation Cleveland, OH | C | $573,271 | approved, future | CROHN'S FISTULIZING PROGRAM INVESTIGATOR INITIATED CLINICAL TRIALS | 202240409349100404 |
| 2021 | Crohn's & Colitis Foundation Inc New York, NY | B | $570,831 | approved, future | SYSTEMATIZING INTERVENTIONS OF URGENT CARE MANAGEMENT IN CD | 202240409349100404 |
| 2021 | Crohn's & Colitis Foundation Inc New York, NY | B | $570,830 | approved, future | IMPROVEMENT INTERVENTIONS OF URGENT CARE MANAGEMENT IN CD | 202240409349100404 |
| 2021 | Children's Hospital Corporation Boston, MA | C | $567,507 | approved, future | GLUCOSE-RESPONSIVE APPROACHES TO INSULIN AND GLUCAGON DELIVERY | 202240409349100404 |
| 2021 | Children's Hospital Medical Center Cincinnati, OH | B | $560,860 | approved, future | PRECISION CROHN'S DISEASE MANAGEMENT UTILIZING PREDICTIVE PROTEIN | 202240409349100404 |
| 2021 | Clalit Health Services Tel Aviv | U | $552,715 | approved, future | CLINICAL TRIAL TO EVALUATE A NOVEL MDI-BGM DECISION SUPPORT SYSTEM | 202240409349100404 |
| 2021 | Clalit Health Services Tel Aviv | U | $552,715 | approved, future | CLINICAL TRIAL TO EVALUATE A NOVEL MDI-BGM DECISION SUPPORT SYSTEM | 202240409349100404 |
| 2021 | University of Melbourne Carlton | D | $552,076 | approved, future | ANIMAL AND CLINICAL EVALUATION OF A NOVEL CONTINUOUS KETONE SENSOR | 202240409349100404 |
| 2021 | Nuru International Washington, CA | U | $550,893 | paid | NURU ETHIOPIA: SUSTAINING IMPACT THROUGH 2021 AND BEYOND | 202240409349100404 |
| 2021 | Nuru International Washington, CA | U | $550,893 | approved, future | NURU ETHIOPIA: SUSTAINING IMPACT THROUGH 2021 AND BEYOND | 202240409349100404 |
| 2021 | The Mayors Fund to Advance New York City New York, NY | B | $550,000 | paid | A CONCEPTUAL PLAN FOR NYC NEIGHBORHOOD GREENWAYS | 202240409349100404 |
| 2021 | University of Melbourne Carlton | D | $549,121 | paid | ANIMAL AND CLINICAL EVALUATION OF A NOVEL CONTINUOUS KETONE SENSOR | 202240409349100404 |
| 2021 | Nebraska Department of Health & Human Services Lincoln, NE | U | $545,083 | approved, future | NEBRASKA FIRST RESPONDER AED PROJECT | 202240409349100404 |
| 2021 | Crohn's & Colitis Foundation Inc New York, NY | B | $544,115 | approved, future | SYSTEMATIZING IMPROVEMENT INTERVENTIONS OF URGENT CARE IN CD | 202240409349100404 |
| 2021 | Alimentiv Inc (fka Robarts) London | U | $542,299 | approved, future | STENOSIS THERAPY AND ANTI-FIBROTIC RESEARCH (STAR) CONSORTIUM | 202240409349100404 |
| 2021 | Beth Israel Deaconess Medical Center Inc Boston, MA | B | $538,077 | approved, future | PROACTIVE OPTIMIZATION OF INFLIXIMAB USING A DASHBOARD | 202240409349100404 |
| 2021 | Beth Israel Deaconess Medical Center Inc Boston, MA | B | $538,077 | approved, future | PROACTIVE OPTIMIZATION OF USING A PHARMACOKINETIC DASHBOARD | 202240409349100404 |
| 2021 | The Chinese University of Hong Kong Shatin | U | $533,765 | paid | MATERNAL TRANSFER OF SPECIALIZED CELLS FOR TREATMENT OF BOWEL DISEASE | 202240409349100404 |
| 2021 | Katholieke Universiteit Leuven Leuven | U | $530,355 | approved, future | AN ENTEROCHROMAFFIN CELL AND MACROPHAGE ATLAS OF THE HUMAN GUT | 202240409349100404 |
| 2021 | Katholieke Universiteit Leuven Leuven | U | $530,354 | approved, future | AN ENTEROCHROMAFFIN CELL AND MACROPHAGE ATLAS OF THE HUMAN GUT | 202240409349100404 |
| 2021 | Shaare Zedek Medical Center Jerusalem | D | $527,468 | approved, future | RCT OF TASTY & HEALTHY DIETARY APPROACH FOR REMISSION IN CROHN'S | 202240409349100404 |
| 2021 | Beth Israel Deaconess Medical Center Inc Boston, NY | U | $526,637 | approved, future | PROACTIVE OPTIMIZATION USING A PHARMACOKINETIC DASHBOARD | 202240409349100404 |
| 2021 | Alimentiv Inc (fka Robarts) London | U | $522,727 | approved, future | STENOSIS THERAPY AND ANTI-FIBROTIC RESEARCH (STAR) CONSORTIUM | 202240409349100404 |
| 2021 | Helmholtz Zentrum Munchen (gmbh) Neuherberg | U | $522,291 | approved, future | SUPPLEMENTATION WITH B. INFANTIS FOR MITIGATION OF T1D AUTOIMMUNITY | 202240409349100404 |
| 2021 | Beth Israel Deaconess Medical Center Inc Boston, MA | B | $519,550 | approved, future | PROACTIVE OPTIMIZATION USING A PHARMACOKINETIC DASHBOARD | 202240409349100404 |
| 2021 | Beth Israel Deaconess Medical Center Inc Boston, MA | B | $519,548 | approved, future | PROACTIVE OPTIMIZATION USING A PHARMACOKINETIC DASHBOARD | 202240409349100404 |
| 2021 | City Parks Foundation New York, NY | B | $518,000 | paid | NYC GREEN RELIEF & RECOVERY FUND | 202240409349100404 |
| 2021 | Clalit Health Services Tel Aviv | U | $514,830 | paid | PEDIATRIC REHAB DEPT AND HYDROTHERAPY POOLS | 202240409349100404 |
| 2021 | Shaare Zedek Medical Center Jerusalem | D | $513,193 | paid | TASTY & HEALTHY DIETARY APPROACH FOR REMISSION IN CROHN'S DISEASE | 202240409349100404 |
| 2021 | Vanderbilt University Medical Center Nashville, TN | C | $509,159 | paid | COMBINATORIAL SINGLE CELL STRATEGIES FOR CROHN'S DISEASE GUT CELL ATLAS | 202240409349100404 |
| 2021 | Vanderbilt University Medical Center Nashville, TN | C | $509,159 | approved, future | COMBINATORIAL SINGLE CELL STRATEGIES FOR CROHN'S GUT CELL ATLAS | 202240409349100404 |
| 2021 | Vanderbilt University Medical Center Nashville, TN | C | $509,159 | approved, future | COMBINATORIAL SINGLE CELL STRATEGIES FOR CROHN'S DISEASE GUT CELL ATLAS | 202240409349100404 |
| 2021 | Vanderbilt University Medical Center Nashville, TN | C | $509,159 | approved, future | COMBINATORIAL SINGLE CELL STRATEGIES FOR CROHN'S DISEASE GUT CELL ATLAS | 202240409349100404 |
| 2021 | Montana State Parks Foundation Inc Missoula, MT | B | $507,500 | paid | FORT OWEN STATE PARK RESTORATION AND SITE IMPROVEMENTS | 202240409349100404 |
| 2021 | The Chinese University of Hong Kong Shatin | U | $506,838 | approved, future | MATERNAL TRANSFER OF SPECIALIZED CELLS FOR TREATMENT OF BOWEL DISEASE | 202240409349100404 |
| 2021 | Palo Alto Veterans Institute for Research Palo Alto, CA | B | $503,575 | paid | CELL ATLAS OF INTESTINAL LYMPHOID TISSUES AND CHANGES IN CROHN'S | 202240409349100404 |
| 2021 | Villages of Hope Africa Society Mississauga | D | $502,010 | approved, future | FOOD PRODUCTION, WATER SUPPLY, EDUCATION FACILITIES | 202240409349100404 |
| 2021 | Palo Alto Veterans Institute for Research Palo Alto, CA | B | $500,825 | approved, future | CELL ATLAS OF INTESTINAL LYMPHOID TISSUES AND CHANGES IN CROHN'S | 202240409349100404 |
| 2021 | Palo Alto Veterans Institute for Research Palo Alto, CA | B | $500,825 | approved, future | CELL ATLAS OF INTESTINAL LYMPHOID TISSUES AND CHANGES IN CROHN'S | 202240409349100404 |
| 2021 | King's College London London | U | $500,000 | approved, future | MULTIPEPT1DE PROOF-OF-CONCEPT STUDY: STAGE III | 202240409349100404 |
| 2021 | King's College London London | U | $500,000 | approved, future | MULTIPEPT1DE PROOF-OF-CONCEPT STUDY: STAGE III | 202240409349100404 |
| 2021 | Cedars-Sinai Medical Center Los Angeles, CA | B | $500,000 | paid | INTEGRATING GENOMIC AND IMAGING DATA WITH SCRNASEQ TO UNDERSTAND CD | 202240409349100404 |
| 2021 | King's College London London | U | $500,000 | approved, future | MULTIPEPT1DE PROOF-OF-CONCEPT STUDY: STAGE III | 202240409349100404 |
| 2021 | Nature Conservancy Arlington, VA | B | $500,000 | paid | FUTURE FOREST NEW YORK CITY PHASE II | 202240409349100404 |
| 2021 | Natural Areas Conservancy Inc New York, NY | B | $500,000 | approved, future | FORMALIZING A NEW YORK CITY TRAIL SYSTEM | 202240409349100404 |
| 2021 | Sioux Empire Triage Center Sioux Falls, SD | B | $500,000 | paid | SIOUX EMPIRE TRIAGE CENTER | 202240409349100404 |
| 2021 | Nature Conservancy Arlington, VA | B | $500,000 | approved, future | FUTURE FOREST NEW YORK CITY PHASE II | 202240409349100404 |
| 2021 | Avera Mckennan Hospital and University Health Center Sioux Falls, SD | U | $500,000 | approved, future | AVERA BEHAVIORAL HEALTH CENTER EXPANSION | 202240409349100404 |
| 2021 | King's College London London | U | $500,000 | approved, future | MULTIPEPT1DE PROOF-OF-CONCEPT STUDY: STAGE III | 202240409349100404 |
| 2021 | University of Cambridge Cambridge | U | $500,000 | approved, future | CLOSED LOOP INSULIN DELIVERY IN NEWLY DIAGNOSED YOUTH WITH T1D | 202240409349100404 |
| 2021 | Dahl Memorial Healthcare Association Inc Ekalaka, MT | B | $500,000 | paid | CT SCANNER AT DAHL MEMORIAL HEALTHCARE ASSOCIATION INC | 202240409349100404 |
| 2021 | Avera Mckennan Hospital and University Health Center Sioux Falls, SD | U | $500,000 | approved, future | AVERA BEHAVIORAL HEALTH CENTER EXPANSION | 202240409349100404 |
| 2021 | King's College London London | U | $500,000 | approved, future | MULTIPEPT1DE PROOF-OF-CONCEPT STUDY: STAGE III | 202240409349100404 |
| 2021 | United Hospital Fund of New York New York, NY | B | $500,000 | paid | NEW YORK STATE MEDICAL RESPITE PILOT PROGRAM DESIGN | 202240409349100404 |
| 2021 | Natural Areas Conservancy Inc New York, NY | B | $500,000 | paid | FORMALIZING A NEW YORK CITY TRAIL SYSTEM | 202240409349100404 |
| 2021 | The One Love Foundation in Honor of Yeardley Love Inc Bronxville, NY | U | $500,000 | paid | CAPACITY BUILDING PROJECT SUPPORT | 202240409349100404 |
| 2021 | Palo Alto Veterans Institute for Research Palo Alto, CA | B | $499,175 | approved, future | CELL ATLAS OF INTESTINAL LYMPHOID TISSUES AND CHANGES IN CROHN'S | 202240409349100404 |
| 2021 | Palo Alto Veterans Institute for Research Palo Alto, CA | B | $499,175 | approved, future | CELL ATLAS OF INTESTINAL LYMPHOID TISSUES AND CHANGES IN CROHN'S | 202240409349100404 |
| 2021 | Katholieke Universiteit Leuven Leuven | U | $497,878 | paid | INNODIA HARVEST | 202240409349100404 |
| 2021 | Katholieke Universiteit Leuven Leuven | U | $497,699 | approved, future | AN ENTEROCHROMAFFIN CELL AND MACROPHAGE ATLAS OF THE HUMAN GUT | 202240409349100404 |
| 2021 | University of Cambridge Cambridge | U | $496,568 | approved, future | CLOSED LOOP INSULIN DELIVERY IN NEWLY DIAGNOSED YOUTH WITH T1D | 202240409349100404 |
| 2021 | Palo Alto Veterans Institute for Research Palo Alto, CA | B | $496,425 | paid | CELL ATLAS OF INTESTINAL LYMPHOID TISSUES AND CHANGES IN CROHN'S | 202240409349100404 |
| 2021 | Crohn's & Colitis Foundation Inc New York, NY | B | $494,615 | approved, future | SYSTEMATIZING INTERVENTIONS OF CARE MANAGEMENT IN CD | 202240409349100404 |
| 2021 | King's College London London | U | $493,562 | approved, future | MULTIPEPT1DE PROOF-OF-CONCEPT STUDY: STAGE III | 202240409349100404 |
| 2021 | Icahn School of Medicine at Mount Sinai New York City, NY | B | $492,812 | approved, future | MODULATING EARLY LIFE MICROBIOME THROUGH DIET IN CROHN'S | 202240409349100404 |
| 2021 | Fort Atkinson Foundation Fort Calhoun, NE | B | $492,500 | paid | FORT ATKINSON STATE HISTORICAL PARK RESTORATION/CENTER REMODEL | 202240409349100404 |
| 2021 | The Chinese University of Hong Kong Shatin | U | $492,017 | approved, future | MATERNAL TRANSFER OF SPECIALIZED CELLS FOR TREATMENT OF BOWEL DISEASE | 202240409349100404 |
| 2021 | City Parks Foundation New York, NY | B | $491,131 | approved, future | GROWING INTENSIVE PARK ENGAGEMENT IN VULNERABLE COMMUNITIES | 202240409349100404 |
| 2021 | Sanford Research Sioux Fall, SD | C | $491,115 | paid | SANFORD PLEDGE: PHASES 1 AND 2 | 202240409349100404 |
| 2021 | The University of Chicago Chicago, IL | U | $487,806 | approved, future | A CELL ATLAS OF THE ILEAL COLONIC CROHN'S DISEASE | 202240409349100404 |
| 2021 | The University of Chicago Chicago, IL | U | $487,806 | paid | A CELL ATLAS OF THE ILEAL COLONIC CROHN'S DISEASE | 202240409349100404 |
| 2021 | The University of Chicago Chicago, IL | U | $487,806 | approved, future | A CELL ATLAS OF THE ILEAL COLONIC CROHN'S DISEASE | 202240409349100404 |
| 2021 | The University of Chicago Chicago, IL | U | $487,806 | approved, future | A CELL ATLAS OF THE ILEAL COLONIC CROHN'S DISEASE | 202240409349100404 |
| 2021 | University of Texas System Austin, TX | D | $487,302 | paid | MAPPING THE CROSSTALK IN THE EPITHELIUM-MICROBIOME-IMMUNE AXIS | 202240409349100404 |
| 2021 | Katholieke Universiteit Leuven Leuven | U | $486,399 | paid | COMBINATION THERAPY OF DIET WITH BIOLOGICALS FOR CD | 202240409349100404 |
| 2021 | Katholieke Universiteit Leuven Leuven | U | $481,994 | approved, future | INNODIA HARVEST | 202240409349100404 |
| 2021 | The Chinese University of Hong Kong Shatin | U | $481,225 | approved, future | MATERNAL TRANSFER OF SPECIALIZED CELLS FOR TREATMENT OF BOWEL DISEASE | 202240409349100404 |
| 2021 | City Parks Foundation New York, NY | B | $479,444 | approved, future | GROWING INTENSIVE PARK ENGAGEMENT IN VULNERABLE COMMUNITIES | 202240409349100404 |
| 2021 | Icahn School of Medicine at Mount Sinai New York City, NY | B | $479,190 | approved, future | MODULATING EARLY LIFE MICROBIOME THROUGH DIET IN CROHN'S | 202240409349100404 |
| 2021 | Trustees of the University of Pennsylvania Philadelphia, PA | B | $478,518 | paid | DURABLE ISLET TRANSPLANT BY ADMINISTRATING ENGINEERED T CELLS | 202240409349100404 |
| 2021 | The Broad Institute Inc Cambridge, MA | B | $476,319 | approved, future | HUMAN COLON AND SMALL INTESTINE CELL ATLAS IN HEALTH AND CROHN'S | 202240409349100404 |
| 2021 | Clalit Health Services Tel Aviv | U | $475,863 | paid | CLINICAL TRIAL TO EVALUATE A NOVEL MDI-BGM DECISION SUPPORT SYSTEM | 202240409349100404 |
| 2021 | Aphp St Antoine Hospital Paris | U | $474,464 | approved, future | FECAL MICROBIOTA TRANSPLANTATION IN CROHN'S DISEASE | 202240409349100404 |
| 2021 | Aphp St Antoine Hospital Paris | U | $474,464 | approved, future | FECAL MICROBIOTA TRANSPLANTATION IN CROHN'S DISEASE | 202240409349100404 |
| 2021 | Washington University St Louis, MO | C | $473,975 | paid | VACCINE SAFETY AND EFFICACY | 202240409349100404 |
| 2021 | Washington University St Louis, MO | C | $473,150 | approved, future | VACCINE SAFETY AND EFFICACY | 202240409349100404 |
| 2021 | University of North Carolina at Chapel Hill Chapel Hill, NC | B | $472,065 | paid | MONITORING COVID-19 VACCINE EFFECTIVENESS IN IBD PATIENTS | 202240409349100404 |
| 2021 | The University of Edinburgh Edinburgh | U | $469,844 | approved, future | MITOCHONDRIAL AS MECHANISTIC BIOMARKERS OF MUCOSAL INFLAMMATION | 202240409349100404 |
| 2021 | Forschergruppe Diabetes Ev Neuherberg | U | $467,844 | approved, future | FR1DA-PLUS COHORT STUDY | 202240409349100404 |
| 2021 | Monash University Clayton | U | $466,285 | paid | DOSE OPTIMIZATION AND CLINICAL TESTING FOR IVERMECTIN | 202240409349100404 |
| 2021 | The Broad Institute Inc Cambridge, MA | B | $463,755 | approved, future | HUMAN COLON AND SMALL INTESTINE CELL ATLAS IN HEALTH AND CROHN'S | 202240409349100404 |
| 2021 | The Broad Institute Inc Cambridge, MA | B | $463,751 | approved, future | HUMAN COLON AND SMALL INTESTINE CELL ATLAS IN HEALTH AND CROHN'S | 202240409349100404 |
| 2021 | Icahn School of Medicine at Mount Sinai New York City, NY | B | $462,745 | paid | MODULATING EARLY LIFE MICROBIOME THROUGH DIET IN CROHN'S | 202240409349100404 |
| 2021 | President and Fellows of Harvard College Boston, MA | C | $462,155 | approved, future | CREATING MICRONEEDLE-BASED SENSOR TO AUTOMATED INSULIN DELIVERY | 202240409349100404 |
| 2021 | President and Fellows of Harvard College Boston, MA | C | $462,154 | approved, future | CREATING MICRONEEDLE-BASED SENSOR TO AUTOMATED INSULIN DELIVERY | 202240409349100404 |
| 2021 | Massachusetts Institute of Technology Cambridge, MA | B | $462,050 | paid | IMPLANTABLE DEPOTS FOR DETECTION OF PERI-ANASTOMOTIC INFLAMMATION | 202240409349100404 |
| 2021 | Australasian Gastro Intestinal Research Foundation Ltd Fitzroy | U | $456,536 | approved, future | FECAL MICROBIOTA TRANSPLANTATION IN CROHN'S DISEASE | 202240409349100404 |
| 2021 | The Sheba Fund for Health Services and Research (ra) Ramat Gan | U | $452,624 | approved, future | COMPREHENSIVE INDIVIDUALIZED PROACTIVE THERAPY OF CROHN'S DISEASE | 202240409349100404 |
| 2021 | The University of Edinburgh Edinburgh | U | $444,247 | approved, future | GCA - HUMAN GUT CELL ATLAS - NORMAL INTESTINE AND CROHN'S DISEASE | 202240409349100404 |
| 2021 | The University of Edinburgh Edinburgh | U | $444,246 | approved, future | GCA - HUMAN GUT CELL ATLAS - NORMAL INTESTINE AND CROHN'S | 202240409349100404 |
| 2021 | Yale University New Haven, CT | U | $443,827 | approved, future | EXPOSOMICS FOR EARLY LIFE CROHN'S DISEASE | 202240409349100404 |
| 2021 | Forschergruppe Diabetes Ev Neuherberg | U | $437,691 | paid | FR1DA-PLUS COHORT STUDY | 202240409349100404 |
| 2021 | Katholieke Universiteit Leuven Leuven | U | $435,842 | paid | PREDICTIVE SEROLOGICAL BIOMARKER SIGNATURES FOR RESPONSE TO ANTI-TNFS | 202240409349100404 |
| 2021 | The Regents of the University of California San Francisco San Francisco, CA | U | $433,333 | approved, future | ID ANALYSIS OF FORMS OF T1D, ESTABLISHMENT OF PATIENT REGISTRY | 202240409349100404 |
| 2021 | The Regents of the University of California San Francisco San Francisco, CA | U | $433,333 | approved, future | ID ANALYSIS OF EXTREME FORMS OF T1D, ESTABLISHMENT OF PATIENT REGISTRY | 202240409349100404 |
| 2021 | The Regents of the University of California San Francisco San Francisco, CA | U | $433,333 | paid | ID ANALYSIS OF EXTREME FORMS OF T1D, ESTABLISHMENT OF PATIENT REGISTRY | 202240409349100404 |
| 2021 | Jdrf International New York, NY | U | $432,631 | approved, future | DEVELOPMENT OF NOVEL INSULIN INFUSION SET | 202240409349100404 |
| 2021 | The Chinese University of Hong Kong Shatin | U | $430,508 | approved, future | GLOBAL IBD VISUALIZATION OF EPIDEMIOLOGY STUDIES | 202240409349100404 |
| 2021 | The Regents of the University of California San Diego La Jolla, CA | C | $428,180 | paid | 3D MEDICAL IMAGING PILOT TO IMPROVE CROHN'S SURGICAL OUTCOMES | 202240409349100404 |
| 2021 | Institut Nationale de la Sante Et de la Recherche Medicale Paris | U | $426,271 | approved, future | BENIGN ISLET AUTOIMMUNITY TO T1D: T-CELL BIOMARKERS OF PROGRESSION | 202240409349100404 |
| 2021 | Children's Hospital of Philadelphia Philadelphia, PA | C | $426,038 | paid | CROHN'S DISEASE EPITHELIAL STEM CELL ATLAS | 202240409349100404 |
| 2021 | Children's Hospital of Philadelphia Philadelphia, PA | C | $424,937 | approved, future | CROHN'S DISEASE STEM CELL ATLAS: PEDIATRIC TO ADULT CONTINUUM | 202240409349100404 |
| 2021 | The Chinese University of Hong Kong Shatin | U | $423,667 | approved, future | GLOBAL IBD VISUALIZATION OF EPIDEMIOLOGY STUDIES | 202240409349100404 |
| 2021 | Aphp St Antoine Hospital Paris | U | $421,680 | approved, future | FECAL MICROBIOTA TRANSPLANTATION IN CROHN'S DISEASE | 202240409349100404 |
| 2021 | State of South Dakota Unified Judicial System Pierre, SD | U | $418,840 | paid | UNIFIED JUDICIAL SYSTEM CRIMINAL JUSTICE RESPONSES TO MENTAL ILLNESS | 202240409349100404 |
| 2021 | Ludwig-Maximilians-Universitat Munchen Munich | U | $416,756 | paid | FMT FOR MAINTENANCE OF REMISSION IN PEDIATRIC CROHN'S DISEASE | 202240409349100404 |
| 2021 | Shaare Zedek Medical Center Jerusalem | D | $415,669 | approved, future | RCT OF TASTY & HEALTHY DIETARY APPROACH FOR REMISSION IN CROHN'S | 202240409349100404 |
| 2021 | Shaare Zedek Medical Center Jerusalem | D | $413,468 | approved, future | PREVENTION OF INFLAMMATORY BOWEL DISEASES IN PERSONS AT RISK | 202240409349100404 |
| 2021 | The Sonia Nabeta Foundation Inc New York, NY | C | $412,944 | approved, future | PROJECT BODA-BODA | 202240409349100404 |
| 2021 | The University of Chicago Chicago, IL | U | $411,939 | approved, future | IMMUNO PHARMACOGENOMICS TO PREDICT RESPONSE IN CROHN'S | 202240409349100404 |
| 2021 | The University of Chicago Chicago, IL | U | $411,939 | paid | IMMUNO PHARMACOGENOMICS TO PREDICT RESPONSE TO BIOLOGICS | 202240409349100404 |
| 2021 | The University of Chicago Chicago, IL | U | $411,939 | paid | IMMUNO PHARMACOGENOMICS TO PREDICT RESPONSE TO BIOLOGICS | 202240409349100404 |
| 2021 | Icahn School of Medicine at Mount Sinai New York City, NY | B | $409,388 | approved, future | MODULATING EARLY LIFE MICROBIOME THROUGH DIET IN CROHN'S | 202240409349100404 |
| 2021 | Katholieke Universiteit Leuven Leuven | U | $408,046 | approved, future | COMBINATION THERAPY OF DIET WITH BIOLOGICALS FOR CD | 202240409349100404 |
| 2021 | Yale University New Haven, CT | U | $405,488 | approved, future | EXPOSOMICS FOR EARLY LIFE CROHN'S DISEASE | 202240409349100404 |
| 2021 | Herlev Og Gentofte Hospital Herlev | U | $402,594 | approved, future | TARGETING GIP/GLP-2 RECEPTORS TO PREVENT HYPOGLYCEMIA IN T1D | 202240409349100404 |
| 2021 | The Chinese University of Hong Kong Shatin | U | $400,533 | paid | GLOBAL IBD VISUALIZATION OF EPIDEMIOLOGY STUDIES, 21ST CEN | 202240409349100404 |
| 2021 | The University of Edinburgh Edinburgh | U | $400,400 | approved, future | GCA - HUMAN GUT CELL ATLAS - NORMAL INTESTINE AND CROHN'S | 202240409349100404 |
| 2021 | Cedars-Sinai Medical Center Los Angeles, CA | B | $400,218 | paid | TARGETING MICROORGANISMS IN CREEPING FAT | 202240409349100404 |
| 2021 | King's College London London | U | $400,000 | approved, future | MULTIPEPT1DE PROOF-OF-CONCEPT STUDY: STAGE III | 202240409349100404 |
| 2021 | Jdrf International New York, NY | U | $400,000 | approved, future | AUTOIMMUNITY SCREENING IN KIDS (ASK) RENEWAL | 202240409349100404 |
| 2021 | Jaeb Center for Health Research Foundation Inc Tampa, FL | C | $400,000 | approved, future | EXERCISE IN DIABETES INITIATIVE: PEDIATRIC STUDY | 202240409349100404 |
| 2021 | Stichting Pharmaccess International Amsterdam | U | $397,018 | paid | INVESTING IN QUALITY HEALTHCARE THROUGH SAFECARE | 202240409349100404 |
| 2021 | Clinical Data Interchange Standards Consortium Inc Austin, TX | C | $395,077 | paid | CDISC STANDARDS DEVELOPMENT PROJECT FOR CROHN'S DISEASE | 202240409349100404 |
| 2021 | Cedars-Sinai Medical Center Los Angeles, CA | B | $393,039 | approved, future | TARGETING MICROORGANISMS IN CREEPING FAT | 202240409349100404 |
| 2021 | University of Glasgow Court Glasgow | U | $391,290 | approved, future | THE CLINICAL EFFECTIVENESS OF CD-TREAT IN CROHN'S PATIENTS | 202240409349100404 |
| 2021 | King's College London London | U | $390,821 | approved, future | MULTIPEPT1DE PROOF-OF-CONCEPT STUDY: STAGE III | 202240409349100404 |
| 2021 | University of Oxford Oxford | U | $389,575 | approved, future | PHARMACOLOGICAL MODULATION TO ADDRESS GLUCAGON SECRETION IN T1D | 202240409349100404 |
| 2021 | Carilion Medical Center Roanoke, VA | C | $388,860 | approved, future | ESTABLISHING NEW PARADIGMS IN PRE-CLINICAL CROHN'S DISEASE | 202240409349100404 |
| 2021 | Jaeb Center for Health Research Foundation Inc Tampa, FL | C | $387,943 | approved, future | EVAL OF THE RELATIONSHIP OF GLUCOSE METRICS VIA CGM | 202240409349100404 |
| 2021 | Mayo Clinic Rochester, MN | U | $385,906 | approved, future | OFF-SITE REMOTE CONTROL ROBOTIC CORONARY INTERVENTIONS | 202240409349100404 |
| 2021 | Regents of the University of Michigan Ann Arbor, MI | C | $385,780 | approved, future | USE NLP FOR EXTRACTION OF CD RELEVANT DATA FROM CLINICAL RECORDS. | 202240409349100404 |
| 2021 | Jaeb Center for Health Research Foundation Inc Tampa, FL | C | $384,845 | approved, future | EVAL OF THE RELATIONSHIP OF GLUCOSE VIA CGM W/DIAB. RETINOPATHY | 202240409349100404 |
| 2021 | Icahn School of Medicine at Mount Sinai New York City, NY | B | $383,087 | paid | MODULATING MICROBIOME THROUGH DIETARY INTERVENTION IN CROHN'S | 202240409349100404 |
| 2021 | The University of Edinburgh Edinburgh | U | $382,456 | approved, future | GCA - HUMAN GUT CELL ATLAS - NORMAL INTESTINE AND CROHN'S DISEASE | 202240409349100404 |
| 2021 | Regents of the University of Michigan Ann Arbor, MI | C | $381,754 | approved, future | USE NLP FOR EXTRACTION OF CD RELEVANT DATA FROM CLINICAL RECORDS. | 202240409349100404 |
| 2021 | University College London London | U | $380,649 | approved, future | SPIT-C: USING SALIVA TO PREDICT CROHN'S DISEASE | 202240409349100404 |
| 2021 | Shaare Zedek Medical Center Jerusalem | D | $379,439 | approved, future | PREVENTION OF INFLAMMATORY BOWEL DISEASES IN PERSONS AT RISK | 202240409349100404 |
| 2021 | University of Florida Gainesville, FL | U | $379,382 | paid | HUMAN ATLAS OF NEONATAL DEVELOPMENT AND EARLY LIFE-IMMUNITY | 202240409349100404 |
| 2021 | University of Texas System Austin, TX | D | $378,343 | paid | MAPPING THE CROSSTALK IN THE EPITHELIUM-MICROBIOME-IMMUNE AXIS | 202240409349100404 |
| 2021 | Lunds Universitet Lund | U | $377,744 | paid | VALIDATION OF PCR-BASED ISLET AUTOANTIBODY DETECTION | 202240409349100404 |
| 2021 | Children's Hospital Corporation Boston, MA | C | $377,425 | paid | GLUCOSE-RESPONSIVE APPROACHES TO INSULIN AND GLUCAGON DELIVERY | 202240409349100404 |
| 2021 | Children's Hospital Corporation Boston, MA | C | $377,425 | paid | GLUCOSE-RESPONSIVE APPROACHES TO INSULIN AND GLUCAGON DELIVERY | 202240409349100404 |
| 2021 | Avera Health Sioux Falls, SD | B | $377,000 | paid | ECARE TELE-PSYCHIATRY 24/7 CARE TEAM | 202240409349100404 |
| 2021 | Stanford University Stanford, CA | C | $376,108 | paid | EFFECTS OF AN INTERMITTENT REDUCED CALORIE DIET ON CROHN'S | 202240409349100404 |
| 2021 | Cedars-Sinai Medical Center Los Angeles, CA | B | $375,747 | approved, future | TARGETING MICROORGANISMS IN CREEPING FAT | 202240409349100404 |
| 2021 | Icahn School of Medicine at Mount Sinai New York City, NY | B | $375,235 | approved, future | SAFETY AND TOLERABILITY OF ORAL BFAHF-2 IN PEDIATRIC CROHN'S | 202240409349100404 |
| 2021 | International Bowel Ultrasound Group Ev Munster | U | $375,221 | approved, future | THE DEVELOPMENT OF A DISEASE ACTIVITY INDEX FOR INTESTINAL ULTRASOUND | 202240409349100404 |
| 2021 | Children's Hospital Corporation Boston, MA | C | $374,591 | approved, future | MOLECULAR + SPATIAL SINGLE-CELL REMODELING IN PEDIATRIC CROHN'S | 202240409349100404 |
| 2021 | Children's Hospital Corporation Boston, MA | C | $374,591 | approved, future | MOLECULAR + SPATIAL SINGLE-CELL REMODELING IN PEDIATRIC CROHN'S | 202240409349100404 |
| 2021 | Children's Hospital Corporation Boston, MA | C | $374,591 | approved, future | MOLECULAR + SPATIAL SINGLE-CELL REMODELING IN PEDIATRIC CROHN'S | 202240409349100404 |
| 2021 | Children's Hospital Corporation Boston, MA | C | $374,591 | approved, future | MOLECULAR + SPATIAL SINGLE-CELL REMODELING IN PEDIATRIC CROHN'S | 202240409349100404 |
| 2021 | Australasian Gastro Intestinal Research Foundation Ltd Fitzroy | U | $374,589 | paid | FECAL MICROBIOTA TRANSPLANTATION IN CROHN'S DISEASE: THE MIRO STUDY | 202240409349100404 |
| 2021 | University of Miami Coral Gables, FL | U | $374,435 | paid | A HOLISTIC DIET INTERVENTION FOR PEOPLE WITH CROHN'S DISEASE | 202240409349100404 |
| 2021 | Clalit Health Services Tel Aviv | U | $374,087 | paid | EMEK MEDICAL CENTER - NEW OPERATING SUITES | 202240409349100404 |
| 2021 | Association Sante Diabete Grenoble | U | $371,654 | paid | DIABETES SUPPORT TO PEOPLE | 202240409349100404 |
| 2021 | Regents of the University of Michigan Ann Arbor, MI | C | $369,880 | approved, future | USE NLP FOR EXTRACTION OF CD RELEVANT DATA FROM CLINICAL RECORDS. | 202240409349100404 |
| 2021 | Aphp St Antoine Hospital Paris | U | $367,130 | approved, future | FECAL MICROBIOTA TRANSPLANTATION IN CROHN'S DISEASE | 202240409349100404 |
| 2021 | Jdrf Australia Sydney | U | $365,926 | paid | CREATING AN ANALYTICAL METHOD FOR T1D PROGRESSION | 202240409349100404 |
| 2021 | Katholieke Universiteit Leuven Leuven | U | $362,770 | approved, future | COMBINATION THERAPY OF DIET WITH BIOLOGICALS FOR CD | 202240409349100404 |
| 2021 | Helmholtz Zentrum Munchen (gmbh) Neuherberg | U | $361,753 | approved, future | FR1DA ORAL INSULIN INTERVENTION TRIAL AMENDMENT | 202240409349100404 |
| 2021 | Helmholtz Zentrum Munchen (gmbh) Neuherberg | U | $361,752 | approved, future | FR1DA ORAL INSULIN INTERVENTION TRIAL AMENDMENT | 202240409349100404 |
| 2021 | Children's Hospital Los Angeles Los Angeles, CA | U | $360,832 | approved, future | TEAM CLINIC: EXPANSION OF A CARE MODEL FOR ADOLESCENTS WITH T1D | 202240409349100404 |
| 2021 | Katholieke Universiteit Leuven Leuven | U | $358,644 | approved, future | COMBINATION THERAPY OF DIET WITH BIOLOGICALS FOR CD | 202240409349100404 |
| 2021 | American Diabetes Association Inc Arlington, VA | B | $357,500 | paid | 2019-2021 TYPE 1 DIABETES CAMP INITIATIVE | 202240409349100404 |
| 2021 | Shaare Zedek Medical Center Jerusalem | D | $355,916 | approved, future | PREVENTION OF INFLAMMATORY BOWEL DISEASES IN PERSONS AT RISK | 202240409349100404 |
| 2021 | T1d Exchange Inc Boston, MA | U | $354,000 | approved, future | DATA APPROACH TO IMPROVE QUALITY AND OUTCOMES WITH T1D | 202240409349100404 |
| 2021 | T1d Exchange Inc Boston, MA | U | $354,000 | paid | DATA APPROACH TO IMPROVE OUTCOMES FOR INDIVIDUALS WITH T1D | 202240409349100404 |
| 2021 | T1d Exchange Inc Boston, MA | U | $354,000 | approved, future | DATA TO IMPROVE QUALITY AND OUTCOMES FOR INDIVIDUALS WITH T1D | 202240409349100404 |
| 2021 | T1d Exchange Inc Boston, MA | U | $354,000 | approved, future | DATA TO IMPROVE QUALITY AND OUTCOMES FOR INDIVIDUALS WITH T1D | 202240409349100404 |
| 2021 | Trustees of Indiana University Bloomington, MI | U | $353,894 | paid | DEVELOPMENT OF REGULATORY ROADMAP FOR BOWEL PREP FOR CD | 202240409349100404 |
| 2021 | Massachusetts General Hospital Boston, MA | C | $353,249 | approved, future | CROHN'S IN SOUTH ASIANS: DEFINING DISEASE BIOLOGY FOR PREVENTION | 202240409349100404 |
| 2021 | University of Cambridge Cambridge | U | $353,223 | approved, future | CLOSED LOOP INSULIN DELIVERY IN NEWLY DIAGNOSED YOUTH WITH T1D | 202240409349100404 |
| 2021 | Massachusetts General Hospital Boston, MA | C | $352,645 | approved, future | CROHN'S IN SOUTH ASIANS: DEFINING DISEASE BIOLOGY FOR PREVENTION | 202240409349100404 |
| 2021 | Governing Council of the University of Toronto Toronto | D | $351,560 | paid | GLUCOSE RESPONSIVE GLUCAGON MICRONEEDLE-HYPOGLYCEMIA PREVENTION | 202240409349100404 |
| 2021 | Bipartisan Policy Center Inc Washington, DC | B | $350,800 | paid | RURAL HEALTH CARE TASK FORCE | 202240409349100404 |
| 2021 | Massachusetts General Hospital Boston, MA | C | $350,279 | approved, future | CROHN'S IN SOUTH ASIANS: DEFINING DISEASE BIOLOGY FOR PREVENTION | 202240409349100404 |
| 2021 | Massachusetts General Hospital Boston, MA | C | $350,278 | approved, future | CROHN'S IN SOUTH ASIANS: DEFINING DISEASE BIOLOGY FOR PREVENTION | 202240409349100404 |
| 2021 | Center for Excellence in Health Care Journalism Columbia, MO | C | $350,000 | paid | TRAINING AND DEVELOPMENT OF HEALTH CARE JOURNALISTS AND REPORTING | 202240409349100404 |
| 2021 | Regents of the University of Minnesota Minneapolis, MN | U | $350,000 | approved, future | PHASE 2: ENGINEERING ANTIGEN-SPECIFIC REGULATORY T CELLS FOR T1D | 202240409349100404 |
| 2021 | Rambam Health Corporation Haifa | D | $350,000 | approved, future | PREDICTING AND OPTIMIZING DRUG THERAPY IN CROHN'S DISEASE | 202240409349100404 |
| 2021 | Regents of the University of Minnesota Minneapolis, MN | U | $350,000 | paid | PHASE 2: ENGINEERING ANTIGEN-SPECIFIC REGULATORY T CELLS FOR T1D | 202240409349100404 |
| 2021 | Clinical Data Interchange Standards Consortium Inc Austin, TX | C | $343,353 | paid | CDISC STANDARDS DEVELOPMENT PROJECT FOR TYPE 1 DIABETES | 202240409349100404 |
| 2021 | Saint Louis University Saint Louis, MO | B | $341,798 | paid | NOVEL TARGET TO FIGHT ALPHA CELL DYSFUNCTION STOP HYPOGLYCEMIA IN T1D | 202240409349100404 |
| 2021 | Jaeb Center for Health Research Foundation Inc Tampa, FL | C | $340,704 | paid | EXERCISE WITH TYPE 1 DIABETES INITIATIVE: PILOT PHASE | 202240409349100404 |
| 2021 | Yale University New Haven, CT | U | $336,846 | approved, future | THERAPEUTIC TARGETS AT THE HOST MICROBIOTA INTERFACE FOR FIBROSIS | 202240409349100404 |
| 2021 | Stanford University Stanford, CA | C | $334,722 | approved, future | EFFECTS OF AN INTERMITTENT REDUCED CALORIE DIET ON CROHN'S | 202240409349100404 |
| 2021 | Care-for-Rare Foundation Munich | U | $333,298 | paid | DEFINING AND DEVELOPING THE THERAPEUTIC PIPELINE FOR VEO-IBD | 202240409349100404 |
| 2021 | Care-for-Rare Foundation Munich | U | $333,298 | paid | DEFINING AND DEVELOPING THE THERAPEUTIC PIPELINE FOR VEO-IBD | 202240409349100404 |
| 2021 | Washington University St Louis, MO | C | $333,006 | approved, future | VACCINE SAFETY AND EFFICACY | 202240409349100404 |
| 2021 | Stanford University Stanford, CA | C | $331,803 | approved, future | EFFECTS OF AN INTERMITTENT REDUCED CALORIE DIET ON CROHN'S | 202240409349100404 |
| 2021 | Jaeb Center for Health Research Foundation Inc Tampa, FL | C | $331,671 | approved, future | EVAL OF THE RELATIONSHIP OF GLUCOSE METRICS VIA CGM W/DIAB. RETINOPATHY | 202240409349100404 |
| 2021 | Yale University New Haven, CT | U | $330,798 | paid | THERAPEUTIC TARGETS AT THE HOST MICROBIOTA INTERFACE FOR FIBROSIS | 202240409349100404 |
| 2021 | Yale University New Haven, CT | U | $330,246 | paid | THERAPEUTIC TARGETS AT THE HOST MICROBIOTA INTERFACE FOR FIBROSIS | 202240409349100404 |
| 2021 | Stanford University Stanford, CA | C | $330,000 | approved, future | EXPANSION & EVALUATION OF ECHO FOR PEOPLE WITH DIABETES ON IIT | 202240409349100404 |
| 2021 | University of Miami Coral Gables, FL | U | $328,238 | approved, future | THE GEORGE S. EISENBARTH NPOD AWARD FOR TEAM SCIENCE | 202240409349100404 |
| 2021 | University of Miami Coral Gables, FL | U | $326,055 | approved, future | THE GEORGE S. EISENBARTH NPOD AWARD FOR TEAM SCIENCE | 202240409349100404 |
| 2021 | The Milken Institute Santa Monica, CA | B | $325,002 | paid | CURES FOR LIFE: PATIENT ACCESS TO CELL AND GENE THERAPY | 202240409349100404 |
| 2021 | University of Exeter Exeter | U | $324,520 | paid | STIMULATED GLUCAGON LEVELS BIOMARKER OF HYPOGLYCEMIA RISK IN T1D | 202240409349100404 |
| 2021 | University of Miami Coral Gables, FL | U | $323,935 | approved, future | THE GEORGE S. EISENBARTH NPOD AWARD FOR TEAM SCIENCE | 202240409349100404 |
| 2021 | University of Washington Seattle, WA | B | $323,566 | paid | SKIN PATHOLOGY IN PEOPLE WITH T1D: IMPACT OF INSULIN INFUSION VIA PUMP | 202240409349100404 |
| 2021 | University of Exeter Exeter | U | $323,139 | approved, future | STIMULATED GLUCAGON LEVELS BIOMARKER OF HYPOGLYCEMIA RISK IN T1D | 202240409349100404 |
| 2021 | Oregon Health & Science University Portland, OR | U | $322,463 | paid | THE IMPLEMENTATION OF NICH IN ANOTHER HEALTHCARE SYSTEM | 202240409349100404 |
| 2021 | Icahn School of Medicine at Mount Sinai New York City, NY | B | $322,263 | paid | SAFETY AND TOLERABILITY OF ORAL BFAHF-2 IN PEDIATRIC CROHN'S DISEASE | 202240409349100404 |
| 2021 | Avera Health Sioux Falls, SD | B | $317,515 | paid | AVERA HEALTH COVID-19 CARDIAC PREPAREDNESS PROJECT | 202240409349100404 |
| 2021 | The Regents of the University of Colorado Denver Aurora, CO | D | $317,365 | approved, future | SINGLE PERSISTENT ISLET AUTOANTIBODY PHENOTYPE: RISK ANALYSIS | 202240409349100404 |
| 2021 | Beth Israel Deaconess Medical Center Inc Boston, MA | B | $316,515 | paid | PROACTIVE OPTIMIZATION OF INFLIXIMAB USING PHARMACOKINETIC DASHBOARD | 202240409349100404 |
| 2021 | The Sonia Nabeta Foundation Inc New York, NY | C | $314,814 | approved, future | PROJECT BODA-BODA | 202240409349100404 |
| 2021 | The Regents of the University of Colorado Denver Aurora, CO | D | $313,924 | approved, future | DEVELOPMENT OF A CONTINUOUS INSULIN-GLUCOSE SENSOR | 202240409349100404 |
| 2021 | Massachusetts General Hospital Boston, MA | C | $313,795 | paid | DEVELOPMENT OF FAST ON/OFF INSULIN RECEPTOR ACTIVATORS | 202240409349100404 |
| 2021 | Cambridge University Hospitals Nhs Foundation Trust Cambridge | U | $313,576 | approved, future | UK IBD BIORESOURCE: TRANSLATING TODAY'S SCIENCE INTO CD TREATMENTS | 202240409349100404 |
| 2021 | Cambridge University Hospitals Nhs Foundation Trust Cambridge | U | $313,576 | approved, future | UK IBD BIORESOURCE: TRANSLATING TODAY'S SCIENCE INTO CD TREATMENTS | 202240409349100404 |
| 2021 | Billings Clinic Foundation Billings, MT | C | $312,899 | paid | BILLINGS CLINIC COVID-19 CARDIAC PREPAREDNESS PROJECT | 202240409349100404 |
| 2021 | Cambridge University Hospitals Nhs Foundation Trust Cambridge | U | $312,018 | approved, future | UK IBD BIORESOURCE: TRANSLATING TODAY'S SCIENCE INTO CD TREATMENTS | 202240409349100404 |
| 2021 | Cambridge University Hospitals Nhs Foundation Trust Cambridge | U | $312,018 | paid | UK IBD BIORESOURCE: TRANSLATING TODAY'S SCIENCE INTO CD TREATMENTS | 202240409349100404 |
| 2021 | Nebraska Department of Health & Human Services Lincoln, NE | U | $309,887 | approved, future | NEBRASKA FIRST RESPONDER AED PROJECT | 202240409349100404 |
| 2021 | King's College London London | U | $307,619 | approved, future | MULTIPEPT1DE PROOF-OF-CONCEPT STUDY: STAGE III | 202240409349100404 |
| 2021 | The University of Chicago Chicago, IL | U | $305,353 | approved, future | PHARMACOGENOMICS TO PREDICT RESPONSE TO BIOLOGICS IN CROHN'S | 202240409349100404 |
| 2021 | The University of Chicago Chicago, IL | U | $305,349 | approved, future | IMMUNO-PHARMA TO PREDICT RESPONSE TO BIOLOGICS IN CROHN'S | 202240409349100404 |
| 2021 | Tampere University Foundation Sr Tampere | U | $305,030 | approved, future | VIRUSES AND ANTIVIRAL IMMUNE MARKERS IN TWO ENDOTYPES OF T1D | 202240409349100404 |
| 2021 | The Cleveland Clinic Foundation Cleveland, OH | C | $304,248 | paid | STENOSIS THERAPY AND ANTI-FIBROTIC RESEARCH CONSORTIUM | 202240409349100404 |
| 2021 | King's College London London | U | $301,927 | approved, future | MULTIPEPT1DE PROOF-OF-CONCEPT STUDY: STAGE III | 202240409349100404 |
| 2021 | American Diabetes Association Inc Arlington, VA | B | $300,000 | approved, future | FOCUS ON FELLOWS, DIABETES IS PRIMARY, PROFESSIONAL PROJECTS | 202240409349100404 |
| 2021 | City Parks Foundation New York, NY | B | $300,000 | approved, future | NYC GREEN RELIEF & RECOVERY FUND | 202240409349100404 |
| 2021 | King's College London London | U | $300,000 | approved, future | MULTIPEPT1DE PROOF-OF-CONCEPT STUDY: STAGE III | 202240409349100404 |
| 2021 | City Parks Foundation New York, NY | B | $300,000 | approved, future | NYC GREEN RELIEF & RECOVERY FUND | 202240409349100404 |
| 2021 | United Hospital Fund of New York New York, NY | B | $300,000 | approved, future | NEW YORK STATE MEDICAL RESPITE PILOT PROGRAM DESIGN | 202240409349100404 |
| 2021 | American Diabetes Association Inc Arlington, VA | B | $300,000 | paid | FOCUS ON FELLOWS, DIABETES IS PRIMARY, PROFESSIONAL PROJECTS | 202240409349100404 |
| 2021 | City Parks Foundation New York, NY | B | $300,000 | paid | NYC GREEN RELIEF & RECOVERY FUND | 202240409349100404 |
| 2021 | American Diabetes Association Inc Arlington, VA | B | $300,000 | approved, future | FOCUS ON FELLOWS, DIABETES IS PRIMARY, PROFESSIONAL PROJECTS | 202240409349100404 |
| 2021 | The Diatribe Foundation San Francisco, CA | C | $300,000 | paid | DIATRIBE LEARN | 202240409349100404 |
| 2021 | Yale University New Haven, CT | U | $298,606 | approved, future | EXPOSOMICS FOR EARLY LIFE CROHN'S DISEASE | 202240409349100404 |
| 2021 | Katholieke Universiteit Leuven Leuven | U | $297,898 | approved, future | COMBINATION THERAPY OF DIET WITH BIOLOGICALS FOR CD | 202240409349100404 |
| 2021 | The Regents of the University of California San Diego La Jolla, CA | C | $295,887 | paid | 3D MEDICAL IMAGING PILOT TO IMPROVE CROHN'S SURGICAL OUTCOMES | 202240409349100404 |
| 2021 | King's College London London | U | $294,698 | paid | IDENTIFYING THE ROLE OF FOOD ADDITIVE EMULSIFIERS IN CROHN'S DISEASE | 202240409349100404 |
| 2021 | State of South Dakota Pierre, SD | U | $294,000 | paid | SOUTH DAKOTA FIRST RESPONDER AUTOMATED EXTERNAL DEFIBRILLATOR PROJECT | 202240409349100404 |
| 2021 | Trustees of the University of Pennsylvania Philadelphia, PA | B | $293,370 | approved, future | ULTRA PROCESSED DIET, GUT MICROBIOME IN CD | 202240409349100404 |
| 2021 | Cambridge University Hospitals Nhs Foundation Trust Cambridge | U | $292,476 | approved, future | UK IBD BIORESOURCE: TRANSLATING TODAY'S SCIENCE INTO CD TREATMENTS | 202240409349100404 |
| 2021 | Alimentiv Inc (fka Robarts) London | U | $291,998 | paid | STENOSIS THERAPY AND ANTI-FIBROTIC RESEARCH (STAR) CONSORTIUM | 202240409349100404 |
| 2021 | Stanford University Stanford, CA | C | $291,563 | paid | LONGITUDINAL STUDY OF MYOELECTRIC GUTPRINT OF CROHN'S PATIENTS | 202240409349100404 |
| 2021 | Trustees of Indiana University Bloomington, MI | U | $290,356 | approved, future | DEVELOPMENT OF REGULATORY ROADMAP FOR COLONOSCOPY PREP FOR CD | 202240409349100404 |
| 2021 | The Health & Housing Consortium Inc Bronx, NY | C | $290,000 | approved, future | STRATEGY BUILDING FOR HEALTH AND HOUSING CONSORTIUM EXPANSION | 202240409349100404 |
| 2021 | The University of Edinburgh Edinburgh | U | $288,719 | approved, future | DISCERN ALPHA CELL DYSFUNCTION AND CORRECTING GLUCAGON SECRETION | 202240409349100404 |
| 2021 | University of Oxford Oxford | U | $287,947 | approved, future | PHARMACOLOGICAL MODULATION TO ADDRESS GLUCAGON SECRETION IN T1D | 202240409349100404 |
| 2021 | Jdrf Australia Sydney | U | $287,210 | paid | ENDIA SCIENTIFIC DIRECTIONS 2018-2021 | 202240409349100404 |
| 2021 | Jaeb Center for Health Research Foundation Inc Tampa, FL | C | $286,747 | approved, future | EVAL OF THE RELATIONSHIP OF GLUCOSE METRICS VIA CGM RETINOPATHY | 202240409349100404 |
| 2021 | Trustees of the University of Pennsylvania Philadelphia, PA | B | $285,463 | approved, future | ULTRA PROCESSED DIET, GUT MICROBIOME IN CD | 202240409349100404 |
| 2021 | Trustees of the University of Pennsylvania Philadelphia, PA | B | $285,463 | approved, future | ULTRA PROCESSED DIET, GUT MICROBIOME IN CD | 202240409349100404 |
| 2021 | Australasian Gastro Intestinal Research Foundation Ltd Fitzroy | U | $285,429 | approved, future | FECAL MICROBIOTA TRANSPLANTATION IN CROHN'S DISEASE | 202240409349100404 |
| 2021 | Australasian Gastro Intestinal Research Foundation Ltd Fitzroy | U | $285,429 | approved, future | FECAL MICROBIOTA TRANSPLANTATION IN CROHN'S DISEASE | 202240409349100404 |
| 2021 | Clalit Health Services Tel Aviv | U | $285,221 | paid | CROHN'S DISEASE: UNDERSTANDING PATHOGENESIS, BEHAVIOR, RESPONSE | 202240409349100404 |
| 2021 | Trustees of the University of Pennsylvania Philadelphia, PA | B | $285,079 | approved, future | ULTRA PROCESSED DIET, GUT MICROBIOME IN CD | 202240409349100404 |
| 2021 | Weill Medical College of Cornell University New York, NY | U | $283,903 | approved, future | TARGETING THE MYCOBIOME IN CROHN'S DISEASE | 202240409349100404 |
| 2021 | Weill Medical College of Cornell University New York, NY | U | $283,902 | paid | TARGETING THE MYCOBIOME IN CROHNS DISEASE | 202240409349100404 |
| 2021 | The Regents of the University of Colorado Denver Aurora, CO | D | $283,726 | paid | FEASIBILITY EVAL OF AID IN PRIMARY CARE AND THROUGH TELEHEALTH | 202240409349100404 |
| 2021 | Jaeb Center for Health Research Foundation Inc Tampa, FL | C | $283,542 | approved, future | EXERCISE IN DIABETES INITIATIVE: PEDIATRIC STUDY | 202240409349100404 |
| 2021 | Children's Hospital Medical Center Cincinnati, OH | B | $282,554 | approved, future | BIOMARKERS OF INTESTINAL FIBROSIS IN SMALL BOWEL CROHN'S | 202240409349100404 |
| 2021 | Children's Hospital of Philadelphia Philadelphia, PA | C | $281,734 | approved, future | CROHN'S EPITHELIAL STEM CELL ATLAS: PEDIATRIC TO ADULT CONTINUUM | 202240409349100404 |
| 2021 | Oregon Health & Science University Portland, OR | U | $281,554 | paid | DESIGN AND EVALUATION OF A MDI DECISION SUPPORT SYSTEM | 202240409349100404 |
| 2021 | Project Nyame Nsa Ltd Manhasset, NY | U | $280,750 | paid | PROJECT NYAME NSA ZAMBIA EXPANSION | 202240409349100404 |
| 2021 | University of Dundee Dundee | U | $279,562 | approved, future | UNDERSTANDING ORGAN SPECIFIC CONSEQUENCES OF HYPOGLYCEMIA | 202240409349100404 |
| 2021 | Project Nyame Nsa Ltd Manhasset, NY | U | $277,650 | approved, future | PROJECT NYAME NSA ZAMBIA EXPANSION | 202240409349100404 |
| 2021 | University of Washington Seattle, WA | B | $274,851 | paid | COMPUTATIONAL DESIGN OF GLUCOSE RESPONSIVE CYCLIC PEPTIDES | 202240409349100404 |
| 2021 | Children's Hospital of Philadelphia Philadelphia, PA | C | $272,676 | approved, future | CROHN'S EPITHELIAL STEM CELL ATLAS: PEDIATRIC TO ADULT CONTINUUM | 202240409349100404 |
| 2021 | Association Sante Diabete Grenoble | U | $272,362 | approved, future | DIABETES SUPPORT IN BURKINA FASO, MALI AND UNION OF COMOROS | 202240409349100404 |
| 2021 | The Hospital for Sick Children Toronto | U | $271,920 | paid | DEFINING AND DEVELOPING THE THERAPEUTIC PIPELINE FOR VEO-IBD | 202240409349100404 |
| 2021 | Hebrew University of Jerusalem Jerusalem | D | $271,601 | paid | METHYLATION PATTERNS OF CELL-FREE DNA AS A BIOMARKER IN CROHN'S | 202240409349100404 |
| 2021 | Consorci Institut D'investigaciones Biomedicas Barcelona | U | $270,828 | approved, future | EARLY DETECTION OF PERIANAL FISTULIZING DISEASE | 202240409349100404 |
| 2021 | Children's Hospital Corporation Boston, MA | C | $270,512 | paid | DEFINING AND DEVELOPING THE THERAPEUTIC PIPELINE FOR VEO-IBD: BOSTON | 202240409349100404 |
| 2021 | Children's Hospital Corporation Boston, MA | C | $270,512 | paid | DEFINING AND DEVELOPING THE THERAPEUTIC PIPELINE FOR VEO-IBD | 202240409349100404 |
| 2021 | The Sonia Nabeta Foundation Inc New York, NY | C | $270,054 | paid | PROJECT BODA-BODA | 202240409349100404 |
| 2021 | Wyoming Department of Health Cheyenne, WY | U | $269,693 | approved, future | WYOMING FIRST RESPONDER AED PROJECT | 202240409349100404 |
| 2021 | University of Exeter Exeter | U | $268,565 | approved, future | STIMULATED GLUCAGON LEVELS BIOMARKER OF HYPOGLYCEMIA RISK IN T1D | 202240409349100404 |
| 2021 | Cambridge University Hospitals Nhs Foundation Trust Cambridge | U | $268,528 | approved, future | UK IBD BIORESOURCE: TRANSLATING TODAY'S SCIENCE INTO CD TREATMENTS | 202240409349100404 |
| 2021 | Cedars-Sinai Medical Center Los Angeles, CA | B | $268,151 | approved, future | INTEGRATING GENOMIC AND IMAGING DATA TO UNDERSTAND CD | 202240409349100404 |
| 2021 | Friends of the Israel Defense Forces New York, NY | B | $268,000 | paid | IMPACT! SCHOLARSHIP PROGRAM | 202240409349100404 |
| 2021 | Icahn School of Medicine at Mount Sinai New York City, NY | B | $267,814 | approved, future | SAFETY AND TOLERABILITY OF ORAL BFAHF-2 IN PEDIATRIC CROHN'S | 202240409349100404 |
| 2021 | Institut D'investigaciones Biomedicas August Pi I Sunyer Barcelona | U | $267,204 | paid | EARLY DETECTION OF PERIANAL FISTULIZING DISEASE | 202240409349100404 |
| 2021 | Jaeb Center for Health Research Foundation Inc Tampa, FL | C | $263,371 | paid | EXERCISE IN DIABETES INITIATIVE: PEDIATRIC STUDY | 202240409349100404 |
| 2021 | Public Health Solutions New York, NY | B | $262,335 | approved, future | NEW YORK CITY FUND FOR YOUTH AND FAMILY HOMELESSNESS | 202240409349100404 |
| 2021 | Consorci Institut D'investigaciones Biomedicas Barcelona | U | $262,204 | approved, future | EARLY DETECTION OF PERIANAL FISTULIZING DISEASE | 202240409349100404 |
| 2021 | The Hospital for Sick Children Toronto | U | $262,028 | paid | DEFINING AND DEVELOPING THE THERAPEUTIC PIPELINE FOR VEO-IBD | 202240409349100404 |
| 2021 | Consorci Institut D'investigaciones Biomedicas Barcelona | U | $261,948 | approved, future | EARLY DETECTION OF PERIANAL FISTULIZING DISEASE | 202240409349100404 |
| 2021 | T1d Exchange Inc Boston, MA | U | $261,908 | approved, future | DATA TO IMPROVE QUALITY AND OUTCOMES FOR INDIVIDUALS WITH T1D | 202240409349100404 |
| 2021 | University of Glasgow Court Glasgow | U | $260,860 | paid | THE CLINICAL EFFECTIVENESS OF CD-TREAT IN PATIENTS WITH ACTIVE CROHN'S | 202240409349100404 |
| 2021 | Saint Louis University Saint Louis, MO | B | $260,774 | approved, future | NOVEL TARGET TO FIGHT ALPHA CELL DYSFUNCTION STOP HYPOGLYCEMIA IN T1D | 202240409349100404 |
| 2021 | Katholieke Universiteit Leuven Leuven | U | $259,027 | paid | INNODIA HARVEST | 202240409349100404 |
| 2021 | Healthpartners Institute Minneapolis, MN | B | $258,500 | approved, future | DIRECT INTEGRATION OF CGM DATA INTO THE EMR | 202240409349100404 |
| 2021 | Council On the Environment Inc New York, NY | B | $257,703 | paid | INTER-GENERATIONAL, VIABLE GREENSPACE IN NYCHA COMMUNITIES | 202240409349100404 |
| 2021 | Healthpartners Institute Minneapolis, MN | B | $257,534 | paid | DIRECT INTEGRATION OF CGM DATA INTO THE EMR | 202240409349100404 |
| 2021 | King's College London London | U | $257,531 | approved, future | MULTIPEPT1DE PROOF-OF-CONCEPT STUDY: STAGE III | 202240409349100404 |
| 2021 | Trustees of the University of Pennsylvania Philadelphia, PA | B | $256,967 | approved, future | ULTRA PROCESSED DIET, GUT MICROBIOME IN CD | 202240409349100404 |
| 2021 | Trustees of the University of Pennsylvania Philadelphia, PA | B | $256,967 | approved, future | ULTRA PROCESSED DIET, GUT MICROBIOME IN CD | 202240409349100404 |
| 2021 | The Sheba Fund for Health Services and Research (ra) Ramat Gan | U | $255,306 | paid | COMPREHENSIVE INDIVIDUALIZED PROACTIVE THERAPY OF CROHN'S DISEASE | 202240409349100404 |
| 2021 | Massachusetts General Hospital Boston, MA | C | $254,915 | paid | STUDYING RAPID ACTING ANALOG DIFFERENCE ON GLUCOSE CONTROL | 202240409349100404 |
| 2021 | Mayo Clinic Rochester, MN | U | $254,489 | paid | STENOSIS THERAPY AND ANTI-FIBROTIC RESEARCH CONSORTIUM | 202240409349100404 |
| 2021 | Stichting Pharmaccess International Amsterdam | U | $254,457 | approved, future | INVESTING IN QUALITY HEALTHCARE THROUGH SAFECARE | 202240409349100404 |
| 2021 | Simulation in Motion Montana Inc Helena, MT | B | $253,174 | paid | CAPACITY BUILDING TOWARD A SUSTAINABLE SIMULATION IN MOTION MONTANA | 202240409349100404 |
| 2021 | Simulation in Motion Montana Inc Helena, MT | B | $253,173 | paid | CAPACITY BUILDING TOWARD A SUSTAINABLE SIMULATION IN MOTION MONTANA | 202240409349100404 |
| 2021 | Simulation in Motion Montana Inc Helena, MT | B | $253,173 | paid | CAPACITY BUILDING TOWARD A SUSTAINABLE SIMULATION IN MOTION MONTANA | 202240409349100404 |
| 2021 | The Chinese University of Hong Kong Shatin | U | $251,789 | approved, future | GLOBAL IBD VISUALIZATION OF EPIDEMIOLOGY STUDIES | 202240409349100404 |
| 2021 | New York City Health and Hospitals Corporation New York, NY | C | $250,000 | paid | EXPRESSCARE PLATFORM UPDATE AND SERVICE DELIVERY TO HOMELESS | 202240409349100404 |
| 2021 | Vanderbilt University Medical Center Nashville, TN | C | $250,000 | approved, future | DEVELOPING AN ISLET MODEL THAT MIMICS T1D | 202240409349100404 |
| 2021 | Washington University St Louis, MO | C | $250,000 | approved, future | MANIPULATING ALPHA CELL SIGNALING TO RESTORE GLUCAGON SECRETORY | 202240409349100404 |
| 2021 | Barzilai Medical Center Ashkelon | U | $250,000 | paid | COVID-19 PANDEMIC RESPONSE | 202240409349100404 |
| 2021 | Vanderbilt University Medical Center Nashville, TN | C | $250,000 | paid | DEVELOPING AN ISLET MODEL THAT MIMICS T1D | 202240409349100404 |
| 2021 | Regents of the University of Minnesota Minneapolis, MN | U | $250,000 | approved, future | PHASE 2: ENGINEERING ANTIGEN-SPECIFIC REGULATORY T CELLS FOR T1D | 202240409349100404 |
| 2021 | King's College London London | U | $250,000 | approved, future | MULTIPEPT1DE PROOF-OF-CONCEPT STUDY: STAGE III | 202240409349100404 |
| 2021 | Yitzhak Shamir Medical Center Beer Yaakov | U | $250,000 | paid | COVID 19 PANDEMIC RESPONSE | 202240409349100404 |
| 2021 | Galilee Medical Center Naharyia | U | $250,000 | paid | MOBILE X-RAY MACHINES FOR CORONAVIRUS ISOLATION WARDS | 202240409349100404 |
| 2021 | Washington University St Louis, MO | C | $250,000 | paid | MANIPULATING ALPHA CELL SIGNALING TO RESTORE NORMAL GLUCAGON SECRETORY | 202240409349100404 |
| 2021 | University of Miami Coral Gables, FL | U | $250,000 | paid | DEVELOP A METHOD OF STUDYING ALPHA CELL FUNCTION IN PANCREATIC SLICE | 202240409349100404 |
| 2021 | King's College London London | U | $250,000 | approved, future | MULTIPEPT1DE PROOF-OF-CONCEPT STUDY: STAGE III | 202240409349100404 |
| 2021 | Cedars-Sinai Medical Center Los Angeles, CA | B | $250,000 | paid | CREATION OF IBD COVID-19 REGISTRY AND SAMPLE DATABASE | 202240409349100404 |
| 2021 | New York City Health and Hospitals Corporation New York, NY | C | $250,000 | approved, future | EXPRESSCARE PLATFORM UPDATE AND SERVICE DELIVERY TO HOMELESS | 202240409349100404 |
| 2021 | University of Miami Coral Gables, FL | U | $250,000 | approved, future | DEVELOP A METHOD OF STUDYING ALPHA CELL FUNCTION IN PANCREATIC SLICE | 202240409349100404 |
| 2021 | Center for Excellence in Health Care Journalism Columbia, MO | C | $250,000 | approved, future | TRAINING AND DEVELOPMENT OF HEALTH CARE JOURNALISTS AND REPORTING | 202240409349100404 |
| 2021 | Uppsala Universitet Uppsala | U | $249,929 | approved, future | ALPHA-CELL SIGNALING FOR GLUCAGON SECRETION | 202240409349100404 |
| 2021 | University of Utah Salt Lake City, UT | B | $249,717 | approved, future | ANTI-PHAGE ANTIBODIES: CROHN'S DIAGNOSIS AND TREATMENT RESPONSE | 202240409349100404 |
| 2021 | The Chinese University of Hong Kong Shatin | U | $249,337 | approved, future | GLOBAL IBD VISUALIZATION OF EPIDEMIOLOGY STUDIES | 202240409349100404 |
| 2021 | Hebrew University of Jerusalem Jerusalem | D | $249,301 | approved, future | METHYLATION PATTERNS OF CELL-FREE DNA AS A BIOMARKER IN CROHN'S | 202240409349100404 |
| 2021 | Katholieke Universiteit Leuven Leuven | U | $248,850 | paid | AN ENTEROCHROMAFFIN CELL AND MACROPHAGE ATLAS OF THE HUMAN GUT | 202240409349100404 |
| 2021 | University of Florida Gainesville, FL | U | $248,597 | approved, future | T CELL RECEPTOR SEQUENCING IN T1D - BIOMARKER & TECHNOLOGY | 202240409349100404 |
| 2021 | University of Cambridge Cambridge | U | $247,545 | approved, future | CLOSED LOOP INSULIN DELIVERY IN NEWLY DIAGNOSED YOUTH WITH T1D | 202240409349100404 |
| 2021 | Altru Health System Grand Forks, ND | B | $247,298 | paid | ALTRU HEALTH SYSTEM COVID-19 CARDIAC PREPAREDNESS PROJECT | 202240409349100404 |
| 2021 | University of Utah Salt Lake City, UT | B | $246,267 | approved, future | ANTI-PHAGE ANTIBODIES: CROHN'S DIAGNOSIS AND TREATMENT RESPONSE | 202240409349100404 |
| 2021 | University of Utah Salt Lake City, UT | B | $246,267 | approved, future | ANTI-PHAGE ANTIBODIES: CROHN'S DIAGNOSIS AND TREATMENT RESPONSE | 202240409349100404 |
| 2021 | Universite Catholique de Louvain Louvainlaneuve | U | $246,186 | approved, future | DIRECT AND INDIRECT CAUSES FOR THE GLUCAGON SECRETION IN T1D | 202240409349100404 |
| 2021 | University of Utah Salt Lake City, UT | B | $245,583 | paid | ANTI-PHAGE ANTIBODIES: CROHNS DISEASE DIAGNOSIS AND TREATMENT | 202240409349100404 |
| 2021 | Universite Catholique de Louvain Louvainlaneuve | U | $243,257 | paid | DIRECT AND INDIRECT CAUSES FOR THE IMPAIRED GLUCAGON SECRETION IN T1D | 202240409349100404 |
| 2021 | Clalit Health Services Tel Aviv | U | $243,216 | approved, future | THE NUTRITIONAL EDUCATION PROGRAM FOR CD CONTROL & PREVENTION | 202240409349100404 |
| 2021 | Clalit Health Services Tel Aviv | U | $243,216 | approved, future | THE NUTRITIONAL EDUCATION PROGRAM FOR CD CONTROL & PREVENTION | 202240409349100404 |
| 2021 | Mayo Clinic Rochester, MN | U | $243,059 | paid | 2019-2021 MILITARY SCIENCES MEDICAL TRAINING/SUPPORT PROJECT | 202240409349100404 |
| 2021 | Clalit Health Services Tel Aviv | U | $242,153 | approved, future | THE IBDMED NUTRITIONAL EDUCATION PROGRAM FOR CD | 202240409349100404 |
| 2021 | Clalit Health Services Tel Aviv | U | $242,153 | approved, future | THE NUTRITIONAL EDUCATION PROGRAM FOR CD CONTROL & PREVENTION | 202240409349100404 |
| 2021 | Herlev Og Gentofte Hospital Herlev | U | $241,665 | approved, future | TARGETING GIP/GLP-2 RECEPTORS TO PREVENT HYPOGLYCEMIA IN T1D | 202240409349100404 |
| 2021 | Project Nyame Nsa Ltd Manhasset, NY | U | $241,600 | approved, future | PROJECT NYAME NSA ZAMBIA EXPANSION | 202240409349100404 |
| 2021 | South Dakota Division of Parks and Recreation Pierre, SD | U | $240,625 | paid | CUSTER STATE PARK LEGION LAKE FIRE REHABILITATION PROJECT | 202240409349100404 |
| 2021 | The Health & Housing Consortium Inc Bronx, NY | C | $240,000 | paid | STRATEGY BUILDING FOR HEALTH AND HOUSING CONSORTIUM EXPANSION | 202240409349100404 |
| 2021 | The Chinese University of Hong Kong Shatin | U | $239,672 | approved, future | GLOBAL IBD VISUALIZATION OF EPIDEMIOLOGY STUDIES, 21ST CEN | 202240409349100404 |
| 2021 | The Broad Institute Inc Cambridge, MA | B | $239,643 | paid | HUMAN COLON AND SMALL INTESTINE CELL ATLAS IN HEALTH AND CROHN'S DISEASE | 202240409349100404 |
| 2021 | Johns Hopkins University Baltimore, MD | U | $239,373 | approved, future | A MULTIDISCIPLINARY APPROACH TO FISTULA-IN-ANO IN CROHN'S | 202240409349100404 |
| 2021 | Johns Hopkins University Baltimore, MD | U | $239,373 | paid | A MULTIDISCIPLINARY BIOENGINEERING APPROACH TO FISTULA-IN-ANO | 202240409349100404 |
| 2021 | The Legatum Institute Foundation London | U | $236,923 | paid | UNITED STATES PROSPERITY INDEX | 202240409349100404 |
| 2021 | Johns Hopkins University Baltimore, MD | U | $236,110 | paid | A MULTIDISCIPLINARY APPROACH TO FISTULA-IN-ANO IN CROHN'S | 202240409349100404 |
| 2021 | Shaare Zedek Medical Center Jerusalem | D | $235,980 | paid | PREVENTION OF INFLAMMATORY BOWEL DISEASES IN PERSONS AT RISK | 202240409349100404 |
| 2021 | Tampere University Foundation Sr Tampere | U | $235,290 | paid | VIRUSES AND ANTIVIRAL IMMUNE MARKERS IN TWO ENDOTYPES OF T1D | 202240409349100404 |
| 2021 | Cedars-Sinai Medical Center Los Angeles, CA | B | $231,849 | approved, future | INTEGRATING GENOMIC AND IMAGING DATA TO UNDERSTAND CD | 202240409349100404 |
| 2021 | Vanderbilt University Nashville, TN | C | $231,831 | approved, future | UNDERSTANDING CALCIUM SIGNALING IN ALPHA CELLS IN T1D | 202240409349100404 |
| 2021 | The Regents of the University of California San Francisco San Francisco, CA | U | $230,900 | approved, future | RITUXIMAB FOLLOWED BY ABATACEPT FOR PREVENTION OR REVERSAL OF T1D | 202240409349100404 |
| 2021 | The Regents of the University of California San Francisco San Francisco, CA | U | $230,900 | approved, future | RITUXIMAB FOLLOWED BY ABATACEPT FOR PREVENTION OR REVERSAL OF T1D | 202240409349100404 |
| 2021 | The Regents of the University of California San Francisco San Francisco, CA | U | $230,900 | approved, future | RITUXIMAB FOLLOWED BY ABATACEPT FOR PREVENTION OR REVERSAL OF T1D | 202240409349100404 |
| 2021 | Institut Nationale de la Sante Et de la Recherche Medicale Paris | U | $227,975 | approved, future | BENIGN ISLET AUTOIMMUNITY TO T1D: CELL BIOMARKERS OF PROGRESSION | 202240409349100404 |
| 2021 | Vanderbilt University Nashville, TN | C | $225,833 | paid | UNDERSTANDING CALCIUM SIGNALING IN ALPHA CELLS IN T1D | 202240409349100404 |
| 2021 | Stanford University Stanford, CA | C | $225,000 | paid | SUPPORTING INDIVIDUALS IN NEED WITH T1D IMPACTED BY COVID-19 | 202240409349100404 |
| 2021 | The University of Chicago Chicago, IL | U | $223,430 | paid | THE CONNECTOME OF THE HUMAN ENTERIC SYSTEM IN HEALTH AND CROHN'S | 202240409349100404 |
| 2021 | Children's Hospital Medical Center Cincinnati, OH | B | $222,483 | approved, future | PRECISION CROHN'S MANAGEMENT UTILIZING PREDICTIVE PROTEIN PANELS | 202240409349100404 |
| 2021 | Campbell County Hospital District Gillette, WY | B | $220,434 | paid | COVID-19 CARDIAC PREPAREDNESS PROJECT | 202240409349100404 |
| 2021 | Herlev Og Gentofte Hospital Herlev | U | $220,005 | paid | TARGETING GIP/GLP RECEPTORS TO PREVENT HYPOGLYCEMIA IN T1D | 202240409349100404 |
| 2021 | Clalit Health Services Tel Aviv | U | $219,751 | paid | THE IBDMED NUTRITIONAL EDUCATION PROGRAM FOR CD CONTROL & PREVENTION | 202240409349100404 |
| 2021 | Montana Department of Public Health and Human Services Helena, MT | U | $219,190 | approved, future | MONTANA FIRST RESPONDER AED PROJECT | 202240409349100404 |
| 2021 | Jaeb Center for Health Research Foundation Inc Tampa, FL | C | $218,347 | approved, future | EVAL OF THE RELATIONSHIP OF GLUCOSE METRICS VIA CGM W/DIAB. RETINOPATHY | 202240409349100404 |
| 2021 | Association of Diabetes Care & Education Specialists Chicago, IL | B | $216,544 | approved, future | AADE TECHNOLOGY INSTITUTE: DANA - DIABETES ADVANCED NETWORK ACCESS | 202240409349100404 |
| 2021 | Shaare Zedek Medical Center Jerusalem | D | $214,337 | paid | POPULATION-BASED ANALYSES OF IBD USING ADMINISTRATIVE DATABASE | 202240409349100404 |
| 2021 | Providence Medical Center Wayne, NE | B | $214,145 | paid | EPHARMACY AT PROVIDENCE MEDICAL CENTER | 202240409349100404 |
| 2021 | Massachusetts General Hospital Boston, MA | C | $211,564 | paid | DEFINING DISEASE BIOLOGY FOR PREVENTION | 202240409349100404 |
| 2021 | The Regents of the University of Colorado Denver Aurora, CO | D | $211,200 | approved, future | SINGLE PERSISTENT ISLET AUTOANTIBODY PHENOTYPE: RISK ANALYSIS | 202240409349100404 |
| 2021 | Asian Health Care Foundation Hyderabad | U | $210,551 | approved, future | ACCESS TO CROHN'S DIAGNOSTICS IN INDIA FOR PATIENTS LIVING IN POVERTY | 202240409349100404 |
| 2021 | Asian Health Care Foundation Hyderabad | U | $210,221 | paid | ACCESS TO CROHN'S DIAGNOSTICS IN INDIA FOR PATIENTS LIVING IN POVERTY | 202240409349100404 |
| 2021 | Clalit Health Services Tel Aviv | U | $209,642 | approved, future | THE NUTRITIONAL EDUCATION PROGRAM FOR CD CONTROL & PREVENTION | 202240409349100404 |
| 2021 | King's College London London | U | $209,247 | approved, future | MULTIPEPT1DE PROOF-OF-CONCEPT STUDY: STAGE III | 202240409349100404 |
| 2021 | Rambam Health Corporation Haifa | D | $208,850 | paid | PREDICTING AND OPTIMIZING DRUG THERAPY IN CROHN'S DISEASE | 202240409349100404 |
| 2021 | Carilion Medical Center Roanoke, VA | C | $207,652 | approved, future | ESTABLISHING NEW PARADIGMS IN PRE-CLINICAL CROHN'S | 202240409349100404 |
| 2021 | Association Sante Diabete Grenoble | U | $205,984 | approved, future | DIABETES SUPPORT TO BURKINA FASO, MALI AND UNION OF COMOROS | 202240409349100404 |
| 2021 | Simulation in Motion Montana Inc Helena, MT | B | $204,364 | approved, future | CAPACITY BUILDING TOWARD A SUSTAINABLE SIMULATION IN MOTION MONTANA | 202240409349100404 |
| 2021 | Ibd Passport London | U | $201,695 | paid | IBD-PASSPORT: A WEB-BASED SUPPORT PLATFORM FOR TRAVELERS WITH IBD | 202240409349100404 |
| 2021 | King's College London London | U | $201,418 | paid | T CELL RECEPTOR SEQUENCING IN T1D - BIOMARKER & TECHNOLOGY | 202240409349100404 |
| 2021 | Vivli Inc Cambridge, MA | C | $200,918 | paid | VIVLI GLOBAL PLATFORM FOR OPEN REPRODUCIBLE CLINICAL RESEARCH | 202240409349100404 |
| 2021 | Jdrf International New York, NY | U | $200,663 | paid | ADDITIONAL SIGNALS FOR GLUCOSE CONTROL | 202240409349100404 |
| 2021 | American Heart Association Inc Dallas, TX | B | $200,000 | paid | COVID-19 RESPONSE: OXYGENATION AND VENTILATION TRAINING HUB | 202240409349100404 |
| 2021 | University of Florida Gainesville, FL | U | $200,000 | paid | SUPPORTING INDIVIDUALS IN NEED WITH T1D IMPACTED BY COVID-19 | 202240409349100404 |
| 2021 | Care for the Homeless New York, NY | B | $200,000 | paid | COVID-19 PANDEMIC EMERGENCY ASSISTANCE: HOMELESS HEALTHCARE | 202240409349100404 |
| 2021 | The Diatribe Foundation San Francisco, CA | C | $200,000 | approved, future | DIATRIBE LEARN | 202240409349100404 |
| 2021 | Project Renewal Inc New York, NY | B | $200,000 | paid | NEW YORK CITY COLLABORATIVE FOR HOMELESS HEALTHCARE | 202240409349100404 |
| 2021 | Endocrine Society Washington, DC | B | $200,000 | paid | ENDOCRINE FELLOWS SERIES: T1D CARE AND MANAGEMENT (2018-2020) | 202240409349100404 |
| 2021 | For Inspiration and Recognition of Science and Technology Manchester, NH | C | $200,000 | approved, future | INSPIRE YOUNG PEOPLE TO BE SCIENCE AND TECHNOLOGY LEADERS | 202240409349100404 |
| 2021 | Care for the Homeless New York, NY | B | $200,000 | paid | NEW YORK CITY COLLABORATIVE FOR HOMELESS HEALTHCARE | 202240409349100404 |
| 2021 | The Max Stern Academic College of Emek Yezreel | U | $200,000 | paid | SCHOLARSHIP AND AID FOR ETHIOPIAN-ISRAELIS SEEKING NURSING DEGREES | 202240409349100404 |
| 2021 | Project Renewal Inc New York, NY | B | $200,000 | paid | COVID-19 PANDEMIC EMERGENCY ASSISTANCE: HOMELESS HEALTHCARE | 202240409349100404 |
| 2021 | For Inspiration and Recognition of Science and Technology Manchester, NH | C | $200,000 | approved, future | INSPIRE YOUNG PEOPLE TO BE SCIENCE AND TECHNOLOGY LEADERS | 202240409349100404 |
| 2021 | For Inspiration and Recognition of Science and Technology Manchester, NH | C | $200,000 | paid | INSPIRE YOUNG PEOPLE TO BE SCIENCE AND TECHNOLOGY LEADERS | 202240409349100404 |
| 2021 | Shatterproof a Nonprofit Corp Norwalk, CT | U | $200,000 | approved, future | GENERAL OPERATING SUPPORT | 202240409349100404 |
| 2021 | New York-Presbyterian Fund Inc New York, NY | C | $200,000 | approved, future | IMPROVING CARE FOR UNDERSERVED CHILDREN WITH T1D | 202240409349100404 |
| 2021 | Center for Urban Community Services Inc New York, NY | U | $200,000 | paid | NEW YORK CITY COLLABORATIVE FOR HOMELESS HEALTHCARE | 202240409349100404 |
| 2021 | The Mayors Fund to Advance New York City New York, NY | B | $200,000 | paid | STRENGTHENING THE NYC EMERGENCY FOOD SYSTEM DURING COVID | 202240409349100404 |
| 2021 | King's College London London | U | $200,000 | approved, future | MULTIPEPT1DE PROOF-OF-CONCEPT STUDY: STAGE III | 202240409349100404 |
| 2021 | New York-Presbyterian Fund Inc New York, NY | C | $200,000 | paid | IMPROVING CARE FOR UNDERSERVED CHILDREN WITH T1D | 202240409349100404 |
| 2021 | Center for Urban Community Services Inc New York, NY | U | $200,000 | paid | COVID-19 PANDEMIC EMERGENCY ASSISTANCE: HOMELESS HEALTHCARE | 202240409349100404 |
| 2021 | Shatterproof a Nonprofit Corp Norwalk, CT | U | $200,000 | approved, future | GENERAL OPERATING SUPPORT | 202240409349100404 |
| 2021 | The Regents of the University of Colorado Denver Aurora, CO | D | $200,000 | paid | DEVELOPMENT OF A CONTINUOUS INSULIN-GLUCOSE SENSOR | 202240409349100404 |
| 2021 | Youth Development Organization Inc Lawrence, MA | B | $200,000 | paid | EDUCATION AND CHARACTER DEVELOPMENT FOR LOCAL YOUTH | 202240409349100404 |
| 2021 | The Regents of the University of Colorado Denver Aurora, CO | D | $200,000 | paid | DEVELOPMENT OF A CONTINUOUS INSULIN-GLUCOSE SENSOR | 202240409349100404 |
| 2021 | Institut Nationale de la Sante Et de la Recherche Medicale Paris | U | $200,000 | paid | BENIGN ISLET AUTOIMMUNITY TO T1D: T-CELL BIOMARKERS OF PROGRESSION | 202240409349100404 |
| 2021 | Insulin for Life USA Inc Gainesville, FL | B | $199,273 | paid | DIABETES DEVICES FOR CLINICS IN THE U.S. DURING THE COVID-19 PANDEMIC | 202240409349100404 |
| 2021 | Dartmouth- Hitchcock Clinic Lebanon, NH | B | $197,461 | approved, future | CAPACITY BUILDING FOR VIRTUAL IBD TELEMEDICINE NETWORK PROGRAM | 202240409349100404 |
| 2021 | Monument Health Network Inc Rapid City, SD | C | $196,164 | paid | MONUMENT HEALTH COVID-19 CARDIAC PREPAREDNESS PROJECT | 202240409349100404 |
| 2021 | Wyoming Medical Center Foundation Casper, WY | U | $196,164 | paid | WYOMING MEDICAL CENTER COVID-19 CARDIAC PREPAREDNESS PROJECT | 202240409349100404 |
| 2021 | Stanford University Stanford, CA | C | $195,947 | paid | EXERCISE EDUCATION AT NEW ONSET OF T1D | 202240409349100404 |
| 2021 | Dartmouth- Hitchcock Clinic Lebanon, NH | B | $195,140 | approved, future | CAPACITY BUILDING FOR VIRTUAL IBD TELEMEDICINE NETWORK PROGRAM | 202240409349100404 |
| 2021 | Insulin for Life USA Inc Gainesville, FL | B | $193,050 | paid | STRENGTHENING ORGANIZATIONAL CAPACITY | 202240409349100404 |
| 2021 | The Governors of the University of Calgary Calgary | D | $191,883 | approved, future | THE CHANGING EPIDEMIOLOGY OF CROHN'S IN THE WESTERN WORLD | 202240409349100404 |
| 2021 | Montana Department of Public Health and Human Services Helena, MT | U | $191,663 | approved, future | MONTANA FIRST RESPONDER AED PROJECT | 202240409349100404 |
| 2021 | Sanford Research Sioux Fall, SD | C | $190,503 | approved, future | SANFORD PLEDGE: PHASES 1 AND 2 | 202240409349100404 |
| 2021 | The Governors of the University of Calgary Calgary | D | $188,736 | approved, future | THE CHANGING EPIDEMIOLOGY OF CROHN'S IN THE WESTERN WORLD | 202240409349100404 |
| 2021 | Iowa Department of Public Health Des Moines, IA | U | $186,944 | approved, future | IOWA FIRST RESPONDER AED INITIATIVE | 202240409349100404 |
| 2021 | The Governors of the University of Calgary Calgary | D | $186,777 | approved, future | THE CHANGING EPIDEMIOLOGY OF CROHN'S IN THE WESTERN WORLD | 202240409349100404 |
| 2021 | Governing Council of the University of Toronto Toronto | D | $185,460 | approved, future | RESPONSIVE GLUCAGON MICRONEEDLE PATCH - HYPOGLYCEMIA PREVENTION | 202240409349100404 |
| 2021 | Wyoming State Parks and Cultural Resources Cheyenne, WY | U | $185,000 | paid | INTERPRETIVE CENTER AT FORT PHIL KEARNY STATE HISTORIC SITE | 202240409349100404 |
| 2021 | The Sderot Development Foundation Sderot | U | $184,286 | approved, future | SDEROT COMPLEX, RESILIENCE CENTER AND PARENTHOOD HOUSE | 202240409349100404 |
| 2021 | Wyoming Department of Health Cheyenne, WY | U | $183,693 | approved, future | WYOMING FIRST RESPONDER AED PROJECT | 202240409349100404 |
| 2021 | Salvation Army World Service Office Alexandria, VA | C | $183,266 | paid | IMPROVE PRIMARY HEALTH CARE SERVICES IN CHIKANKATA, ZAMBIA | 202240409349100404 |
| 2021 | The Max Stern Academic College of Emek Yezreel | U | $183,251 | paid | AUGMENT EQUIPMENT AND SYSTEMS AT NURSING SCHOOL SIMULATION CENTER | 202240409349100404 |
| 2021 | International Development Enterprises Denver, CO | C | $183,193 | paid | CLOSING THE GAP ON IMPROVED SANITATION IN NORTHERN GHANA | 202240409349100404 |
| 2021 | Stanford University Stanford, CA | C | $183,151 | approved, future | EXERCISE EDUCATION AT NEW ONSET OF T1D | 202240409349100404 |
| 2021 | Carilion Medical Center Roanoke, VA | C | $181,208 | approved, future | ESTABLISHING NEW PARADIGMS IN PRE-CLINICAL CROHN'S | 202240409349100404 |
| 2021 | Regents of the University of California Santa Barbara Santa Barbara, CA | U | $180,000 | paid | NOVEL PATCH PUMP MECHANISM | 202240409349100404 |
| 2021 | State of South Dakota Pierre, SD | U | $178,000 | approved, future | SOUTH DAKOTA FIRST RESPONDER AUTOMATED DEFIBRILLATOR PROJECT | 202240409349100404 |
| 2021 | Technische Universitaet Muenchen Munchen | U | $177,980 | paid | FMT FOR MAINTENANCE OF REMISSION IN PEDIATRIC CROHN'S DISEASE | 202240409349100404 |
| 2021 | King's College London London | U | $177,354 | approved, future | EVALUATE THE BIOLOGICAL, SOCIAL AND ECONOMIC IMPACT OF HYPOGLYCEMIA | 202240409349100404 |
| 2021 | King's College London London | U | $177,354 | approved, future | EVALUATE THE BIOLOGICAL, SOCIAL AND ECONOMIC IMPACT OF HYPOGLYCEMIA | 202240409349100404 |
| 2021 | Clalit Health Services Tel Aviv | U | $177,281 | approved, future | COVID-19 VACCINE RESPONSES IN PATIENTS WITH IBD | 202240409349100404 |
| 2021 | Uppsala Universitet Uppsala | U | $177,173 | approved, future | ALPHA-CELL SIGNALING FOR GLUCAGON SECRETION | 202240409349100404 |
| 2021 | Stanford University Stanford, CA | C | $176,497 | approved, future | EXERCISE EDUCATION AT NEW ONSET OF T1D | 202240409349100404 |
| 2021 | Floresta USA Incorporated San Diego, CA | C | $175,400 | paid | EQUIPPING RURAL FAMILIES IN THE AMHARA REGION OF ETHIOPIA | 202240409349100404 |
| 2021 | Crohn's Colitis Cure Sydney | U | $175,233 | approved, future | DEVELOPMENT OF A PEDIATRIC CD EMR TO DRIVE CONSISTENCY IN CARE | 202240409349100404 |
| 2021 | The Milken Institute Santa Monica, CA | B | $174,998 | approved, future | CURES FOR LIFE: PATIENT ACCESS TO CELL AND GENE THERAPY | 202240409349100404 |
| 2021 | University of Iowa Iowa City, IA | U | $174,321 | approved, future | RUPRI HEALTH PANEL SUPPORT | 202240409349100404 |
| 2021 | North Dakota Department of Health Bismarck, ND | U | $173,689 | approved, future | NORTH DAKOTA LAW ENFORCEMENT AED PROJECT | 202240409349100404 |
| 2021 | University of Cambridge Cambridge | U | $170,680 | paid | CLOSED LOOP INSULIN DELIVERY IN NEWLY DIAGNOSED YOUTH WITH T1D | 202240409349100404 |
| 2021 | Adventist Health Systemsunbelt Inc Orlando, FL | C | $170,340 | paid | DETERMINING WHETHER AGONISTS MIGHT PREVENT HYPOGLYCEMIA | 202240409349100404 |
| 2021 | Jdrf International New York, NY | U | $167,907 | paid | ADDITIONAL SIGNALS TO IMPROVE GLUCOSE CONTROL SURROUNDING EXERCISE | 202240409349100404 |
| 2021 | The Regents of the University of Colorado Denver Aurora, CO | D | $167,721 | paid | SINGLE PERSISTENT ISLET AUTOANTIBODY PHENOTYPE | 202240409349100404 |
| 2021 | University of Iowa Iowa City, IA | U | $167,554 | paid | RUPRI HEALTH PANEL SUPPORT | 202240409349100404 |
| 2021 | Helmholtz Zentrum Munchen (gmbh) Neuherberg | U | $166,791 | paid | FR1DA ORAL INSULIN INTERVENTION TRIAL AMENDMENT | 202240409349100404 |
| 2021 | Clalit Health Services Tel Aviv | U | $166,130 | paid | COVID-19 VACCINE RESPONSES IN PATIENTS WITH IBD | 202240409349100404 |
| 2021 | Clalit Health Services Tel Aviv | U | $165,855 | approved, future | COVID-19 VACCINE RESPONSES IN PATIENTS WITH IBD | 202240409349100404 |
| 2021 | The Weizmann Institute of Science Rehovot | D | $165,000 | approved, future | THE QUANTUM MATERIALS DEVICES FABRICATION LAB | 202240409349100404 |
| 2021 | Rutgers the State University of New Jersey Newark, NJ | U | $162,601 | paid | TARGETING LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN-1 FOR TREATMENT | 202240409349100404 |
| 2021 | Ida County Iowa Community Hospital Ida Grove, IA | B | $162,363 | paid | ECARE PHARMACY AT HORN MEMORIAL HOSPITAL | 202240409349100404 |
| 2021 | Jaeb Center for Health Research Foundation Inc Tampa, FL | C | $161,537 | paid | EVAL OF THE RELATIONSHIP OF GLUCOSE METRICS VIA CGM | 202240409349100404 |
| 2021 | Critical Path Institute Tucson, AZ | C | $160,500 | paid | T1D BIOMARKER CONSORTIUM - SUPPLEMENTATION | 202240409349100404 |
| 2021 | Jaeb Center for Health Research Foundation Inc Tampa, FL | C | $159,838 | approved, future | EXERCISE IN DIABETES INITIATIVE: LARGE ADULT STUDY | 202240409349100404 |
| 2021 | The Weizmann Institute of Science Rehovot | D | $159,809 | paid | THE WEIZMANN QUANTUM NANO-PHYSICS INITIATIVE | 202240409349100404 |
| 2021 | University of North Carolina at Chapel Hill Chapel Hill, NC | B | $157,946 | paid | SURVEILLANCE EPIDEMIOLOGY OF CORONAVIRUS UNDER RESEARCH FOR IBD | 202240409349100404 |
| 2021 | Crohn's & Colitis Foundation Inc New York, NY | B | $156,805 | paid | COVID-19 SUPPORT FOR THE IBD HELP CENTER | 202240409349100404 |
| 2021 | Mayo Clinic Rochester, MN | U | $156,527 | paid | OFF-SITE REMOTE ROBOTIC PERCUTANEOUS CORONARY INTERVENTIONS | 202240409349100404 |
| 2021 | The Regents of the University of Colorado Denver Aurora, CO | D | $155,711 | approved, future | CULTURALLY SENSITIVE GROUP CLINIC MODEL FOR LATINO PATIENTS W/ DIABETES | 202240409349100404 |
| 2021 | Rutgers the State University of New Jersey Newark, NJ | U | $155,671 | paid | TARGETING LYMPHOCYTE FUNCTION ANTIGEN-1 FOR TREATMENT OF CD | 202240409349100404 |
| 2021 | The Cleveland Clinic Foundation Cleveland, OH | C | $155,544 | approved, future | STENOSIS THERAPY AND ANTI-FIBROTIC RESEARCH CONSORTIUM | 202240409349100404 |
| 2021 | Americares Foundation Inc Stamford, CT | C | $155,338 | paid | EMERGENCY SUPPLIES FOR T1D CLINICS IN U.S. | 202240409349100404 |
| 2021 | Ben-Gurion University of the Negev Beer Sheva | D | $154,960 | paid | RANDOMIZED INTERVENTIONAL STUDY OF MINDFULNESS STRESS-REDUCTION | 202240409349100404 |
| 2021 | The Regents of the University of Colorado Denver Aurora, CO | D | $153,959 | paid | ASK - REMOTE SCREENING AND MONITORING | 202240409349100404 |
| 2021 | North Dakota Department of Health Bismarck, ND | U | $153,789 | approved, future | NORTH DAKOTA LAW ENFORCEMENT AED PROJECT | 202240409349100404 |
| 2021 | University of North Carolina at Chapel Hill Chapel Hill, NC | B | $153,617 | approved, future | MONITORING COVID-19 VACCINE EFFECTIVENESS IN IBD PATIENTS | 202240409349100404 |
| 2021 | Project Nyame Nsa Ltd Manhasset, NY | U | $152,810 | paid | SUPPORTING VULNERABLE CHILDREN IN EASTERN GHANA | 202240409349100404 |
| 2021 | University of North Carolina at Chapel Hill Chapel Hill, NC | B | $152,143 | paid | SURVEILLANCE EPIDEMIOLOGY OF COVID UNDER RESEARCH EXCLUSION IBD | 202240409349100404 |
| 2021 | University of Oxford Oxford | U | $152,072 | approved, future | STUDY OF COVID-19 ANTIBODY RESPONSE UNDER IMMUNE SUPPRESSION | 202240409349100404 |
| 2021 | Children's Hunger Fund Sylmar, CA | B | $151,800 | approved, future | FOOD SUPPORT IN ETHIOPIA AND ZAMBIA | 202240409349100404 |
| 2021 | Massachusetts General Hospital Boston, MA | C | $150,449 | paid | GENOMIC RESEARCH ON BIOLOGICS FOR INFLAMMATORY DISEASE AND COVID | 202240409349100404 |
| 2021 | Grantmakers in Health Washington, DC | B | $150,000 | approved, future | GRANTMAKERS IN HEALTH EFFECTIVE PHILANTHROPY FUND | 202240409349100404 |
| 2021 | Project Renewal Inc New York, NY | B | $150,000 | paid | COVID-19 EMERGENCY ASSISTANCE: HOMELESS HEALTHCARE IN NYC | 202240409349100404 |
| 2021 | Jdrf International New York, NY | U | $150,000 | approved, future | HELMSLEY AND JDRF CO-FUNDED WORKSHOPS | 202240409349100404 |
| 2021 | Jdrf International New York, NY | U | $150,000 | approved, future | HELMSLEY AND JDRF CO-FUNDED WORKSHOPS | 202240409349100404 |
| 2021 | West Side Center for Community Life Inc New York, NY | B | $150,000 | paid | COVID-19 PANDEMIC EMERGENCY ASSISTANCE: FOOD SECURITY IN NYC | 202240409349100404 |
| 2021 | National Academy of Sciences Washington, DC | C | $150,000 | approved, future | STRENGTHENING MINORITY SERVING INSTITUTIONS | 202240409349100404 |
| 2021 | Jdrf International New York, NY | U | $150,000 | paid | HELMSLEY AND JDRF CO-FUNDED WORKSHOPS | 202240409349100404 |
| 2021 | Care for the Homeless New York, NY | B | $150,000 | paid | COVID-19 GRANT ASSISTANCE: HOMELESS HEALTHCARE IN NYC | 202240409349100404 |
| 2021 | Center for Urban Community Services Inc New York, NY | U | $150,000 | paid | COVID-19 EMERGENCY ASSISTANCE: HOMELESS HEALTHCARE IN NYC | 202240409349100404 |
| 2021 | St John's Bread & Life Program Inc Brooklyn, NY | B | $150,000 | paid | COVID-19 PANDEMIC EMERGENCY ASSISTANCE: FOOD SECURITY IN NYC | 202240409349100404 |
| 2021 | New York Common Pantry New York, NY | B | $150,000 | paid | COVID-19 PANDEMIC EMERGENCY ASSISTANCE: FOOD SECURITY IN NYC | 202240409349100404 |
| 2021 | River Fund New York Inc Richmond Hill, NY | B | $150,000 | paid | COVID-19 PANDEMIC EMERGENCY ASSISTANCE: FOOD SECURITY IN NYC | 202240409349100404 |
| 2021 | Center for Excellence in Health Care Journalism Columbia, MO | C | $150,000 | approved, future | TRAINING AND DEVELOPMENT OF HEALTH CARE JOURNALISTS AND REPORTING | 202240409349100404 |
| 2021 | Bipartisan Policy Center Inc Washington, DC | B | $149,200 | approved, future | RURAL HEALTH CARE TASK FORCE | 202240409349100404 |
| 2021 | Jdrf International New York, NY | U | $149,008 | paid | DEVELOPMENT OF NOVEL INSULIN INFUSION SET | 202240409349100404 |
| 2021 | Integrated Biobank of Luxembourg (ibbl) Dudelange | U | $148,458 | approved, future | BIOBANKING FOR THE PRIMARY ORAL INSULIN TRIAL | 202240409349100404 |
| 2021 | Bridges to Prosperity Inc Denver, CA | U | $147,890 | paid | ETHIOPIA ASSESSMENT OF BRIDGE INFRASTRUCTURE | 202240409349100404 |
| 2021 | Bridges to Prosperity Inc Denver, CA | U | $147,890 | paid | ZAMBIA ASSESSMENT OF BRIDGE INFRASTRUCTURE | 202240409349100404 |
| 2021 | Columbia University New York, NY | B | $146,811 | approved, future | NOVEL SPATIALLY RESOLVED GENOMIC PROFILING OF CROHN'S DISEASE TISSUE | 202240409349100404 |
| 2021 | Columbia University New York, NY | B | $146,453 | paid | NOVEL SPATIALLY RESOLVED GENOMIC PROFILING OF CROHN'S TISSUE | 202240409349100404 |
| 2021 | Simulation in Motion Montana Inc Helena, MT | B | $145,636 | paid | CAPACITY BUILDING TOWARD A SUSTAINABLE SIMULATION IN MOTION MONTANA | 202240409349100404 |
| 2021 | Crohn's & Colitis Foundation Inc New York, NY | B | $143,195 | paid | COVID-19 SUPPORT FOR THE IBD HELP CENTER | 202240409349100404 |
| 2021 | Bridges to Prosperity Inc Denver, CO | D | $142,110 | approved, future | ETHIOPIA ASSESSMENT OF BRIDGE INFRASTRUCTURE | 202240409349100404 |
| 2021 | Bridges to Prosperity Inc Denver, CO | D | $142,110 | approved, future | ZAMBIA ASSESSMENT OF BRIDGE INFRASTRUCTURE | 202240409349100404 |
| 2021 | Shaare Zedek Medical Center Jerusalem | D | $137,000 | approved, future | POPULATION-BASED ANALYSES OF IBD USING ADMINISTRATIVE DATABASE | 202240409349100404 |
| 2021 | Yad Sarah Jerusalem | D | $136,850 | paid | MOBILE DENTAL CLINICS FOR ISRAEL'S PERIPHERY | 202240409349100404 |
| 2021 | St Alexius Medical Center Bismarck, ND | C | $135,487 | paid | ST ALEXIUS HEALTH COVID-19 CARDIAC PREPAREDNESS PROJECT | 202240409349100404 |
| 2021 | Children's Hunger Fund Sylmar, CA | B | $134,970 | paid | FOOD SUPPORT IN ETHIOPIA AND ZAMBIA | 202240409349100404 |
| 2021 | Crohn's Colitis Cure Sydney | U | $133,983 | paid | DEVELOPMENT OF A PEDIATRIC CD EMR TO DRIVE CONSISTENCY IN CARE | 202240409349100404 |
| 2021 | Rambam Health Corporation Haifa | D | $133,355 | paid | POINT OF CARE ASSAY FOR SERUM NEUTRALIZING ANTI-IFX ANTIBODIES | 202240409349100404 |
| 2021 | Center for Disaster Philanthropy Inc Washington, DC | C | $126,155 | paid | STATE OF DISASTER PHILANTHROPY REPORT 2020 | 202240409349100404 |
| 2021 | Rady Children's Hospital - San Diego San Diego, CA | B | $125,000 | paid | SUPPORTING INDIVIDUALS IN NEED WITH T1D IMPACTED BY COVID-19 | 202240409349100404 |
| 2021 | New York-Presbyterian Fund Inc New York, NY | C | $125,000 | paid | EMERGENCY SUPPORT FOR T1D POPULATIONS IMPACTED BY COVID-19 | 202240409349100404 |
| 2021 | Council On the Environment Inc New York, NY | B | $125,000 | paid | COVID-19 PANDEMIC EMERGENCY GRANT ASSISTANCE | 202240409349100404 |
| 2021 | Washington University St Louis, MO | C | $125,000 | paid | IMPROVING GLUCAGON ASSAYS FOR STUDIES TO PREVENT HYPOGLYCEMIA IN T1D | 202240409349100404 |
| 2021 | Children's Hospital of Philadelphia Philadelphia, PA | C | $125,000 | paid | SUPPORTING INDIVIDUALS IN NEED WITH T1D IMPACTED BY COVID-19 | 202240409349100404 |
| 2021 | Suny Health Science Center at Syracuse Syracuse, NY | U | $125,000 | paid | EMERGENCY SUPPORT FOR T1D POPULATIONS IMPACTED BY COVID-19 | 202240409349100404 |
| 2021 | Mayo Clinic Rochester, MN | U | $124,891 | approved, future | 2019-2021 MILITARY SCIENCES MEDICAL TRAINING/SUPPORT PROJECT | 202240409349100404 |
| 2021 | King's College London London | U | $124,739 | paid | UNDERSTANDING EXTREMELY EARLY-ONSET TYPE 1 DIABETES | 202240409349100404 |
| 2021 | Innovis Health LLC Fargo, ND | B | $123,352 | paid | ESSENTIA HEALTH FARGO COVID-19 CARDIAC PREPAREDNESS PROJECT | 202240409349100404 |
| 2021 | Sioux Valley Memorial Hospital Association Cherokee, IA | B | $121,396 | paid | ECARE EMERGENCY AT CHEROKEE REGIONAL MEDICAL CENTER | 202240409349100404 |
| 2021 | The Governors of the University of Calgary Calgary | D | $121,036 | approved, future | THE CHANGING EPIDEMIOLOGY OF CROHN'S IN THE WESTERN WORLD | 202240409349100404 |
| 2021 | The Sheba Fund for Health Services and Research (ra) Ramat Gan | U | $120,544 | paid | "MSR ON WHEELS" TO SERVE NORTHERN ISRAEL'S HEALTH CARE SYSTEM | 202240409349100404 |
| 2021 | Rambam Health Corporation Haifa | D | $120,355 | approved, future | POINT OF CARE ASSAY FOR SERUM NEUTRALIZING ANTI-IFX ANTIBODIES | 202240409349100404 |
| 2021 | Meeker Memorial Hospital Litchfield, MN | C | $120,176 | paid | EPHARMACY AT MEEKER MEMORIAL HOSPITAL | 202240409349100404 |
| 2021 | Wyoming Community Foundation Laramie, WY | B | $120,138 | paid | WYOMING COVID CARDIAC PREPAREDNESS PROJECT | 202240409349100404 |
| 2021 | Shenandoah Medical Center Shenandoah, IA | B | $119,381 | paid | SHENANDOAH MEDICAL CENTER EEMERGENCY IMPLEMENTATION PROJECT | 202240409349100404 |
| 2021 | The Regents of the University of Colorado Denver Aurora, CO | D | $119,036 | approved, future | DEVELOPMENT OF A CONTINUOUS INSULIN-GLUCOSE SENSOR | 202240409349100404 |
| 2021 | Community Memorial Hospital District Syracuse, NE | U | $117,772 | paid | ECARE EMERGENCY AT SYRACUSE AREA HEALTH | 202240409349100404 |
| 2021 | Council On the Environment Inc New York, NY | B | $116,600 | approved, future | INTER-GENERATIONAL, VIABLE GREENSPACE IN NYCHA COMMUNITIES | 202240409349100404 |
| 2021 | The University of Edinburgh Edinburgh | U | $116,077 | approved, future | DISCERN ALPHA CELL DYSFUNCTION AND CORRECTING GLUCAGON IN T1D | 202240409349100404 |
| 2021 | King's College London London | U | $115,097 | approved, future | T CELL RECEPTOR SEQUENCING IN T1D - BIOMARKER & TECHNOLOGY | 202240409349100404 |
| 2021 | Clalit Health Services Tel Aviv | U | $112,000 | approved, future | EARLY CROHN'S: UNDERSTANDING PATHOGENESIS, BEHAVIOR, RESPONSE | 202240409349100404 |
| 2021 | Columbia University New York, NY | B | $110,040 | approved, future | POVERTY SURVEY: HEALTHCARE NEEDS & USE OF LOW-INCOME NEW YORKERS | 202240409349100404 |
| 2021 | University of Oxford Oxford | U | $110,000 | paid | INNATE AND ADAPTIVE THERAPEUTIC TARGETS OF VEO-IBD - OXFORD STUDIES | 202240409349100404 |
| 2021 | Icahn School of Medicine at Mount Sinai New York City, NY | B | $110,000 | paid | INTEGRATIVE NETWORK APPROACHES FOR VEO-IBD GENE IDENTIFICATION | 202240409349100404 |
| 2021 | University of Oxford Oxford | U | $110,000 | paid | INNATE AND ADAPTIVE THERAPEUTIC TARGETS OF VEO IBD | 202240409349100404 |
| 2021 | Icahn School of Medicine at Mount Sinai New York City, NY | B | $110,000 | paid | INTEGRATIVE NETWORK APPROACHES FOR VEO-IBD TARGET GENE IDENTIFICATION | 202240409349100404 |
| 2021 | The Regents of the University of California San Francisco San Francisco, CA | U | $108,185 | approved, future | VALIDATING A CLASS OF DRUGS THAT MAY PROTECT BETA CELLS IN T1D | 202240409349100404 |
| 2021 | The Weizmann Institute of Science Rehovot | D | $107,892 | paid | DECIPHERING FACTORS DRIVING INCREASED INCIDENCE OF CROHN'S IN CHINA | 202240409349100404 |
| 2021 | Center for Health Care Strategies Trenton, NJ | B | $106,961 | paid | IMPROVING ACCESS TO CGMS FOR MEDICAID BENEFICIARIES | 202240409349100404 |
| 2021 | Columbia University New York, NY | B | $106,706 | paid | THE ROLE OF GAMMA-DELTA T CELLS IN HUMAN EARLY LIFE IMMUNITY | 202240409349100404 |
| 2021 | Mayo Clinic Rochester, MN | U | $103,827 | approved, future | STENOSIS THERAPY AND ANTI-FIBROTIC RESEARCH CONSORTIUM | 202240409349100404 |
| 2021 | University of Birmingham Birmingham | U | $102,647 | approved, future | ANTIGEN SPECIFIC IMMUNOTHERAPY IN TYPE 1 DIABETES | 202240409349100404 |
| 2021 | The Broad Institute Inc Cambridge, MA | B | $100,868 | paid | HUMAN COLON AND SMALL INTESTINE CELL ATLAS IN HEALTH AND CROHN'S | 202240409349100404 |
| 2021 | Children's Hospital Los Angeles Los Angeles, CA | U | $100,000 | paid | SUPPORTING INDIVIDUALS IN NEED WITH T1D IMPACTED BY COVID-19 | 202240409349100404 |
| 2021 | Middle East Media and Research Institute Inc Washington, DC | B | $100,000 | paid | IRAN STUDIES PROJECT | 202240409349100404 |
| 2021 | University at Buffalo Pediatric Associates P C Buffalo, NY | D | $100,000 | paid | EMERGENCY SUPPORT FOR T1D POPULATIONS IMPACTED BY COVID-19 | 202240409349100404 |
| 2021 | The University of Edinburgh Edinburgh | U | $100,000 | approved, future | HUMAN GUT CELL ATLAS - NORMAL INTESTINE AND CROHN'S DISEASE | 202240409349100404 |
| 2021 | Regents of the University of Michigan Ann Arbor, MI | C | $100,000 | paid | SUPPORTING INDIVIDUALS IN NEED WITH T1D IMPACTED BY COVID-19 | 202240409349100404 |
| 2021 | Fuente Latina Inc Miami, FL | C | $100,000 | paid | HISPANIC ISRAEL MEDIA PANDEMIC PROGRAMMING (HIMP) | 202240409349100404 |
| 2021 | University of Washington Seattle, WA | B | $100,000 | paid | SUPPORTING INDIVIDUALS IN NEED WITH T1D IMPACTED BY COVID-19 | 202240409349100404 |
| 2021 | Children's Hospital Corporation Boston, MA | C | $100,000 | paid | SUPPORTING INDIVIDUALS IN NEED WITH T1D IMPACTED BY COVID-19 | 202240409349100404 |
| 2021 | Joslin Diabetes Center Inc Boston, MA | B | $100,000 | paid | SUPPORTING INDIVIDUALS IN NEED WITH T1D IMPACTED BY COVID-19 | 202240409349100404 |
| 2021 | University Physician Group Detroit, MI | B | $100,000 | paid | SUPPORTING INDIVIDUALS IN NEED WITH T1D IMPACTED BY COVID-19 | 202240409349100404 |
| 2021 | Foundation for Morristown Medical Center Inc Morristown, NJ | B | $100,000 | paid | SUPPORTING INDIVIDUALS IN NEED WITH T1D IMPACTED BY COVID-19 | 202240409349100404 |
| 2021 | Crohn's Colitis Cure Sydney | U | $99,842 | approved, future | DEVELOPMENT A PEDIATRIC CD EMR TO DRIVE CONSISTENCY IN CARE | 202240409349100404 |
| 2021 | Sisters of Charity of Leavenworth Health System Inc Broomfield, MT | U | $99,082 | paid | SCL HEALTH COVID-19 CARDIAC PREPAREDNESS PROJECT | 202240409349100404 |
| 2021 | Cheyenne Regional Medical Center Foundation Cheyenne, WY | B | $99,082 | paid | COVID-19 CARDIAC PREPAREDNESS PROJECT | 202240409349100404 |
| 2021 | Chase County Community Hospital Imperial, NE | U | $96,332 | paid | EEMERGENCY AT CHASE COUNTY COMMUNITY HOSPITAL | 202240409349100404 |
| 2021 | Katholieke Universiteit Leuven Leuven | U | $95,814 | paid | PREDICTIVE SEROLOGICAL BIOMARKER SIGNATURES FOR RESPONSE ANTI-TNFS | 202240409349100404 |
| 2021 | West Park Hospital District Cody, WY | U | $95,674 | paid | CODY CARDIOLOGY CENTER CATHETERIZATION LABORATORY PROJECT | 202240409349100404 |
| 2021 | King's College London London | U | $92,994 | paid | TARGETING BETA CELLS BY GENERATING HIGH AFFINITY T CELL RECEPTORS | 202240409349100404 |
| 2021 | University of North Carolina at Chapel Hill Chapel Hill, NC | B | $91,810 | paid | ANTI-TNF COMBINATION CLINICAL TRIAL IN PEDIATRIC CROHN'S DISEASE | 202240409349100404 |
| 2021 | The Regents of the University of Colorado Denver Aurora, CO | D | $90,839 | paid | CONTINUOUS GLUCOSE : WHAT FAMILY DOCS AND EDUCATORS NEED TO KNOW | 202240409349100404 |
| 2021 | Crohn's Colitis Cure Sydney | U | $90,467 | approved, future | DEVELOPMENT OF A PEDIATRIC CD EMR TO DRIVE CONSISTENCY IN CARE | 202240409349100404 |
| 2021 | Stanford University Stanford, CA | C | $90,459 | paid | TARGETING CAR-EXPRESSING REGULATORY T CELLS TO PANCREATIC ISLETS | 202240409349100404 |
| 2021 | Integrated Biobank of Luxembourg (ibbl) Dudelange | U | $90,190 | approved, future | BIOBANKING FOR THE PRIMARY ORAL INSULIN TRIAL | 202240409349100404 |
| 2021 | Insulin for Life USA Inc Gainesville, FL | B | $90,088 | paid | DIABETES DEVICES FOR HOSPITALS IN THE U.S. DURING THE COVID-19 | 202240409349100404 |
| 2021 | Medizinische Hochschule Hannover Hannover | U | $89,605 | paid | CREATING T1D-SPECIFIC ANTIGEN RECEPTORS FOR REGULATORY T-CELLS | 202240409349100404 |
| 2021 | Trinity Hospitals Minot, ND | C | $86,947 | paid | TRINITY HOSPITALS COVID-19 CARDIAC PREPAREDNESS PROJECT | 202240409349100404 |
| 2021 | President and Fellows of Harvard College Boston, MA | C | $86,804 | paid | MICRONEEDLE-BASED SENSOR TO ENHANCE AUTOMATED INSULIN DELIVERY | 202240409349100404 |
| 2021 | Children's Hospital Los Angeles Los Angeles, CA | U | $85,199 | paid | TEAM CLINIC: EXPANSION OF A CARE MODEL FOR ADOLESCENTS WITH T1D | 202240409349100404 |
| 2021 | 4youandme Seattle, WA | U | $84,107 | approved, future | WEARABLES TO MEASURE STRESS AND FORECAST CROHN'S SYMPTOMS | 202240409349100404 |
| 2021 | Boston Medical Center Corporation Boston, MA | B | $82,998 | approved, future | STAGING CROHN'S DISEASE USING MUCOSAL EXOSOMES | 202240409349100404 |
| 2021 | Univesitair Medisch Centrum Utrecht Utrecht | U | $82,500 | paid | EPITHELIAL BASED DIAGNOSTICS FOR VEO-IBD | 202240409349100404 |
| 2021 | Univesitair Medisch Centrum Utrecht Utrecht | U | $82,500 | paid | EPITHELIAL BASED DIAGNOSTICS FOR VEO-IBD | 202240409349100404 |
| 2021 | Integrated Biobank of Luxembourg (ibbl) Dudelange | U | $82,380 | approved, future | BIOBANKING FOR THE PRIMARY ORAL INSULIN TRIAL | 202240409349100404 |
| 2021 | University of Melbourne Carlton | D | $82,000 | paid | DEVELOPMENT AND EVALUATION OF A CONTINUOUS KETONE SENSOR | 202240409349100404 |
| 2021 | The Regents of the University of Colorado Denver Aurora, CO | D | $81,726 | paid | CONTINUOUS GLUCOSE : WHAT FAMILY DOCS AND EDUCATORS NEED TO KNOW | 202240409349100404 |
| 2021 | Columbia University New York, NY | B | $81,367 | approved, future | POVERTY TRACKER: HEALTHCARE NEEDS & USE OF LOW-INCOME NEW YORKERS | 202240409349100404 |
| 2021 | Rambam Health Corporation Haifa | D | $78,850 | approved, future | POINT OF CARE ASSAY FOR SERUM NEUTRALIZING ANTI-IFX ANTIBODIES | 202240409349100404 |
| 2021 | Vivli Inc Cambridge, MA | C | $78,000 | paid | VIVLI GLOBAL PLATFORM FOR OPEN REPRODUCIBLE CLINICAL RESEARCH | 202240409349100404 |
| 2021 | 4youandme Seattle, WA | U | $77,000 | paid | WEARABLES TO MEASURE STRESS AND FORECAST CROHN'S SYMPTOMS | 202240409349100404 |
| 2021 | Crohn's and Colitis Uk Hatfield | U | $75,900 | approved, future | 2021 & 2022 OPERATING SUPPORT FOR CROHN'S AND COLITIS UK | 202240409349100404 |
| 2021 | Crohn's and Colitis Uk Hatfield | U | $75,900 | approved, future | 2021 & 2022 OPERATING SUPPORT FOR CROHN'S AND COLITIS UK | 202240409349100404 |
| 2021 | Crohn's and Colitis Uk Hatfield | U | $75,900 | approved, future | 2021 & 2022 OPERATING SUPPORT FOR CROHN'S AND COLITIS UK | 202240409349100404 |
| 2021 | Crohn's and Colitis Uk Hatfield | U | $75,900 | approved, future | 2021 & 2022 OPERATING SUPPORT FOR CROHN'S AND COLITIS UK | 202240409349100404 |
| 2021 | University of South Florida Tampa, FL | U | $75,000 | paid | SUPPORTING INDIVIDUALS IN NEED WITH T1D IMPACTED BY COVID-19 | 202240409349100404 |
| 2021 | Northwestern University Chicago, IL | C | $75,000 | paid | SUPPORTING INDIVIDUALS IN NEED WITH T1D IMPACTED BY COVID-19 | 202240409349100404 |
| 2021 | The Regents of the University of California San Diego La Jolla, CA | C | $75,000 | paid | SUPPORTING INDIVIDUALS IN NEED WITH T1D IMPACTED BY COVID-19 | 202240409349100404 |
| 2021 | Children's Hospital of Orange County Orange, CA | B | $75,000 | paid | SUPPORTING INDIVIDUALS IN NEED WITH T1D IMPACTED BY COVID-19 | 202240409349100404 |
| 2021 | The Regents of the University of California San Francisco San Francisco, CA | U | $75,000 | paid | SUPPORTING INDIVIDUALS IN NEED WITH T1D IMPACTED BY COVID-19 | 202240409349100404 |
| 2021 | Sioux Council Boy Scouts of America Sioux Falls, SD | U | $75,000 | approved, future | WETLAND\NATURE STUDY AREA DEVELOPMENT | 202240409349100404 |
| 2021 | Henry Ford Health System Detroit, MI | B | $75,000 | paid | EMERGENCY SUPPORT FOR T1D POPULATIONS IMPACTED BY COVID-19 | 202240409349100404 |
| 2021 | American Diabetes Association Inc Arlington, VA | B | $75,000 | approved, future | PATRON SUPPORT OF THE ASSOCIATION'S 79TH, 80TH, AND 81ST SESSIONS | 202240409349100404 |
| 2021 | American Diabetes Association Inc Arlington, VA | B | $75,000 | paid | PATRON SUPPORT OF THE ASSOCIATION'S 79TH, 80TH, AND 81ST SESSIONS | 202240409349100404 |
| 2021 | University of Southern California Los Angeles, CA | C | $75,000 | paid | EMERGENCY SUPPORT FOR T1D POPULATIONS IMPACTED BY COVID-19 | 202240409349100404 |
| 2021 | Baylor College of Medicine Houston, TX | B | $75,000 | paid | SUPPORTING INDIVIDUALS IN NEED WITH T1D IMPACTED BY COVID-19 | 202240409349100404 |
| 2021 | Carbon County Memorial Hospital Foundation Rawlins, SD | U | $74,812 | paid | COVID-19 CARDIAC PREPAREDNESS PROJECT | 202240409349100404 |
| 2021 | De la Salle Solidariet Internazionale Onlus Rome | U | $74,334 | paid | ESTABLISHING A ROBUST MEDICAL EDUCATION CENTER - ETHIOPIA | 202240409349100404 |
| 2021 | Delaware County Memorial Hospital Manchester, IA | B | $72,983 | paid | EEMERGENCY AND EPHARMACY | 202240409349100404 |
| 2021 | Uppsala Universitet Uppsala | U | $72,756 | paid | ALPHA-CELL SIGNALING FOR GLUCAGON SECRETION | 202240409349100404 |
| 2021 | Burgess Health Center Onawa, IA | B | $71,508 | paid | EEMERGENCY AND EPHARMACY AT BURGESS HEALTH CENTER | 202240409349100404 |
| 2021 | Clalit Health Services Tel Aviv | U | $71,050 | paid | ISRAELI IBD RESEARCH NUCLEUS (IIRN): CONSORTIUM MANAGEMENT | 202240409349100404 |
| 2021 | Massachusetts General Hospital Boston, MA | C | $70,916 | paid | DEVELOPMENT OF FAST ON/OFF INSULIN RECEPTOR ACTIVATORS | 202240409349100404 |
| 2021 | Social Science Research Council Brooklyn, NY | B | $70,000 | paid | DATA2GO.NYC: HEALTH | 202240409349100404 |
| 2021 | Crohn's Colitis Cure Sydney | U | $68,358 | approved, future | DEVELOPMENT OF A PEDIATRIC CD EMR TO DRIVE CONSISTENCY IN CARE | 202240409349100404 |
| 2021 | Guttenberg Municipal Hospital Guttenberg, IA | U | $67,301 | paid | EEMERGENCY AND EPHARMACY AT GUTTENBERG MUNICIPAL HOSPITAL | 202240409349100404 |
| 2021 | Sage Bionetworks Seattle, WA | B | $66,720 | paid | EXTENDING VEOIBD CONSORTIUM THROUGH RESOURCE SHARING | 202240409349100404 |
| 2021 | Sage Bionetworks Seattle, WA | B | $66,720 | paid | EXTENDING IMPACT OF VEOIBD CONSORTIUM THROUGH RESOURCE SHARING | 202240409349100404 |
| 2021 | Crohn's Colitis Cure Sydney | U | $66,267 | approved, future | DEVELOPMENT OF A PEDIATRIC CD EMR TO DRIVE CONSISTENCY IN CARE | 202240409349100404 |
| 2021 | Crohn's and Colitis Canada Toronto | U | $65,990 | paid | SUPPORT FOR CROHN'S & COLITIS CANADA 2020- 21 PATIENT PROGRAMS | 202240409349100404 |
| 2021 | Crohn's and Colitis Canada Toronto | U | $65,990 | paid | SUPPORT FOR CROHN'S & COLITIS CANADA 2020- 21 PATIENT PROGRAMS | 202240409349100404 |
| 2021 | Crohn's and Colitis Canada Toronto | U | $65,990 | approved, future | SUPPORT FOR CROHN'S & COLITIS CANADA 2020- 21 PATIENT PROGRAMS | 202240409349100404 |
| 2021 | Lakes Regional Healthcare Spirit Lake, IA | B | $65,880 | paid | ECARE PHARMACY AT LAKES REGIONAL HEALTHCARE | 202240409349100404 |
| 2021 | University College London London | U | $63,267 | paid | SPIT-C: USING SALIVA TO PREDICT CROHN'S DISEASE | 202240409349100404 |
| 2021 | St Peter's Community Hospital Helena, MT | U | $62,676 | paid | ST. PETER'S HEALTH COVID-19 CARDIAC PREPAREDNESS PROJECT | 202240409349100404 |
| 2021 | Bozeman Deaconess Foundation Bozeman, MT | B | $62,676 | paid | BOZEMAN HEALTH COVID-19 CARDIAC PREPAREDNESS PROJECT | 202240409349100404 |
| 2021 | Big Horn Hospital Association Hardin, MT | B | $62,366 | paid | EEMERGENCY AND EPHARMACY | 202240409349100404 |
| 2021 | The Israel Crohn's Disease and Ulcerative Colitis Foundation Tel Aviv | U | $59,407 | approved, future | 2020 OPERATING SUPPORT FOR CCFI'S EMERGENCY TRANSPORTATION PROGRAM | 202240409349100404 |
| 2021 | Iowa Department of Public Health Des Moines, IA | U | $58,968 | approved, future | IOWA FIRST RESPONDER AED INITIATIVE | 202240409349100404 |
| 2021 | The Israel Crohn's Disease and Ulcerative Colitis Foundation Tel Aviv | U | $57,428 | approved, future | 2020 OPERATING SUPPORT FOR CCFI'S EMERGENCY TRANSPORTATION PROGRAM | 202240409349100404 |
| 2021 | Cedars-Sinai Medical Center Los Angeles, CA | B | $55,631 | paid | GENE DISCOVERY TO CLINICAL UTILITY AND RELEVANCE TO ADULT IBD | 202240409349100404 |
| 2021 | Crohn's & Colitis Foundation Inc New York, NY | B | $55,597 | paid | USE OF FMT FOR POST SURGICAL RECURRENCE | 202240409349100404 |
| 2021 | Engineering Ministries International USA Colorado Springs, CO | C | $55,000 | paid | EMI GLOBAL LEADERSHIP INITIATIVE | 202240409349100404 |
| 2021 | Cedars-Sinai Medical Center Los Angeles, CA | B | $54,368 | paid | GENE DISCOVERY TO CLINICAL UTILITY AND RELEVANCE TO ADULT IBD | 202240409349100404 |
| 2021 | Boston Medical Center Corporation Boston, MA | B | $51,814 | approved, future | STAGING CROHN'S DISEASE USING MUCOSAL EXOSOMES | 202240409349100404 |
| 2021 | Amc Medical Research Bv Amsterdam | U | $50,570 | approved, future | IDENTIFICATION OF BIOMARKERS FOR PERIANAL FISTULIZING DISEASE | 202240409349100404 |
| 2021 | Amc Medical Research Bv Amsterdam | U | $50,570 | approved, future | IDENTIFICATION OF BIOMARKERS FOR PERIANAL FISTULIZING DISEASE | 202240409349100404 |
| 2021 | Daly Hospital Foundation Inc Hamilton, MT | B | $50,541 | paid | MARCUS DALY MEMORIAL HOSPITAL COVID-19 CARDIAC PREPAREDNESS PROJECT | 202240409349100404 |
| 2021 | Memorial Hospital of Sweetwater County Foundation Rock Springs, WY | C | $50,541 | paid | COVID-19 CARDIAC PREPAREDNESS PROJECT | 202240409349100404 |
| 2021 | St John's Hospital Foundation Jackson, WY | D | $50,541 | paid | COVID-19 CARDIAC PREPAREDNESS PROJECT | 202240409349100404 |
| 2021 | St Patrick Hospital Foundation Missoula, MT | B | $50,541 | paid | PROVIDENCE HEALTH COVID-19 CARDIAC PREPAREDNESS PROJECT | 202240409349100404 |
| 2021 | Oregon Health & Science University Portland, OR | U | $50,515 | paid | DESIGN AND EVALUATION OF A MDI DECISION SUPPORT SYSTEM | 202240409349100404 |
| 2021 | University of Florida Gainesville, FL | U | $50,085 | paid | T CELL RECEPTOR SEQUENCING IN T1D - BIOMARKER & TECHNOLOGY | 202240409349100404 |
| 2021 | The Regents of the University of Colorado Denver Aurora, CO | D | $50,000 | paid | SUPPORTING INDIVIDUALS IN NEED WITH T1D IMPACTED BY COVID-19 | 202240409349100404 |
| 2021 | The Mount Sinai Medical Center New York, NY | B | $50,000 | paid | EMERGENCY SUPPORT FOR T1D POPULATIONS IMPACTED BY COVID-19 | 202240409349100404 |
| 2021 | University of Virginia Law School Foundation Charlottesville, VA | B | $50,000 | paid | GENERAL OPERATING SUPPORT | 202240409349100404 |
| 2021 | Trustees of Indiana University Bloomington, MI | U | $50,000 | paid | EMERGENCY SUPPORT FOR T1D POPULATIONS IMPACTED BY COVID-19 | 202240409349100404 |
| 2021 | Diabetes Education and Camping Association Florence, AL | U | $50,000 | paid | DECA 2021 INTERNATIONAL DIABETES CAMPING CONFERENCE | 202240409349100404 |
| 2021 | Scripps Health San Diego, CA | B | $50,000 | paid | SUPPORTING INDIVIDUALS IN NEED WITH T1D IMPACTED BY COVID-19 | 202240409349100404 |
| 2021 | Joslin Diabetes Center Inc Boston, MA | B | $50,000 | paid | EMERGENCY SUPPORT FOR T1D POPULATIONS IMPACTED BY COVID-19 | 202240409349100404 |
| 2021 | The University of Chicago Chicago, IL | U | $50,000 | paid | SUPPORTING INDIVIDUALS IN NEED WITH T1D IMPACTED BY COVID-19 | 202240409349100404 |
| 2021 | University of Massachusetts Medical School Worcester, MA | U | $50,000 | paid | SUPPORTING INDIVIDUALS IN NEED WITH T1D IMPACTED BY COVID-19 | 202240409349100404 |
| 2021 | Tallahassee Memorial Healthcare Inc Tallahassee, FL | C | $50,000 | paid | SUPPORTING INDIVIDUALS IN NEED WITH T1D IMPACTED BY COVID-19 | 202240409349100404 |
| 2021 | The Regents of the University of Colorado Denver Aurora, CO | D | $50,000 | paid | SUPPORTING INDIVIDUALS IN NEED WITH T1D IMPACTED BY COVID-19 | 202240409349100404 |
| 2021 | Beit Uri Afula | U | $50,000 | paid | COVID-19 EMERGENCY FUND | 202240409349100404 |
| 2021 | Yale University New Haven, CT | U | $50,000 | paid | EMERGENCY SUPPORT FOR T1D POPULATIONS IMPACTED BY COVID-19 | 202240409349100404 |
| 2021 | Nemours Children's Clinic Inc Jacksonville, FL | U | $50,000 | paid | SUPPORTING INDIVIDUALS IN NEED WITH T1D IMPACTED BY COVID-19 | 202240409349100404 |
| 2021 | Avera Mckennan for the Avera Merrill Pioneer Hospital Rock Rapids, IA | U | $49,893 | paid | EEMERGENCY AND EPHARMACY AT AVERA MERRILL PIONEER HOSPITAL | 202240409349100404 |
| 2021 | Oregon Health & Science University Portland, OR | U | $49,863 | paid | THE IMPLEMENTATION OF NICH IN ANOTHER HEALTHCARE SYSTEM | 202240409349100404 |
| 2021 | Children's Hospital Medical Center Cincinnati, OH | B | $49,713 | paid | BIOMARKERS OF INTESTINAL FIBROSIS IN SMALL BOWEL CROHN'S | 202240409349100404 |
| 2021 | Integrated Biobank of Luxembourg (ibbl) Dudelange | U | $48,128 | paid | BIOBANKING FOR THE PRIMARY ORAL INSULIN TRIAL | 202240409349100404 |
| 2021 | Stanford University Stanford, CA | C | $48,051 | paid | OPTIMIZING UPTAKE & SUSTAINED USE OF DIABETES DEVICES WITH T1D | 202240409349100404 |
| 2021 | Van Buren County Hospital Keosauqua, IA | B | $44,413 | paid | EEMERGENCY AT VAN BUREN COUNTY HOSPITAL | 202240409349100404 |
| 2021 | Meeker Memorial Hospital Litchfield, MN | C | $43,633 | paid | EEMERGENCY AT MEEKER MEMORIAL HOSPITAL | 202240409349100404 |
| 2021 | Fall River Health Services Hot Springs, SD | B | $43,309 | paid | EEMERGENCY AT FALL RIVER HEALTH SERVICES | 202240409349100404 |
| 2021 | American Camping Association Inc Martinsville, IN | B | $43,275 | paid | ACA PROFESSIONAL DEVELOPMENT 2019-2021 | 202240409349100404 |
| 2021 | Ncd Alliance Geneva | U | $42,500 | paid | GENERAL OPERATING SUPPORT | 202240409349100404 |
| 2021 | Ncd Alliance Geneva | U | $42,500 | approved, future | GENERAL OPERATING SUPPORT | 202240409349100404 |
| 2021 | University of North Carolina at Chapel Hill Chapel Hill, NC | B | $42,022 | approved, future | ANTI-TNF COMBINATION CLINICAL TRIAL IN PEDIATRIC CROHN'S DISEASE | 202240409349100404 |
| 2021 | The Center for Effective Philanthropy Inc Cambridge, MA | B | $41,500 | paid | GENERAL OPERATING SUPPORT | 202240409349100404 |
| 2021 | Providence Medical Center Wayne, NE | B | $41,340 | paid | EEMERGENCY AT PROVIDENCE MEDICAL CENTER | 202240409349100404 |
| 2021 | Clarinda Regional Health Center Clarinda, IA | U | $40,614 | paid | EEMERGENCY AT CLARINDA REGIONAL HEALTH CENTER | 202240409349100404 |
| 2021 | United Ostomy Associations of America Kennebunk, ME | C | $40,350 | approved, future | DEVELOPMENT OF CROHN'S DISEASE CONTENT AND AWARENESS | 202240409349100404 |
| 2021 | Endocrine Society Washington, DC | B | $40,000 | paid | ENDO SCIENTIFIC SESSIONS AND SCIENTIFIC ABSTRACT AWARDS | 202240409349100404 |
| 2021 | Research Institute at Nationwide Childrens Hospital Columbus, OH | U | $40,000 | paid | SUPPORTING INDIVIDUALS IN NEED WITH T1D IMPACTED BY COVID-19 | 202240409349100404 |
| 2021 | University Hospitals Health System Inc Cleveland, OH | U | $40,000 | paid | SUPPORTING INDIVIDUALS IN NEED WITH T1D IMPACTED BY COVID-19 | 202240409349100404 |
| 2021 | Trustees of the University of Pennsylvania Philadelphia, PA | B | $40,000 | paid | SUPPORTING INDIVIDUALS IN NEED WITH T1D IMPACTED BY COVID-19 | 202240409349100404 |
| 2021 | Children's Hospital Medical Center Cincinnati, OH | B | $40,000 | paid | SUPPORTING INDIVIDUALS IN NEED WITH T1D IMPACTED BY COVID-19 | 202240409349100404 |
| 2021 | Rector & Visitors of the University of Virginia Charlottesville, VA | C | $40,000 | paid | SUPPORTING INDIVIDUALS IN NEED WITH T1D IMPACTED BY COVID-19 | 202240409349100404 |
| 2021 | Philanthropy New York Inc New York, NY | B | $39,250 | paid | GENERAL OPERATING SUPPORT | 202240409349100404 |
| 2021 | Mercy Medical Center New Hampton New Hampton, IA | B | $39,103 | paid | EEMERGENCY AT MERCYONE NEW HAMPTON MEDICAL CENTER | 202240409349100404 |
| 2021 | Shenandoah Medical Center Shenandoah, IA | B | $38,299 | approved, future | EEMERGENCY IMPLEMENTATION PROJECT | 202240409349100404 |
| 2021 | Gordon Memorial Hospital District Gordon, NE | C | $38,111 | paid | EEMERGENCY AT GORDON MEMORIAL HOSPITAL | 202240409349100404 |
| 2021 | Floyd Valley Hospital Le Mars, IA | C | $37,092 | paid | EEMERGENCY AT FLOYD VALLEY HEALTHCARE | 202240409349100404 |
| 2021 | Foundation for the Defense of Democracies Inc Washington, DC | B | $35,747 | paid | NATIONAL SECURITY FELLOWS VIRTUAL ISRAEL TRIP TO ISRAEL | 202240409349100404 |
| 2021 | Brigham and Women's Hospital Boston, MA | C | $35,000 | paid | GENERAL OPERATING SUPPORT | 202240409349100404 |
| 2021 | Jaeb Center for Health Research Foundation Inc Tampa, FL | C | $34,905 | paid | VIRTUAL DIABETES CLINIC STUDY EVALUATING REMOTE INITIATION CGM | 202240409349100404 |
| 2021 | Sioux Valley Memorial Hospital Association Cherokee, IA | B | $34,691 | approved, future | ECARE EMERGENCY AT CHEROKEE REGIONAL MEDICAL CENTER | 202240409349100404 |
| 2021 | Beartooth Billings Clinic Red Lodge, MT | U | $33,956 | paid | EEMERGENCY AT BEARTOOTH BILLINGS CLINIC | 202240409349100404 |
| 2021 | Burgess Health Center Onawa, IA | B | $33,587 | approved, future | EEMERGENCY AND EPHARMACY AT BURGESS HEALTH CENTER | 202240409349100404 |
| 2021 | Council On Foundations Inc Washington, DC | B | $33,500 | paid | GENERAL OPERATING SUPPORT | 202240409349100404 |
| 2021 | The Sheba Fund for Health Services and Research (ra) Ramat Gan | U | $33,400 | paid | INTESTINAL RESPONSE TO MICROBIAL SIGNALS IN CROHN'S | 202240409349100404 |
| 2021 | Community Memorial Hospital District Syracuse, NE | U | $33,296 | approved, future | ECARE EMERGENCY AT SYRACUSE AREA HEALTH | 202240409349100404 |
| 2021 | World Affairs Council of Northern California San Francisco, CA | U | $33,000 | paid | GENERAL OPERATING SUPPORT | 202240409349100404 |
| 2021 | Townsend Health Systems Inc Townsend, MT | U | $32,329 | paid | EEMERGENCY AT BROADWATER HEALTH CENTER | 202240409349100404 |
| 2021 | Clalit Health Services Tel Aviv | U | $32,000 | approved, future | ISRAELI IBD RESEARCH NUCLEUS (IIRN): CONSORTIUM MANAGEMENT | 202240409349100404 |
| 2021 | New York University New York, NY | C | $30,912 | paid | EVALUATION OF PILOT ENDOCRINOLOGY TELEECHO CLINIC IN NEW MEXICO | 202240409349100404 |
Match tier: A Reported EIN · B Exact name and place · C Strong name match · D Probable name match · U Unresolved. Tiers C and D are inferred, not reported; see how matching works.
Recipient matching for this dataset version has not yet completed its independent precision check. Tier A rows carry the EIN the filer reported; tiers B–D are the matcher's inference and should be read as leads until the check is published on the methodology page.
Derived from IRS Form 990-PF e-file XML. Dataset version 2026.09.0, built 2026-09-03. All years for this funder.
The same organization elsewhere in the program: exempt status and filing health · federal awards · grant guidance · open opportunities.
This is informational only, derived from public data on the dates shown. It is not an eligibility determination, and not legal, tax, or accounting advice. Verify against the official source before relying on it.